The functional genetics of respiratory syncytial virus induced bronchiolitis : an investigation into the transcriptional regulation of <i>IL8</i> and <i>LTA</i> by Hacking, Doug
Open Research Online
The Open University’s repository of research publications
and other research outputs
The functional genetics of respiratory syncytial virus
induced bronchiolitis : an investigation into the
transcriptional regulation of IL8 and LTA
Thesis
How to cite:
Hacking, Doug (2004). The functional genetics of respiratory syncytial virus induced bronchiolitis : an investigation
into the transcriptional regulation of IL8 and LTA. PhD thesis. The Open University.
For guidance on citations see FAQs.
c© 2004 Doug Hacking
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
Name:
TITLE PAGE
D t D oug Hacking
Degrees: BMSc. Biochemistry (First Class Honours) 
Dundee University 
BM BCh
Oxford University
Thesis Title: The functional genetics o f respiratory syncytial virus 
induced bronchiolitis: An investigation into the 
transcriptional regulation o f IL8  and LX A
Degree for which thesis submitted: PhD
Sponsoring Establishment: Weatherall Institute o f Molecular Medicine, 
John Radcliffe Hospital, Oxford
Collaborating Establishment: Wellcome Trust Centre for Human Genetics, 
University o f Oxford, Oxford 
Department o f Paediatrics,
University o f Oxford,
John Radcliffe Hospital, Oxford
ProQuest Number: C819645
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest C819645
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
INDEX
Chapter Chapter Title Page Number
Abstract 1-2
Chapter 1 Introduction 3-31
Chapter 2 Materials and Methods 32-55
Chapter 3 Establishing an w model of RSV infection 56-69
Chapter 4 In vivo haplotype-spedfic expression of IL8 in primary cells 70-96
Chapter 5 Investigation of the 5’ flanking region of the IL8 gene in
the regulation of IL8 transcription 97-123
Chapter 6 Examination of nuclear factor binding to SNPs in the
IL8 gene 124-149
Chapter 7 Demonstration o f regulatory polymorphisms modulating
haplotype-spedfic expression using HaploChIP 150-173
Chapter 8 Thesis Summary 174-179
Appendices 180-187
Acknowledgements 188-189
References 190-217
11
A Adenine
AP-1 Activator protein-1
C Cytosine
Cl Confidence interval
CTP Cytosine Triphosphate
C/EBP CAAT-enhancer binding protein
NFIL6 Nuclear factor interleukin-6 (also known as C/EBP)
CD Cluster designation
cDNA complementary DNA synthesized by reverse transcriptase
CEPH Centre d’Etude du Polymorphisme Humain
CLD Chronic lung disease
CTD C-terminal domain
c-Myb c-mjb proto-oncogene product
CsCl Cesium chloride
CTL Cytotoxic T  cell lymphocytes
dATP deoxy-Adenine Triphosphate
DBD DNA binding domain
dCTP deoxy-Cytosine Triphosphate
ddATP dideoxy-Adenine Triphosphate
ddCTP dideoxy-Cytosine Triphosphate
ddGTP dideoxy-Guanine Triphosphate
ddTTP dideoxy-Thymidine Triphosphate
dGTP deoxy-Guanine Triphosphate
dTTP deoxy-Thymidine Triphosphate
DMEM Dulbecco’s modified eagles medium
DNA Deoxyribonucleic acid
EBV Epstein-Barr Virus
EDTA Ethylenediatninetetraacetric A dd
ELISA Enzyme-linked immunosorbent assay
EMSA Electrophoretic mobility shift assays
F RSV Fusion protein
F 12K Kaighn’s modified media
FISH Fluorescent in situ hybridization
G Guanine
G RSV Glycoprotein: viral attachment to the cell
GAG Glycosaminoglycans
GM-CSF Granulocyte-macrophage colony stimulating factor
GRO Growth-stimulatory activity/growth-regulated gene
HBD Heparin binding domain
hnRNP heterogeneous nudear ribonucleoprotein
HR Heptad repeat sequences
ICAM Intracellular adhesion molecule
Ig Immunoglobulin
IQR inter-quairile range
IL Interleukin
IFN Interferon
Ill
L RSV Nucleocapsid protein: RNA polymerase
M RSV Matrix protein: viral assembly
M2 RSV M2 transcription elongation factor
MALDI-TOF Matrix-assisted laser desorption time-of-flight mass spectrometry
MAPREC Mutant analysis by PCR and restriction enzyme cleavage
MCP Macrophage chemoattractant protein
MHC Major histocompatibility complex
MIP Macrophage Inflammatory Protein
mRNA messenger RNA
MOI Multiplicity of infection
MPO Myeloperoxidase
N RSV Nucleocapsid protein: Nucleoprotein
NO Nitric Oxide
NF-kB Nuclear factor-KB
N K  Natural KiUer
L-NMMA -monomethyl-L-arginine
NOS Nitric Oxide Synthase
NS 1 or 2 RSV Non-structural proteins
NTP Nucleotide triphosphate
OXREC Oxfordshire research ethics committee
P RSV Nucleocapsid protein: Phosphoprotein
PCR Polymerase chain reaction
PE/M S Primer extension and Mass spectrometry
PEG  Polyethylene glycol
PF-4 Platelet factor-4
PMA 4a-Phorbol 12-myristate 13-acetate
PML Polymorphonuclear neutrophils
Pol Polymerase
PPBP Pro-platelet basic protein
pRSV Purified respiratory syncytial virus
RANTES Regulation upon activation normal T  cell-expressed and secreted
REL Reticuloendotheliosis viral oncogene homolog/NF-KB family
RSV Respiratory syncytial virus
RSVRE RSV response element
RNA Ribonucleic acid
RNI Reactive Nitrogen Intermediates
SH RSV Small hydrophobic protein
SNP Single nucleotide polymorphism
SP Surfactant protein
T  Thymidine
TDT Transmission/disequilibrium test
TE Tris-EDTA
TH T  helper type lymphocyte
TLR ToU-hke receptor
TNF Tumor necrosis factor-a
upRSV Unpurified respiratory syncytial virus
UV Ultraviolet
IV
ABSTRACT
This thesis explores the extent to which natural variation in DNA sequence may influence 
the transcriptional regulation of genes that play a critical role in the immune response to 
infection. As a model system we began by examining Interleukin-8 (IL,-S) as it has been 
implicated in the pathogenesis of a very common infection namely, RSV-induced 
bronchiolitis. Previously, we have described an association between bronchiolitis disease 
severity and a specific IL8 haplotype comprising six single nucleotide polymorphisms 
(SNPs) (-251A/+396G/+781T/+1238deLA./+1633T/+2767T, haplotype 2). Here we 
investigated the functional basis for this association by measuring haplotype-spedfic 
transcription m vivo in human primary cells. We found a significant increase in transcript 
level derived from the ILJ8 haplotype 2 relative to the mirror haplotype 1 
(-251T/+396T/+781C/+1238insA/+1633C/+2767A) in respiratory epithelial cells but not 
in lymphocytes. A promoter polymorphism, -251 A, present on the high producer haplotype, 
had no clear and significant effect on the allele-spedfic level o f transcription when analyzed 
in reporter gene experiments in human respiratory epithelial cell lines. We proceeded to 
systematically screen for allele-spedfic protein-DNA binding in this functional haplotype 
which revealed significant differential binding at the +781T/C polymorphism. C /EBP |3 
was identified as being part of a transcription factor binding complex which preferentially 
bound in the presence of +781T allele. These results suggest that the mechanism for disease 
susceptibility to RSV-induced bronchiolitis may occur through a haplotype-spedfic increase 
in IL8 transcription which may be mediated by functional polymorphisms within that 
haplotype.
However, the unusual mirror haplotype structure of IL8 in European populations gave little 
indication of which SNP within the haplotype was likely to be functional in vivo. In order to 
demonstrate the principle that a non-coding polymorphism may alter transcriptional 
regulation in vivo I used a second technique, namely the haplotype-spedfic chromatin 
immunopredpitation (haploChIP), which once optimised could be applied to the IL8 locus. 
In order to optimise haploChIP I studied a second model system namely the tumor necrosis 
factor/lymphotoxin-a {TNF/L.TA) locus and used it to measures the differences in the 
loading of RNA polymerase between alleles in EBV-immortalized B lymphocytes. 
Consistent with previous studies I demonstrated that allele-spedfic RNA polymerase loading 
was independently assodated with the LTA+80, LTA+368 and LTA+723 polymorphisms. 
This assodafion was refined to demonstrate that the polymerase loading at this locus 
appeared to be determined in vivo by the E7M+80A and LXA+368C alleles both o f which 
occur on the same haplotype. These data imply that HaploChIP could be utilised in 
understanding the transcriptional regulation of IL8. Furthermore it shows that functional 
SNPs may act in concert to influence transcription. This may mean that in future the 
functional basis for allele-spedfic effects at critical candidate genes wül have to be dissected 
in vivo at the level of the haplotype.
CHAPTER ONE
INTRODUCTION
1.1
Respiratory Syncytial Virus (RSV) infection in  childhood
The majority of deaths from RSV-bronchiolitis in children occur under 1 year o f age and in 
infants with specific risk factors for severe bronchiolitis such as congenital heart disease, 
chronic lung disease (CLD) or prematurity (Shay et al. 2001). However, the known risk 
factors associated with RSV-induced bronchiolitis mortality do not provide a full explanation 
for the variation in disease severity across the whole population. By the age o f two years 
most infants will have encountered the virus and the majority will have had a mild Hness 
with only 2% requiring hospital admission (Medical Research Council 1978). The reasons 
why some infants are more severely affected by RSV infection than others remains 
incompletely understood.
In this introduction I wül discuss the rationale for a molecular genetic approach using a 
candidate gene smdy design. I wül go on to examine the biology of the virus and the host 
response to infection. I wül proceed to focus on the role that chemokines, and interleukin-8 
(IL-8) in particular, have in the pathogenesis o f RSV infection. Then, I wül describe the 
evidence for the association between RSV-induced bronchiolitis disease severity and natural 
DNA sequence variation at or close to the ILS gene.
1.2.1
Rational for the molecular genetic approach
Dissecting out the critical events in RSV bronchiolitis that lead to enhanced disease severity 
is hampered by four principal problems. Firstly, there are a large number of mediators 
produced by the host in the event of an infection each of which has the potential to be 
protective or deleterious. Secondly, animal experiments may prove to be misleading, as there 
may be critical differences in the pathogenesis between species. For instance, the 
experiments on RSV bronchiolitis in mice suggest that IL-4 activation of mast cells and IL-5 
mediated chemotaxis of eosinophils may be crucial to the pathogensis of the disease 
(Graham 1995). However, in humans the predominant leukocyte involved in the immune 
response to RSV is the neutrophil (Everard et al. 1994). Thirdly, clinical research may help 
to generate hypotheses through descriptive smdies but may not be able to test these 
hypotheses or demonstrate causality of a particular mediator in the pathogenesis of the 
disease. Finally, inter-spedes genomic sequence comparisons have proved to be a powerful 
means of identifying mammalian ^-acting regulatory elements (Pennacchio and Rubin, 
2001). At the time this thesis was conducted publicly available genome sequence data was 
only available for the mouse. Unformnately, in the case of ILS, human to mouse inter- 
spedes comparisons would be o f limited value as this chemokine is absent in mice (Modi 
and Yoshimura, 1999).
There is no clear evidence to suggest a particular RSV subgroup is assodated with disease 
severity (Fletcher et al. 1997; Smyth et al. 2002). However, a number of smdies of 
inflammation have demonstrated a difference in cytokine production, namely tumor necrosis 
factor-a QTNF), IL-10, and IL-lp, between individuals (Westendrop et al. 1997; Turner et al;
1997, Bloque et al. 1995) which may be related to the increasing number of DNA 
polymorphisms being described located in the coding or promoter regions of these genes. 
The polymorphisms in the gene may modify the protein product of the gene. For instance, 
there is evidence that a polymorphism (A32 deletion) in the chemokine CCR5 gives selective 
advantage in resisting human immunodeficiency virus infection (Murphy 2001). 
Alternatively, polymorphisms in the promoter region may alter the binding affinity of 
transcription factors (Knight et al. 1999) which in turn could change the level of expression 
of a gene. Therefore, investigation of the functional properties of polymorphisms associated 
with increased susceptibility to RSV-induced bronchiolitis may serve to explain both the 
variable clinical severity of the disease as well as demonstrate the causal mechanisms o f its 
pathogenesis.
1.2.2
Association studies with candidate genes
Association smdies using candidate genes have greater power to detect genetic factors 
involved in complex disease than other methods such as linkage analysis (Risch and 
Merikngas, 1996). Candidate gene smdies focus on genes for which there is an a priori 
hypothesis about their role in the aetiology of a disease and are conducted in a population 
sample of affected and unaffected individuals. Therefore, a candidate gene smdy can be 
seen to take advantage of both the increased statistical efficiency of association analysis in a 
complex disease as well as the biological understanding o f the genes and proteins likely to be 
involved its pathogenesis (Tabor et al 2002). However, smdies of candidate genes have been 
criticised as the significance of an association is often either overstated in the original report 
when compared to subsequent smdies or is found not to have been replicated at aU
(Gambaro et al. 2000; loannidis et al. 2001). Carefully conducted candidate gene studies can 
yield reliable results especially when the biological plausibility of the association is strong, the 
strength of the association is great and when the association is consistent across different 
populations. Moreover, a true association is more likely when a dose response relationship 
of the association is seen such that an individual with two copies of the disease associated 
variant is at greater risk than an individual with only one. The important issue of 
unrecognized population stratification, leading to a spurious association, can also be avoided 
by careful smdy design and through the use of family based smdies where parents act as 
biological controls for their affected children (Reider et al. 1999).
Viral Biology
1.3.1
An introduction to RSV
Human respiratory syncytial vims (RSV) was first characterized in 1957 (Chanock et al. 
1957) and has since been recognized as the most common cause of severe respiratory tract 
infection in young infants worldwide. RSV infection is not restricted to children as 
immunity following infection remains incomplete and secondary infections can occur 
throughout life. Despite 45 years of research there is neither an effective treatment nor any 
immediate prospect of a vaccine. Key to the development of novel therapies is a good 
understanding of RSV disease pathogenesis.
1.3.2
RSV structure and genom e
RSV is classified in the genus Pneumovirus of the family Paramjxoviridae (Figure 1.1). The RSV 
genome is composed of single stranded negative sense RNA of 15,200 nucleotides encoding 
11 proteins. The structure of the RSV genome and protein functions are given in detail in 
Figure 1.2.
The ability to reconstitute infective RSV particles by introducing engineered viral genes into 
cells was a break-though in RSV research and is responsible for much of our understanding 
of the function of the proteins in the vims. In this technique the RSV genome is isolated 
and converted from RNA to DNA, This DNA can then be cloned into vectors called 
plasmids which allows a large number o f copies of the genome to be made. Plasmids
encoding the viral proteins as well as the entire viral genome are then introduced in to 
epithelial cells where they are transported to the nucleus. The cell’s own machinery then 
makes all the necessary proteins for viral assembly and finally replicates the RSV genome 
which is then packaged into the viral particle. Mutations of the DNA in the plasmids 
encoding various RSV genes can then be introduced, including deleting entire genes, and 
their effects on viral replication both in vitro and in vivo can be observed. For example, use of 
this system has shown that the genes N Sl, NS2, SH, M2-2 and G can be mutated whilst 
maintaining viral viability (Schmidt et al. 2001). However, deletion of the NSl or NS2 genes 
results in a marked reduction in replication efficacy in vivo (Whitehead et al. 1999, Schlender 
et al. 2000) a difference which has been attributed to the role these genes have in co­
operatively antagonizing a  and P interferon [Feng et al. 2000).
As well as leading to discovery of the function of RSV proteins, this system has been used to 
develop vaccine candidates. An ideal RSV vacdne would be highly attenuated (that is, 
causes no illness), but retain high replication efficiency (so that it can be given as a single 
intra-nasal dose) and high immunogenidty. Unfortunately to date these vaccines have 
proved insuffidently attenuated to be introduced to the population.
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1.3.3
RSV Infection o f  Airway Epithelial Cells
RSV predominantly infects airway epithelial cells. These cells line the nose as well as the 
large and small airways. They form the first line o f defense against the virus and are the site 
of the majority of the inflammation associated with the disease. In immuno-competent 
individuals the virus seldom infects other tissues. The first critical step in the infection 
process is entry of the virus into the cell. Thereafter the virus replicates, is packaged and 
leaves the cell, either through fusion with adjacent cells or following cell rupture (Figure 1.3). 
Blocking viral entry is an attractive mechanism for anti-viral therapies and for this reason 
most research work has been directed towards the functions of the major surface glyco­
proteins F and G. Their importance is emphasized by the observation that effective 
humoral immunity is only conferred by antibodies to these proteins.
1.3.4
Role o f  the G protein
The G glycoprotein was originally identified as the RSV attachment protein in experiments 
in which binding of radio-labeled RSV particles to cultured cells was blocked with specific 
anti-G antibodies (Levine et al. 1987). The G  protein is a glycosylated type II 
transmembrane protein of between 289 to 299 amino adds depending on the viral strain. It 
consists of an N terminal cytoplasmic domain, a hydrophobic anchor region and an 
ectodomain. The ectodomain is made up of two mucin-like regions which are highly 
variable and rich in serine, threonine and proline. These mudn-like regions are also heavily 
glycosylated with N- and O- linked sugars. The mucin-like domains are separated by a 13 
amino add sequence which contains four cystine residues that are conserved across RSV
11
strains. Many of the epitopes recognized by the host antibody response lie in the C terminal 
variable region. The virus may have the potential for changing the antigenic profile of this 
region of the G protein in order to evade the host response (Cane 2001). N-glycosylation 
that masks the epitopes could be another means o f evading immune recognition o f antigens 
(Cane 1997). In addition to the membrane bound G protein an N-terminal truncated 
soluble and secreted form is produced. It was suggested that the soluble G  protein served to 
redirect the immune response away from infected cells and released virus (Cane 2001). 
However, recent experiments have shown that RSV strains lacking the membrane bound G 
protein but expressing the soluble G protein had efficient replication in vitro and were only 
slightly attenuated in vivo (Teng et al. 2001). This may mean that the soluble form can remain 
associated with the virus in order to mediate cell entry. Surprisingly, recombinant RSV in 
which the secreted and membrane bound G  protein have both been deleted are still able to 
infect some cell types as efficiently as wüd-type virus. This mutant form of the virus has a 
much lower efficiency of infection of human airway cells and in the airways o f mice in vivo 
(Teng et al 2001, Karron et al. 1997). These results indicate that the G  protein is not 
essential for cell attachment, but acts as an accessory protein which increases the efficiency 
of the process (Teng et al. 1998).
The cellular receptor for the G  protein has not been identified. The cell surface 
glycosaminoglycans (GAGs) heparan sulfate and chrondroitin sulfate B have been shown to 
be important for infection in vitro through a putative heparin binding domain (HBD) (184- 
198 amino acids) in the G  protein (Feldman et al. 1999). However, RSV with a mutation of 
the HBD remained sensitive to neutralization with soluble heparin in vitro., had normal 
growth in vitro and showed only a rmld reduction in vivo growth (Teng et al. 2001). This
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implies that the HBD is not the sole determinant of heparin sensitivity. Interestingly, the 
same HBD region of the G protein may prove to have other functions as it contains a motif 
at 182-186 amino acids common to the CXC3 chemokine fractalkine (Johnson et al. 1987). 
Tripp and colleagues have gone on to show that the G  protein binds the CX3C receptor 
(CX3CR1) and in doing so can facilitate RSV infection (Tripp et al. 2001). It is possible that 
by competing with fractalkine for the CX3C receptor, RSV is able to alter fraktalkine 
mediated immune responses and favor viral replication and survival.
1.3.5
Role o f  the F protein
RSV has an absolute requirement for the F protein (Teng et al. 1998). Fusion of the viral 
envelope or infected cell membranes with uninfected cell membranes is an essential step in 
the virus life cycle. This process requires the F protein to be intact and is enhanced by the G 
protein. The F protein is a highly conserved protein among the Paramjxoviridae family 
(Collins et al. 1996) and is synthesized as a 67 kDa precursor which undergoes proteolytic 
cleavage to produce two disulfide-linked polypeptides named FI from the C terminus and 
F2 ftom the N  terminus (Collins and Mottet 1991). The part of the F protein that enters the 
cell membrane is situated at the N  terminus of the FI polypeptide, whilst the transmembrane 
segment is located dose to the C terminus. Adjacent to these two regions are two heptad 
repeat sequences, denoted HR-N and HR-C, that form stable trimer hairpin-Hke structures 
that undergo a conformational change to enable the viral and cell membranes to be apposed 
prior to viral entry. The heptad structures may prove to be a successful target for drug 
development as viral fusion can be inhibited by peptides that bind to the HR-C region and
13
prevent the conformational change necessary for membrane fusion (Lambert et al. 1996). 
The F protein also interacts with a Ras family protein called RhoA (Patsey et al. 1999). 
RhoA is a small GTPase that has numerous roles in the cell which include IL -ip , IL-6 and 
IL-8 secretion, cell motility, cell morphology and most importantly actin cytoskeleton 
reorganization. Whilst RSV F and RhoA interaction in the infected cell membrane has yet to 
be demonstrated, RhoA is activated on RSV infection (Gower et al 2001) and RhoA 
expression facilitates syncytia formation in RSV infected HEp-2 cells over-expressing RhoA 
(Patsey et al. 1999). Moreover, a RhoA derived peptide bound to the F protein at high 
affinity prevented cell firee viral entry and syncytia formation in vitro and infection in mice 
(Patsey et al. 2000). Another means of inhibiting RSV induced RhoA activation is by 
preventing RhoA association with the cell membrane following GTP exchange and 
isoprenylation. Accordingly isoprenylation inhibitors, such as lovastatin, have been shown 
to have anti-RSV activity both in vitro and in vivo (Gower and Graham 2001).
1.3.6
RSV assem bly
The M protein is vital for RSV viability and plays a central role in RSV assembly (Figure 1.3) 
and through a series of interactions it co-ordinates the assembly of the envelope proteins F 
and G with the nucleocapsid proteins N P and M2-1 (Schmidt et al. 2001).
14
Ilg - o
*ri
î
r
t
f
(D (O
f
en
S*m
I
S
§
s.
n
1
I
S,
I
3 '^
i l 3
5
3
r |
Ô <O
û) ' ^
0-0  
o
(D
(D
I
(D
Figure 1.3.
RSV attachment occurs via the G protein. Fusion is mediated by the F protein after which 
the viral envelope is incorporated into the cell membrane and the nucleocapsid is released 
into the cytoplasm. RSV mRNA accumulates untdl about 15 hours after infection and then 
remains at constant levels thereby allowing for RNA replication and subsequent viral 
assembly. The M2-2 gene governs this transition ftom transcription to production of 
genomic RNA. The M protein and membrane-destined G  protein meet in the Golgi and can 
interact through a six amino add motif in the cytoplasmic end of the G protein. It is likely 
that the F and G proteins interact with each other via their cytoplasmic domains. Meanwhile 
the N, P, L and M2-1 proteins form inclusions in the cytoplasm and then through M2-1 
interact with the M protein. Through these series o f interactions the M protein can be seen 
to co-ordinate the assembly of the envelope proteins F and G with the nucleocapsid proteins 
N  P and M2-1. Budding appears to be the reverse of penetration and occurs in vitro on the 
apical cell surface.
16
Host Response
1.4.1
The host response to RSV infection
The immune response to RSV infection, as with any other infection is comprised of an 
innate response, and subsequent activation of humoral and cellular specific immunity. 
Autopsy studies of infants who died following bronchiolitis show lymphocytic infiltrate 
around small airways and cell debris in airway lumens (Aheme et al. 1970). Broncho-alveolar 
lavage samples of ventilated RSV infected infants show marked neutrophil infiltrates in the 
airways (Everard et al. 1994). Moreover, these neutrophils adhere to RSV infected epithelial 
cells and become activated thereby causing cytotoxic damage to the epithelium (Wang et al. 
1998). The cellular immune response seems to be important in controlling the infection 
once initiated and for clearance o f the virus. Children with cellular immunodeficiencies have 
prolonged viral carriage (Chandwani et al. 1990). The importance of the host response to 
RSV infection was dramatically illustrated by the formalin-kUled RSV vaccine trial in the late 
1960s. Vaccinees in this trial made an ineffective response to the vaccine and developed 
more severe disease during subsequent natural infection (Kim et al. 1969). The humoral 
immune response is important in providing protection against subsequent infection.
1.4.2
Innate Im m unity to R SV
Respiratory epithelial cells whilst being the principle target for RSV infection are also the 
first defense in the innate immune response to virus (Figure 1.4). Not only do they produce 
opsonins and collectins but also secrete a range o f cytokines such intracellular adhesion 
molecule (1CA1VÇ-1 (Patel et al. 1995) IL-8 (Noah et al. 1995) and RANTES (Regulation
17
upon activation normal T  cell-expressed and secreted) (Becker et al. 1997), that have been 
demonstrated to initiate neutrophil, CD4+ T  helper cell and eosinophil chemotaxsis. In 
addition to the action of epithelial cells alveolar macrophages play an important role in the 
innate immune defense against RSV as they may regulate the immune response (TvRduUa et 
al. 1993), and release inflammatory cytokines when infected (Becker et al. 1991). It has 
recently been shown that the F protein o f RSV binds to the ToU-Hke receptor (TLR) 4 and 
the CD14 receptor on human monocytes stimulating the release of cytokines IL -ip , lL-6, 
IL-8 and TNF (Kurt-Jones et al. 2000). Moreover, mice deficient in TLR4 had reduced 
CD14(+) cell pulmonary trafficking, deficient N K  cell function, and impaired RSV clearance 
(Haynes et al. 2001).
Amongst the collectins produced by epithelial cells surfactant A (SP-A) plays an important 
role in clearance of RSV. In vitro experiments have shown that SP-A binds and neutralizes 
RSV (Ghildyal et al. 1999) whilst mice deficient in SP-A have impaired clearance of the virus 
(LeVine et al. 1999). A possible explanation for this delayed viral clearance could be 
impaired uptake of the virus by mononuclear cells and macrophages as SP-A enhances 
opsonisation of RSV by these cell types (Barr et al. 2000) thereby increasing TNF and IL-10 
production.
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Figure 1.4.
RSV is bound by surfactant protein A and engulfed by macrophages which leads to IL-ip, 
IL-8, IL-6 and TNF release. Infection of epithelial cells stimulates release o f a number of 
cytokines including the neutrophil and macrophage chemoattractants IL-8 and macrophage 
chemoattractant protein (MCP)-1. IL-1 secretion leads to the up-regulation of ICAM-1, a 
receptor vital for neutrophil adherence and activation. IFN a / P  secretion causes the up- 
regulation o f the major histocompatibility complex I (MHC-1).
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1.4.3
Cell M ediated Im m unity to R SV
Infants with a primary RSV infection develop a cellular immune response within 10 days of 
infection (Chiba et al. 1989). Human cytotoxic T  cell lymphocytes (CTL) recognize the N, 
SH, F, M, M2, and NS2 proteins but not the G  protein (Cherrie et al 1992). In mouse 
models it has been su^ested that the failure of the G  protein to induce a CTL response is a 
significant factor in disease pathogenesis (Srikiatkhachom et al. 1997). Both sensitized 
CD4+ and CD8+ T  cells have been demonstrated to have antiviral activity on passive 
transfer to RSV infected mice. Both cell types reduce pulmonary shedding of the virus but 
both also caused increased pulmonary damage (Alwan et al. 1992). Further evidence for the 
role of CTL in RSV pathogenesis came firom animal experiments investigating the effects of 
formalin-inactivated vaccine. Mice immunized with the vaccine produced CD4+ T cells, 
with a cytokine expression pattern suggestive of a T  helper type two (Th2) phenotype 
whereas natural infection induces T  helper type one (Thl) Hke cytokine expression (Graham 
et al. 1993). These data suggested that the formalin-inactivated vaccine induced an 
imbalance in favor of the Th2 allergy associated response over the T h l delayed 
hypersensitivity related response. This proved to be an attractive model to explain the post 
RSV-induced bronchiolitis recurrent wheeze as well as the allergy associated features of 
bronchiolitis such as the activation of eosinophils (Garofalo et al. 1992) and the presence of 
RSV specific IgE (WeUiver et al. 1981). However, the Th2 and T hl CD4+ cell subgroups 
were first described in mice (Mosmann et al. 1989) and the distinction between the two 
groups may be less dear in humans (Krug et al. 1996). Moreover, there are contradictory 
reports on Th2 and T hl cytokine profiles in human RSV-induced bronchiolitis (Roman et al.
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1997, van Schaik et al. 1999) with recent studies relating disease severity more to chemokine 
production than to Th2 cytokine levels (Garofalo et al. 2001).
1.4.3
Humoral Im m unity to RSV
Although the humoral response is not Hkely to be helpful in influencing the course of a 
primary infection once it has occurred, there is good evidence that protection from 
subsequent infections is mediated though antibodies. Breast fed infants with high titers of 
transplacentally acquired antibodies are less likely to succumb to severe bronchiolitis 
(Holberg et al. 1991) and passive immunization with RSV-spedfic IgG has been shown to be 
effective at protecting against hospital admission with RSV infection (Impact-RSV study 
Group 1998). N ot aU humoral responses are favorable and RSV-spedfic IgE has been 
assodated with more severe disease and with subsequent wheezing (WeUiver et al. 1980, 
WeUiver et al. 1986).
Chemokine Biology
1.5.1
Chemokines
The position and movement of cells is essential for normal development and immune 
fimction. A fundamental mechanism for cell migration which is shared by both primitive 
and higher complex organisms is the presence of chemoattractants that signal via seven- 
membrane G  protein-coupled receptors. In humans the most important mediators of
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leukocyte migration are a subgroup of these G protein-coupled receptors called 
chemoattractant cytokines otherwise known as chemokines (MacKay 2001).
1.5.2
Chemokine classiûcation
Though the first chemokine to be discovered was platelet factor 4, chemokines were not 
recognized to have a chemotactic function until IL-8 was characterized (Yoshtmura et al. 
1987). Similarly, the first chemokine receptor to be cloned was the IL-8 receptor (Holmes et 
al. 1991). There are now over 40 known chemokines and 20 chemokine receptors which are 
classified in four families: CC, CXC, C and CXjC according to the structure of cysteine 
residues at the NHg-terminus (Rossi et al. 2001). For instance, IL-8 is classified as a CXC 
ligand 8 or CXCL8 whilst the IL-8 receptors are named CXCRl and CXCR2.
1.5.3
Chemokine and IL-8 fimction
Consistent with the importance of the chemokines to cell movement is the conservation of 
these molecules across species. The most likely primordial chemokine is stromal cell-derived 
factor 1 (CXCL12) whilst the putative primordial chemokine receptor is CXC chemokine 
receptor 4 (CXCR4)-like receptor. Both CXCL12 and CXCR4 are common to humans and 
Drosophila and have roles in development as well as in the immune system (Gerard and 
Rollins, 2001). For example, where either molecule is mutated in mice there are major 
defects in cerebellar development, cardiac septum formation and gastrointestinal 
development.
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Within die immune system chemokines have four main functions. Firstiy, chemokines 
initiate leukocyte mobility through the generation o f a chemokine gradient, which the 
migrating cell follows. The chemokine system allows for specificity in cell migration as the 
expression of a chemokine from an organ will only promote migration o f leukocytes 
expressing the relevant receptor. Secondly, chemokines have a central role in leukocyte- 
endothelial cell interactions. This is described in the multi-step model which starts with 
leukocyte adhesion to the vessel wall using selectin molecules and is followed by integrin 
binding. On binding the integrins undergo rapid conformational changes which initiate firm 
adhesion and subsequent trans-endotheHal migration. Chemokines, and IL-8 in particular, 
have been demonstrated to have a role in integrin activation (Gerszten et al. 1999). 
Moreover, the use of chemokine, integrin and selectin molecules in combination for 
successful leukocyte extravasation allows for further selection of migrating leukocytes by the 
tissues. Thirdly, chemokines stimulate leukocytes to release inflammatory mediators. For 
instance, IL-8 stimulates neutrophil granule exocytosis, and also initiates the respiratory burst 
which allows production of reactive oxygen intermediates. Finally, chemokines stimulate 
angiogenesis and angiostasis. The CXC chemokines, such as IL-8 and CCL2, have 
angiogenic properties (Koch et al. 1992) whereas the CXCR3 ligands, for example CXCLIO, 
have angiostatic properties. The biological relevance of angiogenesis and angiostasis could 
relate to inflammatory responses and tumour rejection respectively. These four properties 
are used in combination depending on the biological response required. For instance, 
tumour rejection requires leukocyte recruitment as well as angiostasis whilst allergic 
inflammation requires leukocyte recruitment as well as inflammatory mediator release.
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RSV-induced bronchiolitis and IL-8
1.6.1
The associated o f  genetic polym otphism s a t or close to the IL8 gene with RSV- 
induced bronchiolitis disease severity
The Kwiatkowski laboratory has shown that a common single nucleotide polymorphism 
(SNP) -251 (A/T) nucleotides upstream of the ÏLS transcription start site is associated with 
susceptibility to RSV-induced bronchiolitis (Hull et al. 2000). A further nine SNPs in a 7.6 
kilobase segment spanning the IL8 gene and its promoter were identified o f which six 
(-1722insT, -25lA , +396G, +781T, +1633T and +2767T) were used to define the haplotype 
structure (Table 1.1) of the LL8 locus. Using these SNPs it was shown that in European 
populations the haplotype structure is unusual as it is dominated by two common haplotypes 
(Figure 1.5) (HuU et al. 2001). The definition of these haplotypes allowed the IL8 -251A 
bronchiolitis association to be refined as Haplotype 12, which contains the -251A and 
+781T alleles and is associated with RSV-bronchiolitis disease susceptibility 
(transmission/disequilibrium test [TDT]/)=0.0008) (HuU et al. 2001).
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T a b le t!
Frequencies of the 12 different Haplotypes observed in a European Population
Haplotype Identifier Haplotype* Freq
1 deinrC C A .52
2 delTTGCCA
3 delTTGTTT .005
4 delTATCCA .01
5 insTATCCA .005
6 delTAGCCA .03
7 insTAGCCA
8 delTAGClT .005
9 delTAGTTA .01
10 delTATTTA .005
11 delTAlTTT
12 delTAGTiT .41
*The SNPs comprising these haplotypes (and haplotype frequencies) are: -1722insT (0.01), -251A (0.47), 396G 
(0.46), 781T (0.43), 1633T (0.44) and 2767T (0.42). ^^Frequencies are estimated from a sample of 190 European 
chromosomes—  = not found.
Adapted from Tables 3 and 4 in HuU et al. (2001) and used with permission from the author.
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Figure 1.5.
Suggested minimiim-mutation network of the IL8 haplotypes in European populations. 
Each haplotype is represented by a circle, the radius of which is proportional to its allele 
frequency. The solid branches ( ) represent mutation events and the dashed branches
) represent recombination events. In each genealogy, the haplotype refers to 
haplotypes shown in table 1.1. Sequence data from the chimpanzee suggests that the 
ancestral root is haplotype 4. Adapted from Figure 1 in Hull et al. (2001) and used with 
permission from the author.
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1.6.2
D etennining functional genetic elements that m ay explain the association between 
the IL8gene and RSV-induced bronchiolitis disease severity
The goal of this thesis is to clarify whether polymorphisms have or-acting regulatory 
properties in vivo on genes relevant to common infections. Given the ubiquity of RSV 
infection in European populations and the robust nature o f the disease severity association 
between JJL8 and RSV-induced bronchiolitis I reasoned that investigation of polymorphisms 
close to the IL8 locus would serve as a reasonable model for this investigation. My 
challenge was to deiSne whether the polymorphisms studied had a functional effect on IL^S 
regulation or whether these polymorphisms were merely linked to another genetic factor 
close to the IL8 gene.
Prior to undertaking detailed functional smdies of the haplotypes associated with 
RSV-induced bronchiolitis disease susceptibility I set out to develop an in vitro model for 
RSV infection. Given the importance o f the respiratory epithelium to the innate immune 
response (outlined above) I began by establishing an in vitro culture of the A549 respiratory 
epithelial cells. Then I went on to optimize a method for purifying RSV within our 
laboratory. Using these resources I was able to smdy the kinetics of IL-8 induction in A549 
cells following activation with purified RSV (pRSV), unpurified RSV (upRSV) and 
recombinant TNF.
In order to undertake functional studies the haplotypes described above were redefined as 
haplotype 1 and haplotype 2 and haplotype 3 (Figure 1.6). The -1722insT SNP was not 
included in this new haplotype definition as it occurs at low frequency in European
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populations (0.01) and is unchanged between the two major haplotypes (Table 1.1). The 
unusual population structure of IL8 in the European population allows us to examine 
haplotypes 1 and 2 for haplotype-specific differences in transcription using primary cells 
heterozygous for these haplotypes. This approach ensures that the DNA was investigated in 
the presence of chromatin and in the context of the usual flanking sequences that may 
contain important co-regulatory elements. In these circumstances important DNA-to- 
protein and protein-to-protein interactions that may affect gene regulation would be 
examined. However, as the European population is dominated by two haplotypes the results 
of haplotype-specific expression allow a limited insight as to which SNPs, alone or in 
combination, are functionally related w vivo to ILJ8 and bronchiolitis disease severity. 
Therefore I sought to examine the individual SNPs in the 5’ region prior to IL8 and in the 
IL8 gene with in vitro methods of plasmid reporter gene assays and electrophoretic mobility 
shift assays (EMSAs) to assess what effect the SNPs had on transcriptional regulation and 
protein-DNA interactions. A limitation of plasmid reporter assay systems is that only SNPs 
that are simated prior to the translational start site of the gene can be assessed in the context 
of the normal sequence of regulatory elements found in the promoter. To overcome this 
technical limitation EMSAs were used to systematically screen SNPs positioned beyond the 
translational start site for allele-specific protein-DNA binding. Where allele-specific binding 
occurred an attempt to identify transcription factors that were a part of differentially binding 
complexes was made through antibody mediated super-shift EMSAs. Where particular 
aspects of tir-acting regulation by polymorphisms were not adequately demonstrated at the 
IJL8 locus then experiments using the TN F /LTA  locus were used as proof of the underlying 
principle that is central to this thesis.
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Transcript length 1631 base pairs
Exon 1 Exon 2 Exon 3 Exon 4
IL8 gene Promoter Intron Intron Intron 3’ Frequency
1 2 3 untranslated
SNP -251 +396 +781 +1238 +1633 +2767
Haplotype 1 T T C InsA C A 0.52
Haplotype 2 A G T delA T T 0.41
Haplotype 3 A G C del A T T 0.005
Figure 1.6
DNA sequence polymorphisms at the IL8 locus. Schematic representation of the IL8
promoter and gene depicting the exons (filled boxes), introns (line), the position of the 
polymorphisms (arrow), the different haplotypes and the haplotype frequency in a European 
population.
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1.6.3
Concluding Points
•  The severity of RSV-induced bronchiolitis is highly variable with only 5% of infants 
requiring hospital admission.
•  RSV strain type does not appear to explain this variation in disease severity. Differences 
in the host immune response may prove to be a better explanation.
•  Recent evidence suggests that the innate immune system and chemokines in particular 
play a central role in the initial host response to RSV.
• Since pulmonary polymorpholeucocyte chemotaxis is characteristic o f RSV-induced 
bronchiolitis TL8 is implicated as an important candidate gene as it is the principal 
leucocyte chemoattractant.
•  Genetic epidemiology studies using both family based and case control methods show 
that SNPs close to and in the IL8 gene are associated with RSV-induced bronchiolitis 
disease severity.
•  We proposed to use IL8 as a model system to explore the hypothesis that SNPs acting 
alone or in concert as haplotypes might modulate gene regulation.
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CHAPTER TWO 
MATERIALS AND METHODS 
Materials
2.1.1
Chemical Reagents
All chemicals used were of analytical grade with the majority being obtained from Sigma- 
Aldrich (Poole, United Kingdom). Cell culture materials, media and additives were all of 
tissue culture grade and were obtained from Invitrogen (Paisley, United Kingdom (UK)) and 
Sigma-Aldrich (Poole, UK). Rapid-Hyb buffer, poly(dA-dT) and poly(dl-dC) were supplied 
by Amersham Pharmacia Biotech (Little Chalfont, UK). Ludferase assay reagent was 
obtained firom Promega Corporation (Southampton, UK). Fugene-6 transfection reagent 
was obtained from Roche Diagnostics Limited (Lewes, UK). Sterile de-ionised water was 
used in the preparation of aU solutions.
2.1.2
Cytokines, antibodies andJurkat cell lysate
Monoclonal anti-human IL-8 antibody was obtained from R and D systems (Abingdon, UK) 
whilst spedfic rabbit polyclonal antiserum to respiratory syncytial virus was purchased from 
Biogenesis (Poole, UK). Recombinant human interleukin-1 P and recombinant human 
interferon-y were purchased from Roche Diagnostics Limited. 4a-Phorbol 12-myristate 13- 
acetate (PMA) and TNF and ionomydn was obtained from Sigma-Aldrich (Poole, UK). 
Anti-c-Myb (clone 1-1) antibody was obtained from Upstate biotechnology (Lake Pladd, 
New York, United States of America (USA)). Anti-c-Myb (C-19 and M l9) antibodies, anti-
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B-Myb (C-20) antibodies, anti-Oct-1 antibodies, anti-NFxB antibodies and anti-C/EBP P 
(C-19) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, USA). Jurkat 
cell lysate was obtained from Upstate biotechnology (Lake Placid, New York, USA). Anti­
mouse Immunoglobulin horseradish peroxidase linked whole antibody from sheep was 
obtained from Amersham Pharmacia Biotech. Antibodies against phosphylated serine 
residues of the C-terminal domain (CTD) o f Pol II (Ser5, MMS-134R clone H14; Ser2, 
MMS-129R clone H5) were obtained from Covance (CaHfomia, USA). Antibodies to anti-T 
antigen pAblOl (sc-147) were obtained from Santa Cruz Biotechnology (Santa Cruz, USA).
2.1.3
Enzym es
Restriction endonucleases Bgl II and Nhe I were obtained from Roche Diagnostics (Lewes, 
United Kingdom). Restriction endonuclease Bst Z 171 was obtained from New England 
Biolabs (Hitchin, UK). Biotaq DNA polymerase was obtained from Bioline (London, UK).
2.1.4
Northern and Western blots
All Northern blots and Western blots were performed using Hybond-N+ membranes and 
Hybond-P membranes respectively (Amersham Pharmacia Biotech). Western blots were run 
on the XceU II blot module using NO VEX pre cast NuPAGE Bis-Tris SDS-PAGE mini­
gels all obtained from Invitrogen (Paisley, UK).
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2.1.5
XrayGlm, Luminometer and Phosphoimager equipm ent
All autoradiography was performed using X-OMAT AR film from Kodak (Hemel 
Hempstead, United Kingdom). Cyclone storage phosphor screen and imager were obtained 
from Packard Bioscience (Pangboume, UK). Luminometer readings were obtained from a 
Turner TD-20e Luminometer (Sunnyvale, California, USA).
2.1.6
Molecular K its
Promega Corporation 
Qiagen Ltd (Crawley, UK) 
Amersham Pharmacia Biotech 
Amersham Pharmacia Biotech 
Amersham Pharmacia Biotech 
Amersham Pharmacia Biotech
Dual-Ludferase reporter assay system 
Qiagen Plasmid Midi Kit 
Megaprime DNA label system 
QuickPrep micro mRNA Purification 
First-Strand cDNA synthesis Kit 
ECL+Plus Western blotting detection system
2.1.7
N ucleotides
Nucleotides [a- P] dCTP, 371.2 MBq/ml were supplied by Amersham Pharmacia Biotech.
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2.1.8
RNA and D NA Size markers
RNA size markers for Northern Blot agarose gel electrophoresis were obtained firom Sigma- 
Aldrich. DNA size markers for agarose gel electrophoresis were obtained from Invitrogen 
(Paisley, UK).
2.1.9
DNA Primers
All DNA primers and oligonucleotide probes were obtained from Invitrogen (Paisley, UK) 
and MWG-Biotech (Ebersberg, Germany).
2.1.10
Virus and Human Cell Lines
Human HEp-2 laryngeal epithelial cells. Human A549 pulmonary type II epithelial cells. 
Human H460 pulmonary epithelial cells, acute T-ceU leukaemia cell line Jurkat and human 
long strain of RSV (A2) and COS-7 cells were obtained from the American Type Culture 
Collection, (Manassas, Va), EBV-transformed B ceU lines were obtained from the Centre 
d’Etude du Polymorphisme Humain (CEPH) collection (Coriell Institute for Medical 
Research). Competent D H 5a bacterial cells of library efficiency were obtained from 
Invitrogen (Paisley, UK).
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Methods
2.2.1
A549 cell culture
A549 cells were cultured in Kaighn’s modified media (F12K) (Invitrogen, Paisley, UK) 
supplemented with lOOU/ml peniciUin, 100 m g/m l streptomycin, 2 mM L-glutamine and 
10% foetal bovine serum and incubated at 37°C in 5% COj.
2.2.2
H460 cell culture
H460 cells were cultured in RPMI medium supplemented with lOOU/ml penicillin, 100 
mg/ml streptomycin, 2 mM L-glutamine, 1.5g/l sodium bicarbonate, 4.5g/l glucose, lOmM 
HEPES and 10% fetal bovine serum. Cells incubated at 37°C in 5% CO^
2.2.3
H Ep2 cell culture
Human HEp-2 laryngeal epithelial cells were grown in Dulbecco’s modified eagles medium 
(DMEM) (Sigma-Aldrich) supplemented with lOOU/ml penicillin, 100 m g/m l streptomycin, 
2 mM L-glutamine and 5% foetal bovine serum. Cells were incubated at 37°C in 5% CO2.
2.2.4
Jurkat cell culture
Jurkat cells were cultured in RPMI medium supplemented with lOOU/ml penicillin, 100 
mg/ml streptomycin, 2 mM L-glutamine and 10% foetal bovine serum. Cells were incubated 
at37°C in5%  COg,
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2.2.5
COS cell culture
COS-7 cells were cultured in DMEM supplemented with 10% foetal bovine serum, lOOU of 
penicillin per ml, lOOmg of streptomycin per ml, 0.2mM L-glutamine and 0.1% glucose. 
Cells were incubated at 37°C in 5% CO2  CeU culture of COS-7 ceUs was performed by 
Senior Research FeUow Irina Udalova and used with her permission.
2.2.6
EBV-transformed B  cell line culture
EBV-transformed B ceU lines from the CEPH coUecdon (CorieU Institute for Medical 
Research) were cultured to a ceU count of 16 x 10  ^ ceUs per ml in RPMI medium 
supplemented with lOOU/ml penicUlin, 100 m g/m l streptomycin, 2 mM L-glutamine and 
10% foetal bovine serum at 37°C in 5% CO2  CeUs were stimulated with 200nM PMA and 1 
pM ionomydn. EBV-transformed B ceU line culture and stimulation was performed by 
Brendan Keating, D.PhU student.
2.2.7
Primary respiratory epithelial cell harvest and culture
Consent to approach patients for anonymous tissue coUecdon was obtained from the 
Oxfordshire research ethics committee (OXREC) number 99/5/27. Healthy adult patients 
admitted to the John Raddiffe Hospitals NHS Trust for routine day surgery were consented 
for primary nasal epitheUal ceU harvest by odbrush ceU coUector (Orifice Medical AB, 
Henleys Medical, Welwyn Garden City, UK) brushes under general anaesthetic. CeU
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collections were taken by brushing on the lateral wall of the pharynx below the inferior 
turbinate. The cells from each nostril were then pooled in 4 mis of Kaighn’s modified media 
(FjjIQ supplemented with lOOU/ml penicillin, 100 m g/m l streptomycin, 2 mM L-glutamine 
and 10% foetal bovine serum and 30 ng/ml TNF. They were then divided into two aliquots 
of 2 mis and incubated at 37°C in 5% CO^ for three and six hours respectively. AU patients 
had a 5 ml venous blood sample taken for genotyping for -251 and +2767 SNPs and to act 
as a source of genomic DNA. Regular smokers were excluded as they were likely to have a 
significant proportion of stratified squamous epitheUa present in their pharynx as opposed to 
the normal pseudo-stratified dUated columnar epitheUum. AU ceU coUections were checked 
under a microscope for the presence of motile dUa indicative of the presence of dUated 
columnar epitheUal ceUs. In total 30 patients were recruited aU of whom were Caucasian in 
ethnic origin. There were 21 women and 9 men.
2.2.8
RSV culture
HEp-2 ceUs were cultured in DMEM supplemented with with lOOU/ml penidUin, 100 
mg/ml streptomycin, 2 mM L-glutamine, 2.5% foetal bovine serum and 20mM Hepes. 
When confluent the ceUs were infected with unpurified RSV at a multipUdty of infection 
(MOI) of 1. After two hours of incubation at 37 °C the media were replaced with fresh 
medium. The ceUs were incubated for a further 48 hours untU viral cytopathological changes 
were present in 75 to 100% of the HEp-2 ceUs. The RSV virus was then harvested 
according to the purification protocol detaUed below. For the experiments, A549 ceUs were 
grown to approximately a 60% monolayer in F 12K  media supplemented with lOOU/ml 
penidUin, 100 mg/ml streptomycin, 2 mM L-glutamine 2.5% fetal bovine serum and 20mM
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Hepes. During this logarithmic growth phase cells were infected with purified RSV at a 
multiplicity of infection (MOI) of 1. After two hours of incubation at 37 °C the media were 
replaced with fresh medium.
2.2.9
RSVpurification
RSV purification was performed using a protocol modified from a previously published 
method (Ueba 1978). Infected HEp-2 cells were scraped from the flask with glass beads 
after which the supernatant was collected and centrifuged at 2,000g for 15 minutes at 4°C. 
The RSV supernatant was then pooled and mixed for 2 hours at 4°C with 50% polyethylene 
glycol (PEG) such that the final concentration was 10% PEG. Then the RSV 
supematant/PEG mix was centrifuged at 10,000g for 30 minutes at 4°C. The resulting 
supernatant was divided and placed on a discontinuous sucrose gradient of 30% sucrose and 
60% sucrose diluted in media supplemented with lOOU/ml penicillin, 100 m g/ml 
streptomycin, 2 mM L-glutamine 2.5% foetal bovine serum and 20mM Hepes. This gradient 
was then centrifuged at 82,000g at 4°C for 90 minutes. A white band containing the purified 
RSV was identified within on the sucrose gradient, isolated and pooled. The pooled 
concentrated RSV was then divided into aliquots and snap frozen in dry ice and ethanol after 
which it was stored for 24 hours at —80 °C and thereafter liquid nitrogen. No TNF was 
found in the sucrose purified RSV (pRSV) preparation.
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2.2.10
R SV  inactivation
RSV was inactivated following exposure to a 254 nm Ultra-violet light source for a time of 
three minutes.
2.2.11
RSVprotein staining
To confirm that the cells were infected with RSV, cultures were stained for viral protein 24 
hours post-infection using a specific rabbit polyclonal antiserum.
2.2.12
Northern B lot
Six well plates containing the cultured A549 cells were placed on ice after which the cells 
were washed twice with pre cooled phosphate buffered saline (PBS) at 4°C. TRI reagent 
(Sigma-Aldrich) was then added and mixed to achieve a homogeneous lysate. RNA 
extraction then proceeded as per protocol (Sigma-Aldrich 1999). Extracted RNA was heated 
at 65°C for 10 minutes after which it was cooled on ice and run on a denaturing 1.4% 
agarose and formaldehyde gel. Movement of the RNA to the Hybond-N+ membrane was 
performed by overnight capillary transfer. The RNA was subsequently stabilized with UV- 
cross linking. IL8 and P-actin DNA probes were radio-labeled with [a-^^P] dATP using the 
Megaprime DNA label system and after heat dénaturation at 98°C were hybridised to the 
membrane in the presence of Rapid-Hyb buffer at 65°C overnight. Unhybridised probe was 
removed by stringency washing in SSC and SDS buffers (Sigma-Aldrich) before the 
membrane was exposed to OMAT AR film (Kodak).
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2.2.13
N itric Oxide assay
In these experiments reactive nitrogen intermediates (RNI) were measured as these include 
aU the immediate products of the NOS reaction (.NO radical, NO', NO^) and their resulting 
conversion products such as N 0 2 , N 02-, N 03 , and peroxynitrite (ONOO). Reactive 
nitrite intermediates (RNI) were measured in culture supernatants using the Griess reaction 
after reduction of nitrate to nitrite as previously described (Rockett et al. 1998). JSF- 
monomethyl-L-arginine (L-NMMA) was synthesized as previously described (Patthy et al. 
1977).
2.2.14
Total Protein Assay
A549 cells were washed twice with PBS and lysed with passive lysis buffer preparation 
(Promega Corporation). Protein contents of this cellular extract were measured by a 
spectrophotometric (Bradford) assay using Bovine serum albumin as a standard (Bio-Rad 
protein detection reagent, Bio-Rad Laboratories, Hemel Hempstead, UK).
2.2.15
Enzym e linkedim m unosorbant assay (ELISA)
IFNy, TNF and IL -ip  were quantitated in cell culture supernatants by double antibody 
(sandwich) quantitative enzyme-linked immunosorbent assay (ELISA) (Smith 1993) kits 
(R&D Systems, Abingdon, United Kingdom) according to manufacturer’s protocol. The 
sensitivity of detection of the IFNy, TNF, IL -lp  and IL-8 assays were 15.6 pg/ml, 15.6 
pg/ml, 3.9 pg/m l and 10 pg/m l respectively.
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2.2.16
IL8 construct
The 1.4kb 5’-flanking promoter region of the LL8 gene was obtained by polymerase chain 
reaction (PCR) ILS gene amplification of human genomic DNA and cloned into a basic 
pGL2 vector that contains the firefly ludferase gene in the absence of DNA that confers any 
transcriptional activity. In order to examine the relative importance o f this gene region to 
IL-8 expression truncated constructs at —1019, -789, -389, -169, -109 and -49 base pairs from 
the transcription start site were also constructed. Construct design and synthesis was 
performed by Senior Research Fellow Irina Udalova and used with her permission.
2.2.17
C /E B P P  construct
The original CMV-NFIL6 construct was a kind gift from D r Aldra. The EcoRI/Sall 
fragment, encoding the fuU length protein was subsequently recloned into EcoRI/XhoI 
pcDNA3.
2.2.18
IL8 construct bacterial transformation, culture andpurification
Competent D H 5a bacterial cells (25 pX) were transformed with the interleukin-8 construct 
by heat shock at 37 ®C for 45 seconds followed by immediate incubation for 2 minutes at 
4®C. Following selective culture on LB/ampidllin plates (50 pg/ml) a single colony was 
grown up in liquid LB media overnight after which the IL-8 construct was extracted using
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the Qiagen Plasmid Midi Kit according to the manufacture’s instructions. Construct 
integrity was checked by restriction endonuclease digest with Bg/ll and Nhe I enzymes.
2.2.19
Interleukin-8 construct transfection into AS49 and H460 cells
A549 ceUs were transfected using the FuGene 6 Hpid-based transfection reagent (Roche 
Diagnostics Limited). On the day before transfection A549 and H460 cells were seeded at 
60,000 ceUs/cm^ to achieve 50 to 80% confluence 16 hours later. Fugene 3 pi per welf was 
placed in 100 pi of F 12K  after which 1 pg o f plasmid DNA solution (0.5 pg/pl) was added. 
After incubation for 45 minutes at room temperature 100 pi transfection mix was added to 
each 35 mm well which contained 2ml of F 12K  serum containing media. After 24 hours the 
cells were stimulated with either RSV or cytokines and then harvested at the appropriate 
time point according to the Promega ludferase assay system protocol. Briefly, A549 cells 
were placed on ice after which the cells were washed twice with PBS at 4°C. They were then 
lysed with 250 pi of Promega cell culture lysis reagent, scrapped firom the well and stored at 
—70°C until assayed. Prior to the assay aU samples were centrifuged to remove cell debris. 
Ludferase activity measurement was made by mixing 10 pi o f cell lysate with 90 pi of 
Promega Ludferase reagent II. Peak light intensity was determined on a luminometer. 
Ludferase measurements were corrected for protein content of the cell lysate, by Total 
Protein assay protocol as detailed below, and expressed in terms of fold activation of 
stimulated over unstimulated cell lysate ludferase values. To control for transfection 
effidency a pRL-TK plasmid co-reporter vector was co-transfected with the experimental 
vector at a ratio of 1:50. The pRL-TK contains a herpes simplex virus thymidine kinase
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promoter upstream of a renilla ludferase gene. Assay of the ludferase signal and correction 
with the renilla luminescence was performed using the Dual-Ludferase reporter assay 
system.
2.2.20
Nuclear extracts and Electrophoretic m obility shift assay (EMSA)
Oligonucleotide probes were annealed at 100 degrees and slowly cooled to room temperature 
after whch they were radiolabeled with [a-^^P]dCTP using Klenow enzyme (Roche). The 
individual probes used were:
251A (F: agctGAAATAAAAAAGCATACAATTGATAATTCACCAAATrG;
R: agctCAATlTGGTGAATrATCAATrGTATGCTrmTATlTg;
251T (F: agctGAAATAAAAAAGCATACATTTGATAATrCACCAAATTG;
R: agctCAATITGGTGAATTATCAAATGTATGCrrmTA'nTQ;
396G (F: agctATlTATACCAGGTAGCATGCA; R: agctTGCATGCTACCTGGTATAAA'I);
396T (F: agctATTTATACCATGTAGCATGCA; R: agctTGCATGCTACATGGTATAAAT);
781T (F; agctTATAGGAAGTTGTTCAATGTT; R: agctAACATTGAACAAdTCCTATA);
781C (F: agctTATAGGAAGTCGTTCAATGTT; R: agctAACATTGAACGACTTCCTATA);
1238delA (F: agctCAAAACAAAATAAAAATATlT; R: agctAAATAlTTTT ATITrGTlTTG);
1238insA (F: agctCAAAACAAAAATAAAAATATTT; R; agctA A A TA l'lTTlA TlTriG TnTG );
1633T (F; agctnTGTTGTACITATGACCAGAA; R: agctTTCTGGTCATAAGTACAACAA);
1633C (F: agctTTTGTTGTACTCATGACCAGAA; R: agctTTCTGGTCATGAGTACAACAA);
2767T (F: agctATTTCAGATATACAACAAATA; R: agctTATTTGTTGTATATGTGAAAT);
2767A (F: agctATITCAGATAAACAACAAATA; R: agctTATrrGTTGTITATGTGAAAT)
c-Myb wild type (F: agctTCTACACCCTAACTGACACAT; R: agctATGTGTCAGTTAGGGTGTAGA) 
C-Myb mutant (F: agctTCTACACCCTGGCTGACACAT; R; agctATGTGTCAGCCAGGGTGTAGA)
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A549 cells were stimulated with pRSV at an MOI of 1 and harvested at 0, 2, 4, 8, 16, 24 and 
48 hours after activation. Jurkat cells were stimulated with PMA (50 ng/ml) for a duration 
of 20 hours. Nuclear extracts were prepared as described previously (Schreiber et al. 1989). 
The binding reaction contained 12mM HEPES, pH 7.8, 80-100 mM KCl, 1 mM EDTA, 1 
mM EGTA, 12% glycerol, and 0.125 to 0.25 pg/m l of poly(dI-dC) or poly(dA-dT). Nuclear 
extracts (2 pi) were mixed in an 8 pi reaction with 0.2-0.5 ng of labeled probe (1 to 5 x lO'^  
counts per minute) and incubated at room temperature for 10 minutes. The reaction was 
analysed by electrophoresis in a nondenaturing 5% polyacrylamide gel at 4°C in 0.5xTBE 
buffer. For supershift analysis, the reaction mixture was incubated with appropriate 
antiserum at room temperature for 5-10 minutes prior to the addition o f the labeled probe. 
Indicated gels were quantified using the Phosphoimager.
2.2.21
UV Cross linking
The binding reaction was performed with radiolabelled oligoduplex corresponding to the 
-251A in which a dT close to the SNP were substimted with bromodeoxyuridine (BrdU) as 
follows:
251.BrdUA (F: agctGAAATAAAAAAGCATACAAT(BrdU)GATAATTCACCAAATTG;
The EMSA gel was UV illuminated at 302nm for 30 minutes at 4°C and exposed to 
autoradiography for 2 to 4 hours at the same temperature. The region corresponding to the 
DNA-protein complex was excised and the proteins were eluted in 2xSDS buffer (lOOmM 
Tris-Cl, ph 6.8, 200mM dithiothreitol, 4% SDS, 20% glycerol) at 37°C overnight. Final
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products were analysed on either a 10% Bis-Tris MOPS-SDS NuPAGE gel (Invitrogen) or 
on a 4-12% Bis Tris MOPS-SDS NuPAGE gel (Invitrogen).
2.2.22
mKNA extraction and cDNA synthesis
For IL-8 transcripts mRNA extraction and cDNA synthesis were performed with QuickPrep 
micro mRNA Purification kit and First-Strand cDNA synthesis kit respectively according to 
manufacturer’s instructions. For transcripts from EBV-transformed B cell lines total RNA 
was isolated using TRI reagent (Sigma). Following this cDNA was prepared with random 
decamers and AMV reverse transcriptase after which relative quantitative RT-PCR (Ambion) 
was performed according to manufacturer’s instructions. Transcripts from EBV- 
transformed cell lines were prepared by Brendan Keating, D.PhU student.
2.2.23
Semiquantitative Polymerase Chain Reaction and allelic-speciûc restriction digest 
otherwise known as m utant analysis b y  PCR and restriction enzym e cleavage 
(MAPREC)
Genomic DNA and cDNA dissolved in TE were assayed by semiquantitative PCR as 
described previously (Takahashi et al. 2000) with the following primers:
[1] F: ACCCAGTTAAATnTCATITCAGGTA; [2] R: CAGCTGGCAATGACAAGACTG.
First round PCR amplification was performed using 5ng genomic DNA or cDNA in a 15 pi 
reaction volume using 0.25U Biotaq in Ix PCR reaction buffer with 0.4 mM dNTPs, 1.9 mM 
MgClj, and 0.2 pM each primer. The reactions were denatured at 94°C for 2 minutes 
followed by 28 cycles of 94°C for 30 seconds, 60°C for 30 seconds, 72®C for 30 seconds
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followed by final extension at 72*^ C for 10 minutes. Amplification was carried out in skirted 
96 well plates using an M[ Tetrad thermal cycler. To ensure the PCR reaction produced 
adequate amplification a 5pi aliquot from each reaction was then electrophoresed on a 5% 
agarose gel. A 1.5pl volume PCR reaction mix containing Ix PCR reaction buffer with 0.4 
mM dNTPs, 1.9 mM MgCl^, and 0.02 mM [a-^^P]dCTP was then added to each reaction and 
denatured at 94°C for 2 minutes followed by 60°C for 30 seconds and 72®C for 15 minutes. 
Primer [1] was designed to introduce a Bst Z 171 restriction site in the 2767T allele. The 
amplification products were restriction digested with Bst Z 171 and then electrophoresed on 
an 8% non-denaturing polyacrylamide gel. The quantity of amplification product was then 
quantified using the Phosphoimager.
2.2.24
Primer extension and M ass spectrom etry (PE/M S) for IL8 transcript allele-speciflc 
quantitation
First round PCR amplification was performed using 50ng genomic DNA or cDNA in a 20 
pi reaction volume using 0.025U Biotaq in Ix PCR reaction buffer with 0.8mM dNTPs, 
1.9mM MgCl^, and 0.2pM each primer ([1] F: ACGTTGGATGTCAGATAAACAATAATGTAC; [2] 
R: ACGTrGGATGGGGTACCCAGTTAAATnTC). The reactions were denatured at 96°C for 4 
minutes followed by 5 cycles of 96®C for 45 seconds, 56°C for 45 seconds, 72°C for 30 
seconds and then 30 cycles of 94°C for 45 seconds, 65°C for 45 seconds, 72®C for 30 
seconds and finished by a final extension at 72°C for 10 minutes. Amplification was carried 
out in skirted 96 well plates using an ]V^  Tetrad thermal cycler. Each PCR reaction was
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subaliquoted into 4 wells on a 384 well plate, 4pl per well, Non-incorporated dNTPs were 
removed using shrimp alkaline phosphatase by incubating at 37°C for 20 minutes followed 
by 85°C for 5 minutes. Primer extension was performed using homogeneous 
MassEXTEND (Sequenom) reaction comprising a mix of 100 pM extension primer 
(CCAGTTAAATrrTCATrTCAGATA), 0.576U MassEXTEND enzyme, buffer and a 
termination mix of dATP, ddTTP, ddCTP and ddGTP. Primer extension was performed at 
94°C for 2 minutes then 40 cycles o f 94°C for 5 seconds, 52°C for 5 seconds and 72®C for 5 
seconds. Products of primer extension were desalted using SpectroCLEAN (Sequenom) 
resin and transferred onto a SpectroCHIP (Sequenom) microarray by SpectroPOINT 
(Sequenom) nanolitre dispenser. Matrix-assisted laser desorption time-of-flight mass 
spectrometry (MALDI-TOF) analysis was performed using a SpectroREADER (Sequenom) 
mass spectrometer.
2.2.25
Preparation o f  Chromatin
Cells were lysed and sonicated using a protocol modified from that which has been 
previously described (Takahashi et al. 2000). Approximately, 16 x 10  ^cells were cross-linked 
using formaldehyde at a final concentration of 1% for 45 minutes at room temperature after 
which the reaction was quenched using glycine at a final concentration of 0.125M. Cells 
were lysed and the nuclei collected by incubating and then centrifuging the cell pellets in the 
following buffers: buffer A 20mls (50mM Hepes-KOH pH 7 .5 ,140mM NaCl, ImM EDTA, 
10% Glycerol, 0.5% NP-40, 0.25% Triton X-100, Ix Complete protease inhibitors (Roche) 
ImM benzamidine, 50pg/ml TLCK, 50pg/ml TPCK, Ipg/m l pepstatin, lOmM sodium
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pyrophosphate) at 4°C for 10 minutes; buffer B 16 mis (200mM NaCl, ImM EDTA pH 8, 
0.5mM EGTA pH 8, lOmM Tris pH 8, Ix Complete protease inhibitors (Roche) ImM 
benzamidine, 50jLig/ml TLCK, 50pg/ml TPCK, Ipg/m l pepstatin, lOmM sodium 
pyrophosphate) at 25°C for 10 minutes and finally buffer C lOmls (ImM EDTA pH 8, 
0.5mM EGTA pH 8, lOmM Tris-HCl pH 8, Ix Complete protease inhibitors (Roche) ImM 
benzamidine, 50pg/ml TLCK, 50pg/ml TPCK, Ipg/m l pepstatin, lOmM sodium 
pyrophosphate) at 4°C for 10 minutes. Cells were sonicated at 4°C using a Branson 450 
sonifier using a medium tip first for 40 cycles (4 second burst with 8 seconds pause) at an 
amplitude of 20% followed by 40 cycles (4 second burst with 8 seconds pause) at an 
amplitude of 30%. The lysed sonicated cells were then centrifuged, the pellets discarded and 
the chromatin supernatant saved for further processing.
In experiments to optimize the purification of chromatin fragments chromatin suspension 
was adjusted to contain 0.5% N-laurosarcosine and placed on a discontinuous cesium 
chloride (CsCl) gradient as follows: 30.29g, 20.21g and 12.07g of CsCl were diluted in 30 ml 
o f Tris-EDTA (TE) solution (lOmM Tris-HCl pH8, ImM EDTA) to give 1.75g/cm^ 
1.5g/cm^ and 1.3g/cm^ density CsCl solutions respectively. CsCl gradients are formed by 
gently overlaying successively less dense solutions in ultraclear centrifuge tubes 14 x 89mm 
(Beckman). Chromatin solutions were added to the top of the CsCl gradient and centrifuged 
at 165,000g for 20 hours at 20%. After centrifugation 1ml fractions were removed from the 
gradient and the distribution of chromatin estimated by running a 12pl aliquot of each on a 
1% TBE agarose gel. Fractions containing chromatin were pooled (usually 3 to 5 in
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number) and dialysed overnight in 2 litres of dialysis buffer (lOmM Tris-HCl pH 8, ImM 
EDTA pH 8, 0.5mM EGTA pH 8, 10% glycerol, lOmM sodium pyrophosphate) using 
spectra/por (Fisher) dialysis membrane. The Chromatin was divided into 1ml aliquots, snap 
frozen in dry ice and ethanol and then stored at -80°C
When not ustilising caesium chloride gradient purification a small aliquot of the Chromatin 
supernatant was diluted with N-laurosarcosine (Sigma) to 0.5% and run on a 1.4% TBE 
agarose gel to ensure that the chromatin fragments were sonicated to between 0.5 and 3 
kilobases. A second small aliquot was used to estimate the chromatin concentration by OD 
quantitation. The Chromatin was then diluted with glycerol to a final concentration o f 10%, 
divided into 1ml aliquots, snap frozen in dry ice and ethanol and then stored at -80°C.
2.2.26
Chromatin immunoprécipitation
Immunoprécipitation of chromatin was achieved through the use of magnetic beads. 
Dynabeads M-280 precoated with sheep anti-mouse IgG (Dynal) were washed twice in 
Phosphate buffered saline containing 5mg/ml BSA (PBS-BSA) (Sigma) and then incubated 
overnight at 4°C on a nutator with the relevant mouse monoclonal antibodies in PBS-BSA. 
For the immunoprécipitation of phosphorylated Pol II specific antibodies against 
phosphorylated serine residues of the Crterminal domain (CTD) of the enzyme (Ser5, MMS- 
134R clone H I4; Ser2, MMS-129R clone H5; Covance, Princeton, USA) were used. As a 
control a mock antibody raised against the anti-T antigen pAblOl (sc-147; Santa Cruz 
Biotechnology, Santa Cruz, USA) was used. Unbound antibody was removed from the
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beads by washing three times with PBS-BSA after which the antibody-beads were incubated 
overnight at 4°C on a nutator with 200pg chromatin in Ix RIPA buffer (lOmM Tris HCl pH 
8, ImM EDTA, 0.5mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 
560mM NaCl) containing in addition 5mM Sodium pyrophosphate, Ix complete protease 
inhibitors (Roche) and 5jig/ml pepstatin (Roche). The bead-chromatin 
immunoprécipitations were washed twice with Ix RIPA-POL buffer (lOmM Tris HCl pH 8, 
ImM EDTA, 0.5mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 1% sodium 
deoxycholate, 0.1% SDS, Ix complete protease inhibitors, 5pg/ml pepstatin lOmM sodium 
pyrophosphate) containing 140mM NaCl, once with Ix RIPA-POL buffer containing 
lOOpg/ml Salmon sperm, once with Ix RIPA-POL buffer containing lOOpg/ml Salmon 
sperm and 300mM NaCl and once with Ix RIPA-POL buffer containing 250mM liC l. To 
remove the monoclonal antibody the washed beads were then re-suspended beads in 50pl of 
TE digestion buffer containing 1% SDS and incubated at 65°C for 10 minutes. The beads 
were pelleted by centrifugation after which 120pl of TE was added. In order to reverse the 
crosslinks between the transcription factors and the DNA the beads were incubated at 65°C 
overnight to reverse cross-links. The proteins that were associated with the DNA were then 
digested by the addition of proteinase K  to a final concentration of 200pg/ml and incubated 
at 37°C for 2 hours. The DNA was then purified with a phenol-chloroform extraction and 
precipitated with ethanol in the presence of 20pg glycogen. To remove RNA from the 
preparation the pellets were re-suspended in 30pl TE containing lOjilg RNase A and 
incubated at 37°C for 1 hour. Finally the DNA was purified through a spin column 
(Qiagen) and eluted in 200pl of TE. In order to ensure the specificity of each 
immunoprécipitation a sample of DNA template derived from Anti-H14, Anti-H5 and
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Anti-SV40 antibody immunoprécipitations was amplified under the following conditions: 
denatured at 96*^ C for 1 minutes followed by 5 cycles of 96°C for 35 seconds, 68®C for 45 
seconds, 72°C for 35 seconds and then 21 cycles of 96°C for 25 seconds, 65°C for 50 
seconds, 72®C for 40 seconds and finished by 6 cycles of 96°C for 35 seconds, 56°C for 60 
seconds, 72®C for 1 minute 30 seconds. The products were run on a 1% TBE agarose gel. 
No significant DNA was detected after immunoprécipitation using anti-SV40 antibodies.
2.2.27
Primer extension and M ass spectrom etry (PE/M S) for TN F/LTA locus allele- 
specific quantitation byhaploCH IP
First round PCR amplification was performed using 50ng genomic DNA or cDNA in a lOpl 
reaction volume using 0.2U Biotaq in Ix PCR reaction buffer with 0.2mM dNTPs, 1.9mM 
MgCl2, and 0.2|LiM each primer. The following primers were used:
LTA+10 (1«: ACGTTGGATGTATAAAGGGACCTGAGCGTQ
2”d: ACGTTGGATGTAGTCCAAAGCACGAAGCAC);
LTA+80 (1®‘: ACGTTGGATGATCCAGGCAGCAGGTGCAG;
2”d: ACGTTGGATGCCGTGCTrCGTGCnTGGAC);
LTA+252 (F*: ACGTTGGATGGAGAGACAGGAAGGGAACAG;
2”d: ACGTTGGATGACTCTCCATCTGTCAGTCTQ;
LTA+368 (1« ACGTTGGATGCTGCATCITGTCCCCTrCTC
2“d;ACGTrGGATGAAGACAGACCTCCCGCCCT);
LTA+723 (F‘: ACGTTGGATGTCAGCACCCCAAGATGCATQ
2"d: ACGTTGGATGGAGGTCAGGTGGATGTITAQ;
TNF-1032 (F‘: ACGTTGGATGGGGAAGCAAAGGAGAAGCTG;
2«d; ACGTTGGATGTACATGTGGCCATATCTCCC);
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The reactions were denatured at 96®C for 1 minute followed by 5 cycles of 96®C for 35 
seconds, 68*^ C for 45 seconds, 72®C for 35 seconds and then 21 cycles of 96°C for 25 
seconds, 65°C for 50 seconds, 72°C for 40 seconds and finished by 6 cycles o f 96°C for 35 
seconds, 56®C for 60 seconds, 72°C for 1 minute 30 seconds. Amplification was carried out 
in skirted 96 well plates using an MJ Tetrad thermal cycler. Each PCR reaction was 
sub-aHquoted into 2 wells on a 384 well plate, 4\xl per well. Non-incorporated dNTPs were 
removed using shrimp alkaline phosphatase by incubating at 37°C for 20 minutes followed 
by 85®C for 5 minutes. Primer extension was performed using homogeneous 
MassEXTEND (Sequenom) reaction comprising a mix of 100 |xM extension primer, 0.576U 
MassEXTEND enzyme, buffer and a termination mix of ddATP, ddTTP, ddCTP and 
dGTP. The following extension primers were used:
LTA+10 GAGAGCCTCACCTGCTGTG
LTA+80 GTGdTTGGACTACCGCCC
LTA+252 CACATrCTCTGTITCTGCCATG
LTA+368 CCTCCCGCCCTGGGAGA
LTA+723 GGTGAGCAGCAGGTTTGAGG
TNF-1032 CCAGACCCTGACl'lTT'CCrrC
Primer extension was performed at 94°C for 2 minutes then 40 cycles of 94°C for 5 seconds, 
52‘^ C for 5 seconds and 72°C for 5 seconds. Products of primer extension were desalted 
using SpectroCLEAN (Sequenom) resin and transferred onto a SpectroCHIP (Sequenom) 
microarray by SpectroPOINT (Sequenom) nanolitre dispenser. Matrix-assisted laser 
desorption time-of-flight mass spectrometry (MALDI-TOF) analysis was performed using a 
SpectroREADER (Sequenom) mass spectrometer. In order to control for random variation
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between experiments immunopredpitated DNA was paired with genomic DNA from the 
same cell line on each chip and then assayed by PE/MS.
2.2.28
Western Blotting
A549 and Jurkat nudear extract preparations as well as Jurkat cell lysate preparations were 
denatured by heating at 75°C for 5 minutes and then run on a NuPAGE Bis-Tris SDS- 
PAGE pre-cast mini-gel using NuPAGE MEPS SDS running buffer after which the gels 
were blotted onto Hybond-P membranes at 100 V over 1 hour. The membranes were then 
dried as directed by the manufacturer’s instructions (Invitrogen, Paisley, UK). c-Myb and 
C/EBP P proteins were bound with rabbit polyclonal M-19 anti-c-Myb antibody (Santa 
Cruz) and anti-C/EBP P (C-19) antibodies (Santa Cruz) respectively. Detection of bound 
antibody occurred with streptavidin-conjugated anti-rabbit antibody (Amerhsam Pharmada) 
and then ECL solution according to manufacturer’s instructions (Amersham Pharmada). 
The western blot was exposed to OMAT AR film (Kodak) for 10 to 120 seconds.
2.2.29
Statistics
Data are summarized as means with standard errors, geometric means with 95% confidence 
intervals or medians with an inter-quarrile range as most appropriate depending on whether 
they were normally distributed. The significance of differences in mean values, where the 
data had a normal distribution, was determined using Student’s t test or in the case of paired 
data with a paired t test. The sd test was used in parametric analysis to check the assumption 
of equal variance between groups. A two-sided p value was considered significant if  below
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0.05. All analyses were performed using the statistical software package STATA Versions 6 
and 7 (Stata Corporation, College Station, Texas, USA).
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CHAPTER THREE
ESTABLISHING AN I N  VITRO MODEL OF RSV INFECTION
3.1.1
Introduction
Early experiments of unpurified RSV (upRSV) in vitro infection o f human bronchial epithelial 
cell lines showed that multiple cytokines were induced by viral infection including IL-8, IL-6 
and granulocyte macrophage colony-stimulating factor (GMCSF) (Noah, 1993). These in 
vitro studies were confirmed with in vivo studies on children suffering from upper respiratory 
tract RSV infection where nasal lavage fluid showed the presence of IL-lp, IL-8, IL-6 and 
TNF (Noah, 1995). Focused investigation into the role of IL-8, as a chemotactic and 
activating cytokine, began with the observation that polymorphonuclear neutrophils (PMN) 
accounted for 70% of the inflammatory cells in the lower ahway and 93% of the 
inflammatory cells in the nasal lavage samples (Everard, 1994).
The initial experiments on upRSV induced IL-8 expression in Human A549 pulmonary type 
II epithelial cells (A549) showed very early IL8 transcription and a dose response 
relationship between the upRSV multiplicity of infection (MOI) and IL-8 which was 
observed for both active and inactive virus (Fiedler et al. 1995). A possible explanation for 
these data is that contaminating cytokines in the upRSV preparation could have been 
activating IL8 expression. Transfection experiments exaniining the 5’-fianking region of the
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IL8 gene with upRSV as a stimulus showed up to a 13 fold activation of the reporter gene 
(Fiedler et al. 1996).
However, subsequent studies showed that infection o f A549 cells with purified RSV (pRSV) 
induced expression of a number of IL-8 activating cytokines such as IL-1 (3, TNF, IFNy and 
IL -la  (Patel et al. 1995). To remove these cytokines RSV was purified with polyethylene 
glycol precipitation and centrifuge sucrose density gradients (Ueba, 1978). Moreover, pRSV 
stimulation of IL8 promoter constructs transfected into A549 cells showed only a 4 to 5 fold 
activation o f the reporter gene over uninfected controls (Casola et al, 2000).
Prior to embarking on in vitro studies on the effect polymorphisms had on haplotype-spedfic 
IL8 transcription I sought to establish within our laboratory the purification method o f RSV 
and establish an in vitro model of RSV infection of respiratory epithelial cells. I wished to 
clarify the pattern of upRSV and pRSV induced IL8 expression in A549 cells and compare 
this to that seen with TNF induced IL8 expression.
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Results
3.2.1
PutiBed RSV infects and replicates in AS49 cells
I sought to test whether A549 cells were infected with RSV and whether RSV was able to 
form syncytia in this cell hne. A549 cells were infected with pRSV at an MOI of 0.5. The 
presence of RSV protein expression was confirmed up to 24 hours through 
immunocytochemical staining using polyclonal anti-RSV antibodies (Table 3.1). I observed a 
steady increase in RSV protein expression and syncytia formation prior to 48 hours 
following the infection both of which indicate active viral replication.
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Figure 3.1. Expression of RSV protein over time in A549 cells infected with pRSV.
A549 cells were plated and infected with pRSV at an MOI of 0.5. At the time shown they 
were fixed and stained with anti-RSV polyclonal antibody specific peroxidase.
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3.2.2
ILS activating cytokines detected in unpuritied but n o tpu titied  RSVpreparations
I sought to test the hypothesis that the culture o f RSV in Human HEp-2 laryngeal epithelial 
(HEp-2) cells induced the expression of cytokines, some of which had the potential to 
activate IL8. Therefore the purity of both the upRSV and pRSV preparations was tested 
with ELISA assays for known ZL^-activating cytokines. Whilst 165 pg/m l o f IL8 was 
measured no IFN-y, TNF or IL-1 (3 were detected in the sucrose purified viral preparation. 
In contrast, upRSV samples grown on HEp-2 cells showed evidence of IL-8 (7403 pg/ml), 
TNF (16 pg/ml) and IL -ip  (6 pg/ml).
3.2.3
IL-8 production significantly different between upRSV andpRSVpreparations
Having established that cytokines with the potential to activate ILS were present in the 
UpRSV samples but not in the pRSV preparation we sought to investigate whether this 
affected the IL-8 production from A549 cells. A549 cells were incubated with unpurified 
and purified live RSV as well as UV-inactivated unpurified and purified RSV after which the 
IL-8 concentration in the supernatant was measured at different time points. As shown in 
Table 3.1 over the time course unpurified RSV (upRSV) produced a fold increase of 63 in 
IL-8 production (554ng/ml) over cells incubated in media alone. In contrast, purified RSV 
(pRSV) induced only a 3.3 fold increase (27.4ng/ml) in IL-8 production. Therefore IL-8 
production between purified and unpurified RSV preparations was significantly different. 
Moreover, UV -inactivated unpurified RSV also produced 19 fold more IL-8 (516ng/ml) 
than the purified RSV preparation. In contrast, inactivated purified RSV produced no more 
IL-8 (mean 6.68ng/ml) than media controls. These data support earlier work suggesting that
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contaminating cytokines in the unpurified RSV preparation induce IL-8 production both 
independent o f the virus and in synergy with it (Patel et al. 1998). Furthermore this 
phenomenon is not specific to IL-8 as Nitric Oxide is induced also by cytokines and RSV in 
a synergistic manner (Appendix 1).
Table 3.1 IL-8 production after RSV infection
Mean ILrS concentration (ng/ ml) 95% Confidence Interval
upRSV 554 (223,894)
upRSV
UV -inactivated 516 (220,812)
pRSV 27.4 (11.7,43)
pRSV
UV-inactivated 6.6 (3.1,10.3)
Media alone 8.8 (5.8,11.9)
IL-8 production at 72 hours from A549 cells after incubation with purified RSV (pRSV), 
unpurified RSV (upRSV), inactivated pRSV and inactivated upRSV at multiplicity of infection 
o f 1. Observations are mean values from duplicate readings taken fcom four separate 
experiments.
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3,2.4
pR SV  infection ofA549 cells produces IL8 activating cytokines
The induction of ILS activating cytokines from respiratory epithelial cells may prove to be a 
general phenomenon that is not restricted to HEp-2 cells. These cytokines may have a role 
in IL-8 production in A549 cells even after infection with pRSV. In order to determine the 
time course o f ZL^-activating expression from A549 cells infected with pRSV the 
concentrations of TNF, IL -ip  and IFNy were assayed in the supernatant o f cells cultured in 
media alone, cells infected with purified RSV and from cells treated with inactivated RSV. 
T N Fa, IL -ip  and IFNy were not detected in the supernatant in cells cultured in media 
alone or from cells stimulated with inactivated RSV. Whilst neither IL -ip  nor IFNy were 
detected from purified RSV treated A549 cell supernatants TNF was found (as shown in 
Figure 3.3.) at both 48 hours (mean 88.6 pg/ml, SE 51.6) and 72 hours (mean 165.9 pg/ml, 
SE 37.7).
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Figure 3.3. Mean TNF concentrations over time in A549 cell supernatants after 
exposure to purified RSV. Vertical bars represent the standard errors of the mean for 
duplicate readings from two separate experiments.
62
3.2.5
Comparison o f  IL8 transcription in response to TNF andpRSVstim ulation
Having established that TNF is produced following pRSV infection in A549 cells we sought 
to confirm that TNF induced IL8 and to compare the kinetics of IL8 transcription between 
TNF and pRSV. A549 cells were exposed to 40 ng/m l of TNF or pRSV at an MOI of 1 
and the RNA harvested at time points over 48 hours. As shown in the Northern blots of 
Figure 3.4 (a) and (b) IL8 mRNA expression following TN F stimulation was first noted at 
half an hour after stimulation and was at a maximum within 2 hours. This ILS mRNA 
expression was sustained over the 48 hours of the experiment. By contrast, ILS mRNA 
expression following pRSV infection was first noted at 4 hours (Figure 3.4 (c) and (d)) and 
increased over time to reach a maximum level of transcription at the 36 and 48 hour time 
points.
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Figure 3.4. Northern Blot analysis over time of IL8 after TNF stimulation and pRSV 
stimulation. IL8 (a) and P-actin (b) mRNA expression from A549 cells treated with 
TNF at 40 ng/ml with IL8 (c) and P-actin (d) mRNA expression from A549 cells either not 
activated (NA) or treated with pRSV at an MOI of 1. TNF induced ILS transcription 
performed by Dr Helen Fox and shown with permission from the author.
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Discussion
3.3.1
Differences in IL-8 protein production in  A549 cells following upRSV andpR SV  
stimulation
I have demonstrated that within the Kwiatkowski laboratory A549 cells are readüy infected 
by pRSV. The kinetics of viral replication described here are consistent with previous 
reports as Garofalo and colleagues noted that the RSV F protein was present in the 
cytoplasm 8 hours after infection (Garofalo et al 1996). I have shown that the pRSV 
preparation is free from ILS activating cytokines where as the upRSV samples are not. I 
have demonstrated that upRSV infection of A549 cells produces a statistically significant 
increase in IL-8 production when compared with pRSV infection. The dose response 
relationship described here, and in previous reports (Fielder et al 1995), between either active 
or inactive upRSV and IL-8 implies that there are additional activators of IL8 present in the 
UpRSV samples other than RSV. Moreover, I have confirmed that pRSV infection o f A549 
cells produces other inflammatory mediators other than IL-8 such as Nitric Oxide 
(Appendix I) and TNF.
Laboratories using upRSV could not detect IL -ip  or TNF in initial upRSV stock 
preparations grown on HEp-2 cells using an ELISA assay with detection limits o f 20 pg/m l 
(Noah et al. 1993; Fiedler et al. 1995). However, subsequent studies have shown that pRSV 
infection of respiratory epithelial cells did produce a number of inflammatory mediators 
which included IL -la  (121 pg/ml), IL-1 (3 (19 pg/ml) and TNF (77 pg/ml) (Patel et al. 
1995). IL -la , IL-1 (3 and TNF are all known activators of IL8 and it has been reported that
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as little as 10 pg/m l of TNF or IL-1 (3 could induce both IL8 and 1CAM1 expression (Patel 
et al, 1995, Patel et al. 1998). Furthermore autocrine and synergistic up-regulation of IL8 
expression by IL -la , IL -ip  and TNF in pRSV-infected A549 cells has been described (Patel 
et al. 1998). Taken together these reports imply that cytokine contamination of upRSV 
samples could be functionally significant for in vitro studies of A549 cells.
3.3.2
IL8 transcription following upRSV, pR SV and TNF stimulation
Differences in the kinetics o f cytokine production from A549 cells have been noted between 
unpurified and purified RSV. In common with TN F stimulation of A549 cells (Fiedler et al. 
1998; Jamaluddin et al. 1998) upRSV has been reported to induce early ILS mRNA and 
protein expression at 2 hours (Fiedler et al. 1995) whereas purified RSV first induces LLS 
mRNA and protein from 6 hours (Garofalo et al. 1996). The pattern of ILS mRNA 
production described here is consistent with previous reports of pRSV-induced activation as 
transcription starts at low levels by 4 hours and gradually rises to peak by 36 hours.
NF-kB is an essential transcription factor for the transcriptional activation o f ILS 
(Mastronarde et al. 1998; Casola et al. 2000). These distinct patterns in IL-8 protein 
expression in response to upRSV and pRSV are consistent with differences in the kinetics of 
NF-KB binding between the two stimuli. Activation with upRSV causes NF-KB activation at 
15 minutes (Fiedler et al, 1996) a pattern which is similar to that described following TN F
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stimulation (Fiedler et al. 1998; Jamaluddin et al. 1998). In contrast, pRSV produced a 
slower rate o f RelA activation which peaked by 3 fold at 24 hours (Jamaluddin et al. 1998).
Differences in the electrophoretic gel mobility shift assay binding patterns were seen 
between TN F and pRSV stimulated A549 cells. When stimulated with recombinant TNF 
both C l and C2 complexes were present. The C l band predominated and consisted of RelA 
homodimers whereas C2 was supershifted by antibodies to both RelA (p65) and NF-kB1 
(p50) (Jamaluddin et al. 1998). In contrast, pRSV also induced C l and C2 complexes but in 
this instance C2 predominated (Garofalo et al. 1996).
A detailed study of the IL8 gene promoter elements required for activation provided more 
evidence for differences between TNF and pRSV induction of IL8 (Casola et al. 2000). 
TNF stimulated reporter genes when the preceding promoter contained only multimers of 
the NF-kB site. In contrast, pRSV induced activity is reconstituted by an RSV response 
element (RSVRE) (-162 to —132 nt), an AP-1 binding site (-132 to —99) and an NF-IL6 site 
in addition to the NF-kB sites. This imphes that there are very different protein to protein 
as well as DNA to protein interactions required for RSV induced IL8 activation as opposed 
to TNF activation.
Both RSV and TNF cause translocation of NF-kB to the nucleus. The ability o f TN F to 
induce transcription could be explained by differences in REL family subunits (p65 
homodimers predominating over p65-p50 heterodimers) or through post-translational 
modifications of these subunits. For instance, both TNF and IL-1 can stimulate 
phosphorylation of p65 (Zhong et al. 1997; Wang and Baldwin 1998) which is associated
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with both an increase in association with co-activators (such as p300/CPB) as well as an 
increase in transcription (Zhong et al. 1997). Given that TNF and IL-1 are present in 
UpRSV preparations, post-translational modification of REL famüy transcription factors may 
provide some of the explanation for the differences in IL8 induction between upRSV and 
pRSV.
I recognize that in vivo RSV infection of epithelial cells induces the expression of a number 
of cytokines which may act in concert to enhance ILS expression. Even within an in vitro 
model I have shown that the pRSV induces late TNF production which may go on to 
augment IL8 expression (Patel et al. 1998). However, the complexity o f the interactions 
present between RSV and the ILS activating cytokines present in the upRSV preparation 
would be great. The upRSV preparation may prove to be too heterogeneous a stimulus to 
use when attempting to dissect how RSV affects the functional genetics of SNPs within the 
ILS gene.
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3.3.3
Concluding Points
• Purified RSV made within this laboratory infected A549 respiratory epithelial cells 
resulting in RSV protein production and syncytia formation.
•  TNF and IL-1 (3, which are known to be ILS activating cytokines, were detected in 
unpurified but not purified RSV preparations.
•  Activation of ILS is considerably greater when unpurified RSV is used as compared to 
purified RSV.
• TNF is produced on purified RSV infection of A549 cells.
•  TNF induces sustained and profound ILS transcription.
•  Synergistic activation of ILS by the combined action of RSV and IL8 inducing cytokines 
is likely in RSV-induced bronchiolitis.
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CHAPTER FOUR
I N  VIVO HAPLOTYPE-SPECIFIC EXPRESSION OF ILS IN  
PRIMARY CELLS
4.1.1
Introduction
Traditionally, aUele-spedfic variation in gene expression has been associated with epigenetic 
phenomena such as X-chromosome inactivation and genomic imprinting. However, it has 
become apparent that gene expression in non-imprinted autosomal genes varies greatly 
between individuals (Cheung et al. 2003), populations (Oleksiak et al. 2002) and species 
(Enard et al. 2002). Moreover, through experiments conducted in mice it appears that 
allele-spedfic expression patterns are inherited (Cowles et al. 2002). These findings have 
served to undetiie the potential importance of natural variation in non-coding DNA 
sequences in governing gene regulation and subsequent phenotypic diversity (Knight 2004).
There is evidence that DNA sequence variation in the form of SNPs does result in 
allele-spedfic differences in expression in mice (Cowles et al 2002). Cowles and co-workers 
studied FI crosses of four in-bred mice and showed on a screen of genes expressed in liver, 
spleen and brain that 7 out of 69 genes showed allele-spedfic expression. These results were 
verified in the four mouse strains by examining other SNPs within the transcript o f the 7 
genes. Allele-spedfic expression was confirmed in 4 o f the genes where differences in 
expression above 1.5-fold were observed but not in the 3 which had lower degrees of
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differential transcription. O f considerable interest is the observation that aUele-spedfic 
expression is frequently tissue specific in nature. Cowles and colleagues noted that two of 
the four genes under study were aUele-spedficaUy expressed in the liver but not in the brain 
or the spleen (Cowles et al. 2002).
However, the number of genes which are estimated to have allele-spedfic expression is likely 
to be influenced by both the sensitivity of the detection technique and the spedes in which 
the study is conducted. For instance, Cowles et al (2002) used a fluorescently labeled 
dideoxynucleotide primer extension technique which could measure a 1.5-fold difference or 
greater in expression between alleles. Studies of humans have used three different 
techniques namely, the Affymettix HuSNP chip system (Lo et al. 2003), a fluorescent 
dideoxy terminator-based method (Yan et al. 2002) and a primer extension with Genescan 
detection technique (Bray et al. 2003a). For each method the threshold sensitivities for 
differences in fold expression were 2.0, 1.2 and 1.2 respectively. AH three techniques 
estimate that the proportion of aUele-spedfically expressed genes in humans is higher than 
that seen in mice. A smdy of 602 genes using an Affymettix HuSNP chip system conduded 
that in at least one of the 7 individuals allele-spedfic expression occurs in 54% of genes. It 
remains to be seen whether the Affymettix HuSNP chip system is a suffidently accurate 
measure of allele-spedfic expression (Knight 2004). Analysis of human lymphocytes and 
brain tissue using the fluorescent dideoxy terminator-based method (Yan et al. 2002) showed 
that a more modest 46% of genes were allele-spedficaUy expressed. The same proportion of 
aUele-spedficaUy expressed genes was seen with a study using the primer extension with 
Genescan detection technique on brain tissue (Bray et al. 2003a).
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Taken together these data suggest that mammalian aUele-spedfic expression of genes is likely 
to be both common and context spedfic. Given the genetic epidemiological evidence 
suggesting that JJL8 had a role in RSV-induced bronchioHtis disease severity I sought to 
investigate whether IJL8 showed aUele-spedfic expression in primary respiratory epitheUal 
ceUs. As contextual factors appear to be important to aUele-spedfic transcription I sought 
also to investigate whether any such differential expression was tissue spedfic by looking at 
IL-8 production in primary lymphocytes. However, at present there is Uttle understanding of 
what level of aUele-spedfic expression is Ukdy to be physiologicaUy important. I reasoned 
that relatively smaU differences in the expression o f a chemokine with potent properties of 
neutrophU chemotaxis could have an effect on disease outcome. In order to detect these 
smaU differences I sought to measure IL8 aUele-spedfic expression using two different 
techniques namely, mutant analysis by PCR and restriction enzyme cleavage (MAPREC) and 
primer extension mass spectrometry (PE/MS).
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Results 
4.2.1
Optimisation o f  M APREC as a m ethod for haplotype-specitic quantitation
PCR primer [1] was designed so as to introduce a G residue, instead o f the normal A. residue, 
into the PCR product. For example in the +2767T allele forward strand the primer would 
change the normal sequence (the SNP being marked in bold) from 5’-TCAG/lTATAC-3’ to 
5’-TCAGGTATAC-3’. This had the effect of introducing a Bst Z 171 restriction site 
(5’-GTATAC-3’; where the cut occurs at the underlined A residue) into the reverse strand in 
the presence of the +2767T aUele (+2769 5’-GTATACCTGA-3’ +2760) but not the 
+2767A allele (+2769 5’-GTTTACCTGA-3’ +2760). Therefore restriction digestion o f the 
amplified PCR product would produce an uncut 129 base pair (bp) fragment in the case of 
the +2767A allele but 103 bp and 29 bp fragments where the +2767T allele is present.
To ensure that the +2767T and +2767A template alleles had equal amplification the PCR 
reaction was terminated at a cycle number where the amplification process was still in the log 
phase (Figure 4.1). The optimal cycle number was then set between 28 to 30 cycles.
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Figure 4.1
Quantification of product amplification to PCR cycle number. The PCR reaction used 
genomic DNA and [a-^^P]dCTP labeled nucleotides with samples taken every other cycle. 
The PCR samples were electrophoresed on a non-denaturing polyacrylamide gel and the 
amplification product quantified using the Phosphoimager. The graph shows the log phase 
for product amplification occurred between 26 and 30 cycles.
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The restriction digest would be unable to cut the PCR products amplified from the +2767A 
allele but would also be unable to digest heterodimers (for example +2767T Forward 
(5’-TCAGGTATAC-3’) with +2767A Reverse (5’-GTTTACCTGA-3’); and +2767A 
Forward (5’-TCAGGTAAAC-3’) with +2767T Reverse: (5’-GTATACCTGA-3’); the SNP is 
marked in bold) formed through incorrect annealing from the previous PCR cycle. This has 
the potential to bias the quantitation of the PCR products towards the +2767A allele. To 
ensure that does not occur the [a-^^P]dCTP was added in the last cycle only so that there 
would be no further dénaturation and annealing after the incorporation of the radioactive 
signal to the PCR products.
To test the sensitivity of the PCR and the quantification of the radiolabeled digested 
products the technique was tested on a range of standards. Genomic DNA homozygous for 
either the +2767A or the +2767T allele was mixed with concentrations of the other allele at 
ratios (for +2767A/+2767T) of 0.5, 0.8, 1.0, 1.2 and 2.0 (Figure 4.2). After PCR and 
restriction digest over three independent and consecutive experiments the following mean 
values were obtained: 0.58 (95% Cl 0.52, 0.64); 0.88 (95% Cl 0.79, 0.97); 0.99 (95% Cl 0.93, 
1.07); 1.18 (95% Cl 1.1, 1.27) and 1.7 (95% Cl 1.59, 1.81). Therefore, the PCR and 
restriction digest were sensitive enough to detect a significant difference between DNA 
samples of 20% or above.
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Figure 4.2
Standard Curve for haplotype-specific radiolabeled PCR. Standard curves were 
produced for the +2767 SNP by preparing different ratios of genomic DNA (shown on the 
X axis) from two individuals, homozygous AA or homozygous TT at that polymorphism. 
The observed ratios between the A and the T  aUeles were then measured by radiolabelled 
PCR and restriction digest (shown on the y axis). These data were derived from duplicate 
readings for three independent experiments using concentration ratios of homozygous 
genomic DNA (+2767AA over +2767TT) at 0.5, 0.8, 1.0, 1.2 and 2.0. After radiolabeUed 
PCR and restriction digest the following mean values were observed; 0.58, 0.88, 0.99, 1.18 
and 1.7. The regression co-effident is 0.71 (standard error 0.026), R-squared = 95%,
p<0.001.
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4.2.2
Harvest, culture and stimulation o f  prim ary respiratory epithelial cells
30 healthy adult volunteers were recruited from day case surgery operation lists and agreed 
to have primary respiratory epithelial cells harvested from their nasopharynx under general 
anaesthetic. Consent to approach patients for anonymous tissue collection was obtained 
fcom the Oxfordshire research ethics committee (OXREC) number 99/5/27. The primary 
cells were incubated in media containing TNF (5ng/ml) and harvested at 3 or 6 hours. 
Venous blood was taken for genotyping for both the -251 and +2767 SNPs and as a source 
of genomic DNA. O f the 30 patients consented 8 individuals (2 men and 6 women) were 
heterozygote for both the -251 and +2767 SNPs. From these 8 patients the mRNA was 
extracted and the complementary DNA (cDNA) synthesized with no detectable 
contamination by genomic DNA. Maximal IL-8 production from primary epithelial cells 
had previously been observed by 3 hours after stimulation with 30ng/ml of TNF Q Hull 
personal communication). Stimulation with purified RSV resulted in lower level IL-8 
production which, given the relatively small number of primary cells, was not sufficient for 
haplotype-specific expression analysis.
4.2.3
H aplotype-specitic expression o f  IL8 n ot detected b y  M APREC
The +2767 polymorphism is present in the mature mRNA. The quantification of the ratio 
of the +2767A over the +2767T cDNA was obtained by PCR radiolabelled amplification of 
the cDNA and restriction digest. As a control the ratio of the cDNA was compared to that 
o f the genomic DNA as the latter should have a ratio of close to 1. As shown in Figure 4.3 
there was not a significant difference seen between the +2767A/+2767T ratio for cDNA
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compared to genomic DNA for cells incubated for 3 hours. However, the trend was for 
more of the +2767T haplotype to be transcribed than the +2767A haplotype. When the 
+2767A/+2767T ratio for cDNA and genomic DNA was compared in cells incubated for 6 
hours (Figure 4.4) again no significant differences were seen between the two ratios. In this 
case the trend was in the opposite direction with greater transcription of the +2767A 
haplotype.
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Figure 4.3
Allele specific PCR of IL8 Genomic and cDNA from primary respiratory epithelial 
cells after TNF stimulation for 3 hours. The 2767A/2767T mean ratio for genomic 
DNA was 1.23 (95% Cl 1.12, 1.33) compared to 1.15 (95% Cl 1.05, 1.25) for cDNA. All 
data are reported as the median increase (with inter-quartdle range (IQR)) in eight individuals 
from two separate experiments. ^Paired t testp — 0.06.
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Figure 4.4
Allele specific PCR of IL8 Genomic and cDNA from primary respiratory epithelial 
cells after TNF stimulation for 6 hours. The 2767A/2767T mean ratio for genomic 
DNA was 0.99 (95% Cl 0.87, 1.11) compared to 1.11 (95% Cl 1.06, 1.17) for cDNA. AU 
data are reported as the median increase (with inter-quartile range (IQR)) in eight individuals 
fcom two separate experiments. Taired t test p = 0.09.
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4.2.4
Optimisation o f  P E /M S as a m ethod for haplotype-specific quantitation
As before the +2767 polymorphism was used to assess the relative abundance, as measured 
by PE/M S (Knight et al 2003), of the transcripts derived from each of the two haplotypes. 
To assess the accuracy of the PE/M S method with the +2767 SNP we prepared a standard 
curve by mixing genomic DNA at different ratios from two individuals who were 
homozygous for the +2767A and +2767T aUeles (Figure 4.5). We observed a close linear 
relationship between the ratio o f the aUeles and the observed ratio o f peak areas (r^  0.95, 
p=0.0000). The SNP +2767 shows a systematic difference in signal intensity from the 
expected value of 1:1 with genomic DNA. Since we expect the genomic DNA to represent 
a 1:1 ratio between aUeles the average difference fcom 1 in the genomic samples was used to 
provide a correction factor that was appUed to both the genomic and cDNA samples for 
each experiment as previously demonstrated (Bray et al 2003a).
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Figure 4,5
Standard Curve for haplotype-specific radiolabeled PCR. Standard curves were 
produced for the +2767 SNP by preparing different ratios of genomic DNA (shown on the 
X axis) from two individuals, homozygous AA or homozygous TT at that polymorphism. 
The observed ratios between the A and the T  allelic peaks were then measured by PE/M S 
(shown on the y axis).
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4.2.5
H aplotype-specitic expression ofJLS detected b y  PE /M S
The abundance of the two alleles from the +2767 SNP transcribed marker was quantified by 
PE/MS. For each individual, the ratio of the +2767A allele (haplotype 1) over the +2767T 
allele (haplotype 2) in the cDNA and genomic DNA was compared. The relative abundance 
of the haplotype 2 transcript when compared with that of haplotype 1 transcript was 
significantiy increased over time reaching a ratio of 0.94 at 6 hours (^=0.037) (Figure 4.6a). 
To explore whether the in vivo aUele-spedfic difference demonstrated in primary respiratory 
epithelial cells was present in other primary cells, we harvested primary lymphocytes from six 
individuals heterozygote for haplotypes 1 and 2. After stimulation with EPS we observed no 
significant increased transcription for one IL8 haplotype over another (Figure 4.6b).
We anticipated that the mechanism for the haplotype-specific expression demonstrated here 
might require exploration through in vitro studies of plasmid reporter genes and DNA- 
protein interaction. As these in vitro studies would take place within immortalized cells lines 
we sought to determine what patterns o f IL f  haplotype-specific expression occurred in this 
cell type. In contrast to our findings with primary cells, human H460 pulmonary epithelial 
cells stimulated with TNF showed a significant increase in production o f the Haplotype 1 
(Figure 4.7) in both non-activated cells (at 0 hours ratio 1.075, p=0.009) and activated cells 
(at 6 hours ratio 1.11, p=0.0001).
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Figure 4.6 Haplotype-specific ttanscription of ILS in ptimaty epithelial cells and in 
primary lymphocytes.
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Figure 4.6  Haplotype-specific ttanscription of ILS in primary epithelial cells and in 
primary lymphocytes. After incubation in media containing the appropriate stimulant (a, 
30ng/ml TNF for Primary Nasal Epithelial cells; b, 10 pg/m l LPS for Primary Lymphocyte 
cells) mRNA was extracted at the times shown and analyzed by RT-PCR using primers 
specific for the +2767A and +2767T polymorphisms. For each individual, cDNA and 
genomic DNA were amplified in four independent PCR reactions which in turn were each 
spotted as four replicates on the spectroCHIP before PE/MS. After correction for 
systematic difference in signal intensity the +2767 allelic ratio the genomic DNA was 
compared with the cDNA for each individual by a paired /-test. Genome represents the 
+2767 allelic ratio for genomic DNA. Values are expressed as the mean ratio + the standard 
error of the mean of the +2767A allele over the +2767T allele, (a) At 3 hours 0.95, 
^=0.067; at 6 hours 0.94, ^=0.037. (b) At 0 hours 1.03, ^=0.67; at 3 hours 1.0, ^=0.34; at 6 
hours 1.03, ^=0.31.
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Figure 4.7 Haplotype-specific transcription of IL8 in Human H460 pulmonary 
epithelial cells. After incubation in media containing the appropriate stimulant (30ng/ml 
TNF for Human H460 pulmonary epithelial cells) mRNA was extracted at the times shown 
and analyzed by RT-PCR using primers specific for the +2767A and +2767T 
polymorphisms. For each individual, cDNA and genomic DNA were amplified in four 
independent PCR reactions which in turn were each spotted as four replicates on the 
SpectroCHIP before PE/MS. After correction for systematic difference in signal intensity 
the +2767 allelic ratio the genomic DNA was compared with the cDNA for each individual 
by a paired /-test. Genome represents the +2767 allelic ratio for genomic DNA. Values are 
expressed as the mean ratio ± the standard error of the mean of the +2767A allele over the 
+2767T allele. At 0 hours 1.075, ^=0.009; at 3 hours 1.08, ^=0.002; at 6 hours 1.11, 
•>=0.0001.
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4.2.6
Karyotype and Fluorescent in  situ hybridization (FISH) for IL8 in  Human H460 
pulm onary epithelial cells
In order to explain the marked differences in the haplotype-specific expression of IJL8 
between primary cells and the H460 pulmonary epithelial immortalized cell Hne we enlisted 
the assistance o f Emmanula Volpe and Andrew Jefferson of the Molecular Cytogenetics 
Department of the Wellcome Trust Centre for Human Genetics. As expected from the 
American Tissue Culture Collection (ATCC) description the H460 cell line had a hypo- 
triploid karyotype. When analysed by FISH for chromosome 4 number, this cell Une shows 
two apparently normal number 4 chromosomes in 69% of cells whüst in 12% of cells there 
was either only one or more than two number 4 chromosomes. In the remaining 19% of 
cells the result was not clear. FISH analysis for the IL8 gene copy number shows that of 33 
metaphases analysed, all of them presenting two chromosome 4 homologues, 30% had two 
copies of IL8 whilst in 45% of cells there was just one copy. In 24% of cells the IL8 copy 
number was uncertain. We could not easily determine IF8 haplotype in the ceUs where there 
was only copy. In conclusion, this FISh study appears to show that a large proportion of 
cells in the H460 cell line were not heterozygote for the IL8 haplotypes o f interest. This 
finding means that the results o f any IL8 haplotype-specific experiments in this cell Une are 
impossible to accurately interpret.
8 6
Figure 4,8
Karyotype and FISH probe for the IL8 gene
Representative photomicrograph of H460 chromosomes counterstained with DAPI (blue) 
to which a FISH IL8 cDNA probe (red) has been added. Karyotype and FISH probe 
conducted by Andrew Jefferson and Emmanula Volpi and is reproduced here with their 
permission.
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Discussion
4.3.1
The biological significance o f  the IL8 haplotype-specitic transcription b y  P E /M S
I sought to investigate the transcriptional regulation of IL8 through examining the 
haplotype-specific differences in mRNA expression between the two main haplotypes 
described in the Caucasian population. Previously it has been shown that the -251A SNP 
was associated with susceptibility to severe RSV-induced bronchiolitis (Hull et al. 2000) and 
that this association was shown to include the SNPs comprising haplotype 2 (Hull et al 2001) 
(Figure 1.6). Using PE/M S alone I have shown that in primary respiratory epithelial cells 
heterozygous for haplotypes 1 and 2, mRNA derived from haplotype 2 was detected 
significantly more than that from haplotype 1. This might occur through either increased 
transcription or through increased mRNA stability of haplotype 2 as compared with 
haplotype 1. This is one of the few studies demonstrating that a gene associated with disease 
susceptibility is subject to in vivo aUele-spedfic expression in primary cells (Bray et al. 2003b). 
The increased abundance of mRNA from haplotype 2 is compatible with the observation 
that the concentration of IjL8 is correlated with severe disease (Smyth et al 2002) and that 
severely affected individuals have increased neutrophil infiltration in the lungs (Everard et al. 
1994, Aheme et al 1970).
Though the size of the difference in mRNA detected between the two haplotypes was 
modest (6%) it remains statistically significant and may be of biological importance for the 
following reasons. IL-8 is a potent chemotactic agent for neutrophils in humans and the 
haplotypes we have studied occur frequently (Figure 1.6). Small differences in the levels of 
gene expression could have important effects on disease outcome and affect a high
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proportion of the population. The IL8 mRNA production measured here occurred in the 
context o f primary respiratory cells isolated from other cell types such as neutrophils and 
macrophages. Both neutrophils and macrophages are known to play an important role in 
the host response to RSV infection and may influence the degree of haplotype-specific 
expression o f IL8 that occurs in epithelial cells.
Moreover, the effect o f the haplotype on mRNA abundance appeared to be cell specific as it 
was observed in primary respiratory epithelial cells but was not seen in primary lymphocyte 
cells. However, the primary respiratory epithelial cells and the primary lymphocytes were 
derived from different populations. The proof for the localization o f haplotype-specific IL8 
transcription to one cell type could only come fcom experiments on a population o f primary 
cells derived from different tissues in the same individual. In addition the degree of 
allele-spedfic LL8 expression may also be limited by developmental stage and environmental 
factors. The presence of marked allele-spedfic expression of IL8 in infants but not adults 
could be an additional factor to explain the severity of RSV-induced bronchiolitis in this age 
group.
IL8 lies within a chemokine cluster that includes CXCLl, CXCL2, CXCL3, CXCL5, 
CXCL6, pro-platelet basic protein (PPBP) and Platelet factor-4 (PF4) (Modi and Chen, 
1998). Moreover, PF4, PPBP and IL-8 all have chemotactic properties in relation to 
lymphocytes (Wuyts et al 1994). It is possible that IL8 is only one of a number of genes in 
that chemokine duster that exhibit haplotype-spedfic expression and it is the combined 
effect of these chemokines which modifies RSV-induced bronchiolitis disease-susceptibüity. 
The Kwiatkowski laboratory has addressed this question recently by attempting to localize
89
the bronchiolitis disease association to one or more of the genes in that chromosomal 
location. (HuU et al. 2004). Three major clusters of high linkage disequilibrium were 
identified that contained a novel gene RASSF6, IL8 and the remaining genes of the 
chemokine cluster respectively. Only markers within the RASSF6 and IL8 haplotype blocks 
appeared to show a disease association to RSV-induced bronchiolitis. Further analysis of the 
data shows that the effect depends on the presence of both elements. The RASSF6 gene is 
of considerable interest as it contains a Ras association domain. Intriguingly, RSV infection 
has been shown to activate RhoA, a member of the Ras superfamily, which in activated state 
can induce IL1J3, JL f and IL8 (Gower et al. 2001). Moreover, preliminary experiments that 
I have conducted appear to show allele-spedfic expression of RASSF6 in lymphocytes. 
Technical difficulties and time constraints prevented the optimization of these allele-spedfic 
experiments in primary respiratory cells.
I acknowledge that we have assumed that the primary mechanism by which IL-8 affects 
susceptibility to RSV-induced bronchiolitis is through transcription. Whilst studies suggest 
that differences in gene expression levels account for a major part of the variation within and 
between spedes (Johnson and Porter 2000, Levine 2002) it is possible that ILS  does not fit 
this pattern. In addition to the modest allele-spedfic differences in IL8 transcription shown 
here there could be more significant mechanisms of translational regulation which may 
contribute to RSV-induced bronchiolitis disease susceptibility.
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4.3.2
M ethodological m erits and lim itations to the demonstration o f  haplotype-specific 
IL8 expression using culturedprim ary cells and PE /M S
The study design used cells heterozygous for the allele of interest allowing the detection of 
small variations in aUele-spedfic transcription independent of other host, environmental and 
technical factors (Knight et al 2003, Yan et al 2002). For instance, the investigative approach 
would control for differences in the cell number and strength of the stimulus between 
experiments. The experimental design would also control for differences in the IL-8 
receptor signaling and signal transduction pathways between individuals as both haplotypes 
of the IL8 gene should be stimulated to the same degree. The host and environmental 
factors may be one reason why, Hke a number of other studies, I observed differences in 
haplotype-spedfic expression of fL8  between individuals (Bray et al 2003a, Lo et al 2003, 
Yan et al 2002, Cowles et al 2002).
However, there are a number of technical limitations to the study design that require further 
consideration. Firsdy, verifying the observed allele-spedfic expression o f ILS by testing 
additional marker SNPs is limited as the +2767 SNP is the only transcribed marker. 
Application of other methods of In vivo allele spedfic expression, such as haploCHIP 
(Knight et al 2003), to certain types of primary cells may be impractical as it requires large 
numbers of cells to obtain suffident chromatin for immunopredpitation. Secondly, the 
systematic allelic difference in PE/M S signal intensity seen with the +2767 SNP using 
genomic DNA is well described for other polymorphisms (Knight et al 2003) and usually 
relates to biases in primer design (Bray et al 2001). Thirdly, I chose to use TN F as a stimulus 
for IL8 activation and not RSV as purified RSV produces a smaller IL8 response from
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respiratory cells. This would have produced an insufficient quantity of IJL8 transcript for the 
allele-spedfic assay as modest numbers of primary respiratory cells were obtained from each 
patient at the time of harvest.
4.3.2
M ethodological lim itations to the demonstration o f  haplotype-specific IL8 
expression using im m ortalized cell lines and PE /M S
There was a significant difference in the in vivo aUde spedfic expression o f ILS between 
primary respiratory cells and the immortalized H460 cell line. This may reflect differences in 
the gene regulation between the two cell types as IIS  increases tumor growth through 
promoting angiogenesis in bronchogenic (Smith et al. 1994) and non-smaU cell lung 
carcinoma (Arenberg et al. 1996) and is constitufively expressed in these cancer cells 
(Arenberg et al. 1996). These factors highlight the potential limitations to studying allele 
spedfic expression of angiogenic chemokines in immortalized cell lines. In common with 
other cell lines derived from cancerous tissue the H460 cells have a hypo-tnploid karyotype. 
In addition a significant number of the cells which contain two copies of chromosome four 
have only one copy of the IL8 gene. Given the large structural rearrangements in the 
genome of these cells they proved to be a poor model system for studying haplotype-spedfic 
expression in heterozygote cells.
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4.3.3
Comparison o f MAPREC and PE /M S as a m ethod for demonstrating haplotype- 
specitic transcription
I have demonstrated a modest but significant degree of haplotype-specific transcription of 
IL8 using PE/M S which was not found using MAPREC. The two techniques have been 
compared before in the analysis o f mutations in live poliovirus vaccines (Amexis et al. 2001). 
In common with our findings Amexis and colleagues (2001) concluded that both techniques 
had excellent correlation, however MAPREC was seen to have a number o f limitations.
For quantification o f the products from each allele MAPREC requires the creation of an 
artificial digest site, radiolabel of the PCR products followed by digest and finally separation 
of the labeled DNA on a polyacrylamide gel. The use of hazardous materials in this 
procedure and the need for a digest step means that the experiment is both time consuming 
and difficult to scale up to incorporate multiple samples. For instance, within the 
Kwiatkowski laboratory it was safe and practical for a sole operator to manage up to a 
maximum of 50 samples in any one MAPREC experiment. By comparison PE/M S allowed 
for the PCR of each sample in four separate reactions which in turn after primer extension 
were spotted four times on the MALDI-TOF plate. Each of these spots was then laser 
ionized a further four times the mean of which was given as the peak height for each allele at 
that spot. Through this study design it was possible to ininirnize random variation from the 
allele quantification using PE/MS. In our laboratory a sole operator could comfortably 
handle up to 384 PCR reactions in an experiment over one day. Quality control o f the 
PE/M S procedure has shown that the greatest variation occurs at the PCR amplification 
stage (Julian Knight and Kirk Rockett, personal communication).
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Further analysis of the MAPREC technique has shown that the digest of the PCR products 
is 96 to 99% efficient in normal circumstances which may be insufficiently sensitive to detect 
differences in allele specific expression as small as 6%. However, the digest efficiency can be 
more severely affected where there is incorrect incorporation of nucleotides in the course of 
amplification by PCR as these incorrect bases may alter the restriction digest site. This has 
the potential to introduce significant bias to the aUele-spedfic quantification. Incorrect base 
incorporation could also occur with PE/M S but would be easier to detect when using 
MALTI-TOF as the product containing the incorrect bases would have a different peak 
molecular mass to the one predicted for that allele.
Whilst MALDI-TOF is a fast and accurate method of allele specific quantitation 
(Tsuchihashi and Dracopoli 2002) as I have demonstrated here it can produce unequal signal 
intensities for alleles of the same SNP (Knight et al. 2003). These unequal signal intensities 
have been attributed to either preferential incorporation of one dideoxynucleotide over 
another at the primer extension step or to sequence specific differences in ionisation (Bray et 
al 2001). Both of these issues can be corrected or ameliorated by modification of the primer 
sequence or through changing the primer sequence to the complementary strand.
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4.3.4
The possible mechanism for the IL8 haplotype-specitic transcription
Identifying and understanding de-acting regulatory units in humans presents a significant 
challenge. It is not possible from knowledge of sequence variation to predict which SNPs 
affect regulation. This difficulty in identifying functional SNPs is made worse by our limited 
ability to define the regulatory regions o f most genes as these regions may be several 
küobases from the transcriptional start site. Moreover, looking at variation in transcript 
levels for a gene from different individuals may not provide the answer as any differences in 
transcription may be due to trans-2icûng or environmental factors. Identification of 
regulatory regions that cause aUele-specific expression can only be done by studying the two 
alleles under identical conditions. The study of gene transcription of ILS in heterozygous 
primary cells fulfills some of these conditions. However, these experiments do not allow us 
to define the extent of the regulatory regions governing ILS transcription nor do they help 
us identify whether the SNPs in the haplotype are merely markers or if  they have a 
functional role. In the presence of a population structure that was not dominated by two 
mirror haplotypes it may have been possible to select SNPs on a number o f different 
haplotypes that were associated with greater degrees of haplotype-specific expression in vivo. 
This question is addressed in Chapter 7 by using the TN F/E TA  locus as a model system. In 
the absence o f a population structure that suggests which SNPs are likely to be functional we 
have adopted in vitro techniques of plasmid transfection experiments and EMSA studies of 
DNA to protein interactions in Chapters 5 and 6 in an attempt to identify some aspects of 
the regulatory mechanism o f ILS haplotype-specific expression.
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4.3.5
Concluding Points
•  Haplotype-spedfic expression o f IJL8 was not detected by MAPREC in primary 
respiratory epithelial cells.
•  Modest increased expression o f the IL8 disease severity associated haplotype-2 was 
detected by PE/M S in primary respiratory epithelial cells.
•  Haplotype-spedfic expression of IL8 not detected by PE/M S in primary lymphocyte 
cells.
• Karyotype and Fluorescent m situ hybridization (FISH) studies for IL8 in Human H460 
pulmonary epithelial cells shows that this cell line is a poor model for haplotype-spedfic 
expression in primary cells.
•  The mirror haplotype structure of the IL8 gene in a Caucasian population prevents 
resolution in vivo of which SNPs in the haplotype show functional properties.
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CHAPTER FIVE
INVESTIGATION OF THE 5' FLANKING REGION OF THE IL8 
GENE IN THE REGULATION OF TRANSCRIPTION
5.1.1
Introduction
Since it was established that IJL8 is readily induced by a number o f agents, including TNF, 
IL-1 and RSV, the 5’ flanking region of the gene has been studied extensively so that 
de-elements involved in activation and silencing could be better understood.
The first transfection experiments examining the 5’ flanking region of the LL8 gene used 
upRSV as a stimulus and demonstrated up to a 13 fold activation of the reporter gene. 
These experiments also suggested that there was a repressor element between —361 and —161 
nucleotides of the IL8 transcriptional start site (Fiedler et al. 1996). Subsequent studies also 
using upRSV examined the relative role of Activator protein-1 (AP-1), CAAT-enhancer 
binding protein (C/EBP) P and nuclear factor (NF)-kB sites in IL-8 production 
(Mastronarde et al 1998). Transfection o f A549 cells with plasmid promoter constructs 
showed a positive cooperative effect between the (AP-1) and the NF-kB sites (Figure 5.1). 
Mutation of the C/EBP P site had very little effect in the presence of intact AP-1 and 
NF-KB sites.
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Subsequent transfection studies using pRSV yielded very different results (Garofalo, 1996). 
Transfection of A549 cells with 5’ flanking region IL8 constructs linked to a luciferase 
reporter gene showed 5-fold activation over uninfected controls at 12 hours and a 4 fold 
induction at 24 hours. The role of different sections of the 5’ flanking region of the IL8 
gene was clarifled further. Casola and colleagues (2000) showed that TN F induced IL8 
expression only requires the region from —99 to —54 nucleotides from the transcriptional 
start site. However, this same region was insuffldent for RSV-induced IL-8 production. 
Instead, RSV requires the AP-1 binding site at —132 to —99 nudeotides as well as an 
additional novel upstream element called the RSV response element (RSVRE) at -162 to 
-132 nucleotides. RSV infection increased RSVRE binding activities and increased synthesis 
of IFN regulatory factor-1 protein (IRF-1) that is present in the RSVRE complex. This 
finding extends the sites that cooperate with IRF-1 to include C/EBP P and AP-1.
In addition to activation elements, the 5’ flanking region o f IL8 also has the capadty to 
silence the gene. Sequence comparison with the IFN-p promoter found a negative 
regulatory element (NRE) in the IL8 promoter partially overlapping the NF-kB response 
element (Nourbakhsh, 2001). The NRE appears to have a dual role in IL8 transcription as 
in the absence of a stimulus it appears to be involved in transcriptional silencing. However, 
it is required also for fuU induction of the IL8 promoter in the presence of IL-1 stimulation.
None of the above studies looking at the detailed function of the 5’ flanking region of IL8 
have included an investigation of the effect SNPs may have on IL8 transcription. Yet since 
the publication of the original assodation studies concerning the IL8 -251A polymorphism 
(HuU et al 2000, HuU et al 2001) that same allele has been assodated with susceptibility to
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tuberculosis (Ma et al 2003) enteroaggregative E.Co/i diarrhea (Jiang et al 2003), prostate 
cancer (McCarron et al 2002), and greater IL-8 protein production (Jiang et al 2003). In this 
chapter I wished to test for function at the -251 SNP in the context o f reporter constructs of 
the 5’ flanking region of the IJL8 gene. The position of a putative repressor element between 
—361 and —161 nucleotides of the transcription start site o f IL8 was of particular interest to 
my inquiry into genetic function at the -251 polymorphism. I wished to test for -251 
polymorphism function after stimulation with both TNF and RSV. Given the different 
mechanisms by which these agents induced IL8 I decided to test whether -251 SNP function 
differed between them. In addition to looking for functional differences at this SNP with 
transfection studies I proposed also to test whether there were allele-spedflc differences in 
DNA-protein binding at this polymorphism.
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Results
5.2.1
N o evidence o f  a repressor elem ent between nucleotides -389 and -169 o f  the 5* 
flanking region o f  the ILS gene
Given the complexity of transcription factor binding sites in the 5’ flanking region o f ILS a 
reporter plasmid was constructed containing 1409 base pairs of the 5’ sequence 5’ to IL8. 
These constructs differed only at the —251 position (Figure 5.1) so that the -251A and -251T 
alleles were assessed from within normal sequence of regulatory elements. Transfection of 
these IL8 constructs into A549 cells showed that maximal luciferase activity occurs 14 hours 
after TNF stimulation (Figure 5.2). D r Irina Udalova’s initial transfection experiments in 
A549 cells appeared to show increased expression of the —389 construct compared with the 
—169 plasmid following TN F (40 ng/ml) (Figure 5.3). However, these experiments were 
repeated as there was wide variability in values between experiments and there was an 
absence of a second co-transfection plasmid to control for transfection efflciency. As shown 
in Figure 5.4, there was no clear increase in expression between the —389 and the —169 
plasmids after correcting for variations in transfection efflciency by co-transfection with the 
reniUa plasmid (pRL-TK). Further experiments using pRSV and upRSV as a stimulus 
showed no difference in reporter gene activity between the —389 and the —169 plasmids (data 
not shown). No difference in expression was noted between a stimulus of TNF at 40 ng/m l 
and lOng/ml (data not shown).
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Figure 5.1 Effects of the -251 polymotphism in the IL8 5’ flanking region on reporter 
gene expression. Schematic representation of up to —1409 nucleotides of the 5’ flanking 
region of the 1F8 gene depicting the main transcription factor binding sites
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Figure 5.2 Transcriptional activity over time of the -251A and -251T polymorphisms 
in the 1409 5’ flanking region of the IL8 gene in response to TNF (5 ng/m l) 
stimulation after transfection into A549 cells. All data are reported as the increase 
observed over controls for two separate experiments. Data points are connected by the 
curve calculated to represent the mean fold increase.
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Figure 5.3.
Transcriptional activity of +1409 nucleotides of the 5’ flanking region of the IL8 gene 
in response to TNF (40 ng/m l) stimulation after transfection into A549 cells. All data 
are reported as the mean increase observed over controls for five separate experiments. 
Error bars represent standard error of the means. Adapted from a figure drawn by Dr Irina 
Udalova and used with permission of the author.
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Figure 5.4
Transcriptional activity of +389 nucleotides of the 5’flanking region of the IL8 gene 
in response to TNF (40 ng/m l) stimulation after transfection into A549 cells. All data 
are reported as the geometric mean increase in observed over controls for six observations 
from three separate experiments. Error bars represent the 95% confidence interval. 
Transfection efficiency was controlled for by co-transfection with the pRL-TK plasmid.
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5.2.2
The -251 (A /T ) polym orphism  in response to TNF stimulation appears to be 
functional in H460 cells bu t n ot in A549 cells
To define whether the -251 (A/T) polymorphism had a fimctional effect on transcription 
plasmids containing either the -251A allele or the -25IT  allele were transfected into Human 
H460 pulmonary epithelial cells (H460) and Human A549 pulmonary type II epithelial cells 
(A549). As shown in Figure 5.5 transfection o f the 1409(-251T) and 1409(-251A) constructs 
into both H460 and A549 cells showed significant induction in the presence of TNF. In 
H460 cells (Figure 5.5a) the fold rise of mean reporter gene expression in activated over 
non-acfivated cells was significantly greater for the 1409(-251T) construct (18 fold) when 
compared with the 1409(-251A) construct (13 fold, p=0.008). By comparison, transfection 
of these plasmids into A549 cells, as shown in Figure 5.5b, did not show a significantly 
different fold rise between the 1409(251T) construct (25 fold) and the 1409(251A) construct 
(21 fold) (p=0.32).
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Figure 5.5 Effects of the —251 polymorphism in the IL-8 promoter sequence 
on reporter gene expression after TNF stimulation.
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Figure 5.5 Effects of the —251 polymotphism in the IL8 ptomotet sequence on 
reporter gene expression after TNF stimulation. H460 cells (a) and A549 cells (b) were 
transiently transfected with 1.4kb of the IL8 promoter region containing either the IL8-251T 
or the IL8-251A allele after which the cells were stimulated with TNF (5ng/ml). Luciferase 
activity was corrected for transfection efficiency by co-transfection with a renfila construct. 
The values are expressed as the mean (± the standard error of the mean) normalized 
luciferase activity for non activated (NA) and activated (TNF 5ng/ml) cells from 4 
independent experiments in (a) and 5 independent experiments in (b). The fold rise 
compares the mean normalized luciferase readings of activated over non-acfivated 
transfected cells. ^-25IT  17.9 fold rise, -251A 12.6 fold rise: paired t test, p=0.008; ^-251T 
25.1 fold rise, -251A 21.2 fold rise: paired / te s t, p=0.32.
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5.2.3
The -251 (A /T ) polym orphism  in response to pR SV  stimulation does n ot appear to 
be hm ctional in either H460 or A549 cells
To define whether the -251 (A /1) polymorphism had a functional effect on IU8 
transcription following pRSV stimulation the H460 and A549 cells were again transfected 
with the IL8 +1409 5’ flanking region plasmid containing the two -251 polymorphic 
variants, A time course experiment was conducted to investigate the peak luciferase activity 
after the pRSV stimulus (data not shown). In both cell lines the fold activation in luciferase 
activity was low at between 4 and 1.5 fold and though there was much variability in the 
readings a time point of 14 hours after activation was selected as optimal for reporter gene 
activity. As shown in Figure 5.6 transfection of the 1409(-251T) and 1409(-251A) constructs 
into both H460 and A549 cells did not show significant induction in the presence of RSV. 
In H460 cells (Figure 5.6a) the fold rise of mean reporter gene expression in activated over 
non-acfivated cells was not significantly different between the 1409(-251T) construct (3.9 
fold) and the 1409(-251A) construct (2 fold, p=0.17). Transfection o f these plasmids into 
A549 cells, as shown in Figure 5.6b, did show a significantly different fold rise between the 
1409(2511} construct (2.4 fold) and the 1409(251A) construct (1.7 fold) (p=0.02). However, 
in this series two experiments failed to show any activation on stimulation with pRSV in the 
presence of the -251A plasmid. When those experiments with failed activation are excluded 
the significant difference between the two does not persist (p=0.08). Given that there is no 
clear induction of the reporter gene on stimulation with pRSV in either cell line the 
difference in fold activation between the -251 constructs in A549 cells does not constitute 
adequate evidence for function at this SNP after pRSV stimulation.
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Figure 5.6  Effects of the —251 polymorphism in the IL8 promoter sequence on 
reporter gene expression after RSV stimulation. H460 cells (a) and A549 cells (b) were 
transiently transfected with 1.4kb o f the ILS promoter region containing either the IL8-251T 
or the IL8-251A allele after which the cells were stimulated with RSV (MOI 1). Luciferase 
activity was corrected for transfection efficiency by co-transfection with a renfila construct. 
The values are expressed as the mean (± the standard error of the mean) normalized 
luciferase activity for non activated (NA) and activated (RSV MOI 1) cells from 4 
independent experiments in (b) and 5 independent experiments in (C). The fold rise 
compares the mean normalized luciferase readings of activated over non-acfivated 
transfected cells. ^-251T 3.9 fold rise, -25lA  2.6 fold rise: paired t  test, p= 0.17; ^-251T 2.4 
fold rise, -251A 1.7 fold rise: paired /  te s t, p= 0.02.
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5.2.4
A Jlele-spedôc protein  to DNA binding to the 5^  ûanldng region o f IL8 is  m odulated 
b y the -251 polym orphism
We performed EMSAs to explore whether the differences in expression at the —251 SNP 
between the A549 and H460 cells were attributable to differential binding o f nuclear 
proteins in the presence of that SNP. Two nucleotide probes spanning the -251A or -25IT  
SNP were incubated in nuclear extracts from TNF stimulated H460 (Figure 5.7a) and A549 
(Figure 5.7b) cells. Two specific protein-DNA complexes (designated I  and IJ) were 
detected in nuclear extracts from both cells by EMSA. In H460 nuclear extracts complex I  
bound to the —251A probe but not to the —25 IT  probe. The specificity of this interaction 
was defined by competition experiments in which complex I  (C1) was competed only by the 
—251A unlabelled oligonucleotide (Figure 5.7a, /ane J). In A549 nuclear extracts complex I  
(Cl) is seen also to specifically bind to the -251A probe (Figure 5.7b, lanes 1 to 5) but in 
addition it binds with lower affinity to the -251T probe. This is seen from competition 
which reveals that complex I  was competed from the -25IT  probe by —251A unlabelled 
oligonucleotide more readily {lanes 7 and 8) than it was by the -25 IT  unlabelled 
oligonucleotide (lanes 9 and 10). Complex I  from A549 (Figure 5.8a) and H460 (Figure 
5.8b) nuclear extracts was analysed by SDS-PAGE and a major band was seen at M^~97kDa 
in both cases. Given that the oligonucleotide probe migrates at about 20kDa in this gel 
system it would s u re s t that the constitutive factor contains a major component of about 
77kDa. Complex II (02) binds to both the -251A and -251T probes in H460 (Figure 5.7a) 
and A549 (Figure 5.7b) nuclear extracts and is specifically competed. We performed 
additional EMSAs to investigate the observation that the consensus binding site (5’- 
ATGCAAAT-3’) for the ubiquitous transcription factor Oct-1 (Fletcher et al. 1987) was
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present on the reverse strand of the -251T allele (5’-TATCAAAT-3’) but not the —251A 
allele (5’-TATCAATT-3’). As seen in Figure 5.9 Complex II appeared to contain the Oct-1 
transcription factor as an EMSA using specific antibodies to Oct-1 showed a supershift of 
complex n  in the presence o f both the -251A and -251T probes whereas control antibodies 
against p65 NF-kB had no effect. No differences in binding for the —251A and —25IT  
probes were seen between unstimulated and stimulated A549 and H460 nuclear extracts 
(data not shown).
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Figure 5.7  Electrophoretic mobility assays demonstrate differences in allele-specific 
binding of nuclear proteins between H460 and A549 cell lines at the —251 SNP.
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Figure 5.7  Electrophoretic mobility assays demonstrate differences in allele-specific 
binding of nuclear proteins between H460 and A549 cell lines at the —251 SNP.
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Figure 5.7  Electrophoretic mobility assays demonstrate differences in allele-specific 
binding of nuclear proteins between H460 and A549 cell lines at the —251 SNP.
Nuclear extracts from H460 cells (3) and A549 cells (b) harvested 6 hours after stimulation 
with TNF (30ng/ml) were used with probes corresponding to the -251A {lams 1 to 5) and 
-251T alleles {lanes 6 to 10). UnlabeUed competitor oligoduplex probes were added in molar 
excess (xlOA and xlOOA refer to xlO and xlOO molar excess o f unlabeUed -251A probe 
respectively, whilst xlOT and xlOOT refer to xlO and xlOO molar excess of unlabelled -25 IT  
probe respectively) as shown in lanes 2 to 5 and lanes 7 to 10. Complex I  (Cl) specifically 
bound to the —251A probe in the presence of H460 (3) and A549 (b) nuclear extract. 
Complex I  (C1) also bound to the —25IT  when incubated with A549 nuclear extract (b). 
Complex II (C2) specifically bound to the —251A and to the -25 IT  probes in the presence of 
H460 ( 3 )  and A549 (b) nuclear extract and was competed by xlOO molar excess of 
unlabelled -251A probe {lanes 3 and 8) as well as xlOO molar excess of unlabeUed -25 IT  {lanes 
5 and 10).
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Figure 5.8 UV cross linked products of a bromodeoxyuridine-substituted probe 
spanning the —251A SNP with nuclear extracts from H460 and A549 cells. Complexes 
were separated by EMSA, subjected to UV illumination, cut from the gel, and analyzed on 
10% Bis-Tris MOPS-SDS NuPAGE gels. Rainbow full range molecular marker (Amersham 
Pharmacia Biotech) is indicated on the right. 3, the complex I  (C1)taken from A549 cells is 
seen at about ~97 kDa. b, complex I (C1) taken from H460 cells is also seen at about 
~97kDa.
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Figure 5.9 Electrophoretic mobility shift assays demonstrate that Oct-1 can bind to 
the -251A allele and to the -251T allele EMSA showing nuclear extract from A549 cells 
{lanes 1 to 6) and H460 cells {lanes 7 to 12) were incubated with probe in the absence {lanes 1, 
2, 7 and S) or presence of antibodies {lanes 3, 4, 9 and 10) to Oct-1. Complex I  (Cl) is 
present after incubation with the -251A and -25IT  probes in A549 nuclear extract {lane 1 and 
2) and after incubation with the -251A probe in H460 nuclear extract {lane 7). Complex II 
(C2) is present after incubation with the -251A and -251T probes in both A549 nuclear 
extract {lane 1 and 2) and in H460 nuclear extract {lane 7 and S). A supershifted band 
(indicated by SS_) formed with the anti-Oct-1 antibody is seen in the presence of the -251A 
and -251T probes in both A549 {lanes 3 and 4) and H460 {lanes 9 and 10) nuclear extract. No 
supershifted bands were seen in the presence of the control antibody to p65 NF-kB.
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Discussion 
5.3.1
IL8 transcriptional regulation b y  a pu ta tive repressor elem ent in  the 5* ûanldng 
region o f the gene
In common with reports from another laboratory (Casola et al. 2000) I could not reproduce 
the result reported by Fiedler et al. (1996) showing a putative repressor element between — 
361 and —161 nt 5’ o f the ILS gene in response to TNF, upRSV or pRSV stimulation. One 
possible explanation for this might lie in the non-standardised nature of the upRSV 
preparation as it may contain a number of cytokines at concentrations which vary between 
laboratories. For instance, two different upRSV preparations have been shown to produce 
very different results in stimulating NO  expression (Tsutsumi et al. 1999; Kao et al. 2001).
5.3.2
Transcriptional activity o f the 251 (A /T ) prom oter polym orphism  o f IL8 in  response 
to TN F stim ulation
Respiratory epithelial cells initiate and regulate the innate immune response (Garofalo and 
Haeberle, 2000; Garofalo et al. 2001) to RSV infection. In addition to the differences seen 
in IL8 regulation between primary and immortalized respiratory cells (Chpater 4) I have 
shown that there may also be differences in regulation between immortalized cell lines. 
Consistent with the increased In mvo allele specific expression of haplotype 1 in H460 cells I 
noted significantly increased reporter gene expression associated with the -251T 
polymorphism in these same cells. Though the pattern of reporter gene activation was 
similar in both cell lines the —251 SNP did not appear to be functional when the IL8 
constructs were transfected into A549 cells. Also, I describe differential binding of nuclear
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factors between the —251A and —25 IT  polymorphisms in the H460 cells which were not 
present in A549 cells. Complex I, which contained an unidentified nuclear factor of about 
77kDa, bound in the presence of the -251A allele alone in H460 cells. However, complex I  
bound in the presence of both -251 alleles in A549 cells. A second complex (complex II) 
was detected in the presence of both -251 alleles. However, there is no difference in the 
binding of complex II between the two alleles or between the cell fines. It is therefore 
unlikely that either complex II, or the factor Oct-1 which was detected within it, play a role 
in explaining the differences in function at the -251 polymorphism.
Previously differences in the functional regulation of the same haplotype, in this case IL-6, 
between immortalized cell fines have been described (Terry et al 2000). In addition, there is 
evidence that IL8 is regulated in a different manner between H292 lung epithelial cells and 
A549 cells (Roger et al 1998, Newton et al 1996). This discrepancy in the regulation of IL8 
between respiratory cell fines has not previously been associated with functional 
polymorphisms.
The extent to which one believes the -251 polymorphism is functional rests in part on which 
of the two respiratory cell fines best represents the gene regulation seen in primary 
respiratory cells. H460 cells are derived from a culture of a Large Cell lung carcinoma and 
have hypotriploid karyotype with a modal chromosomal number of 58. A549 cells are
derived from a Small Cell carcinoma and have hypotriploid karyotype as well but differ in 
that they have a modal chromosomal number of 12 (Giard et al. 1973). The A549 cell was 
selected for the low levels of IL8 that are secreted in the inactivated state. However, 
examination of a number of other respiratory epithelial cell lines by the Kwiatkowski
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laboratory, including H460 cells, has shown that moderate basal expression of IL8 is more 
common. This implies that the patterns o f IL8 induction in A549 cells may be unusual 
compared with similar cell fines. However, it seems that IL8 expression in A549 cells is 
closer to that seen in primary cells. On these grounds the A549 cells appear to be a better 
model within which to study IL8 functional genetic regulation. However, in the absence of 
transient transfection experiments in primary respiratory cells the question o f function at the 
-251 polymorphism would be difficult to determine definitively.
Comparing the results of the transfection experiments with the genetic epidemiological data 
may also help us define whether the -251 polymorphism is functional. The IJL8 -251A allele 
has been associated with susceptibility to bronchiolitis (Hull et al 2000), tuberculosis (Ma et 
al 2003) enteroaggregative E.Co/i diarrhea (Jiang et al 2003), prostate cancer (McCarron et al 
2002), and greater ILS protein production (Jiang et al 2003). HuU and co-workers reported 
that the association between the ILS -251A allele and RSV-induced bronchioifitis was further 
refined by haplotype analysis. They suggested that the functional allele might fie on 
chromosomes of haplotype 2 and that the -251A may not be a functional SNP (HuU et al 
2001). However, the association with haplotype 2 was not reproduced in the context of 
these other disease states though this may have been due to the smaUer sample size used in 
these studies (Ma et al 2003, Jiang et al 2003). The data from transfection experiments in 
A549 ceUs is consistent with the most detailed genetic epidemiological data (Hull et al. 2001) 
that suggests that the -251 SNP is not functional. Moreover, the transfection studies in 
A549 ceUs do not contradict the results of haplotype-spedfic experiments in primary ceUs. 
Therefore taking the data on haplotype-spedfic expression, genetic epidemiology and ILS
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induction together it is likely that the A549 cell is a more accurate model for IL8 regulation 
and that the -251 SNP is not functional after TNF stimulation.
1 have not conducted further experiments looking to see if  any potential functional genetic 
effect at the 251 polymorphism could be seen when it was placed within the shorter IL8 
promoter constructs of 1019, 789, or 389 nucleotides respectively. It has been shown, by 
the Kwiatkowski laboratory (Figure 5.3) and others (Garofalo et al. 1996), that the shorter 
constructs have the same indudbUity in response to TN F as the longer constructs. 
Moreover, an examination of the -251 SNP within the context of the whole promoter is 
more likely to yield data that is free from experimental artifacts.
5.3.3
Transcriptional activity o f the 251 (A /T ) prom oter polym orphism  o f IL8 in  response 
to RSV stim ulation
The ludferase activity of the pRSV stimulated cells in these experiments was variable and 
below the 4 to 5 fold levds of activation previously reported (Casola et al. 2000). In H460 
cells there was no evidence of function at the -251 SNP in response to pRSV stimulation. In 
A549 cells the pRSV failed to induce any activation of the reporter gene of the -251A 
plasmid in some experiments. This produced data showing a statistically significant 
difference between the two plasmids containing the -251 SNPs. However, the levels of 
reporter gene activation were not suffidently distinct from background levels to allow us to 
have confidence in this result. However, experiments where pRSV was used in combination 
with a known concentration of a cytokine, such as IL-1 or TNF, may produce suffident
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synergistic activation of IL8 constructs. This might allow further examination of function at 
the -251 SNP in circumstances which are closer to that seen in RSV infections mw.
5.3.4
The lim itations o f  transfection experim ents in  exam ining the functional genetics o f  
SNPs
The transfection experiments described here examine the effect of a single SNP within a 
section of the 5’ flanking region of the ILS gene that is engineered into bacterial plasmid and 
then expressed within an immortal respiratory epithelial cell Hne. In addition to the 
problems of using immortalized cell lines that have been discussed above there are a number 
of other limitations to the transient transfection experimental strategy.
Transient transfection assays have a peak of reporter gene activity which occurs at 34 hours 
after transfection and 14 hours after cell activation. However, we know from studies of IL8 
transcription in A549 cells (Figure 3.4) that whilst the peak of IL8 induction after TNF 
stimulation occurs at 16 hours the peak of IL8 induction after RSV stimulation occurs as late 
as 36 hours. One of the reasons that the reporter gene induction after RSV stimulation in 
these transfection experiments was so poor could be that the peak transient transfection 
efficiency did not coincide with the peak of IL8 induction. Previous experiments (data not 
shown) have attempted to address this by reversing the order of activation and transfection 
such that cells are transfected 12 hours after activation. This resulted in some increase in 
reporter gene induction but no difference in activation between -251 SNPs. However, the 
efficiency of plasmid transfection in activated cells is much reduced (Irina Udalova, personal 
communication) which calls into question the validity of this unorthodox approach.
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Testing for the function at the reniaining SNPs is complicated by both their position in 
intronic and untranslated regions o f the ILS gene (Figure 1.6) and their location beyond the 
translational start of IL8 that occurs in exon 1. This latter factor prevents the design o f a 
construct where the remaining SNPs can be assessed in the context of the normal sequence 
of regulatory elements found in the promoter. To overcome this technical limitation EMSA 
studies were used to test for aUele-spedfic protein-DNA binding.
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5.3.5
Concluding Points
•  There is no evidence of a repressor element between nucleotides -389 and -169 of the 5’ 
flanking region o f the ]JL8 gene.
•  The -251 (A/T) polymorphism in response to TNF stimulation appears to be functional 
in H460 cells but not in A549 cells.
•  The -251 (A/T) polymorphism in response to pRSV stimulation does not appear to be 
functional in either H460 or A549 cells.
•  AUele-spedflc protein to DNA binding to the 5’ flanking region of IL8 is modulated by 
the —251A polymorphism when using nuclear extracts from H460 and A549 cell lines.
•  A constiment of the aUele-spedflc binding complex at the —251A polymorphism 
contains a major component o f about 77kDa.
•  The data from the haplotype-spedflc expression studies and the genetic epidemiology 
analysis taken together suggest that the A549 cell is a more accurate model for IL8 
regulation in primary respiratory epithelial cells. This implies that the -251 SNP does 
not make a functional contribution to haplotype-spedflc expression in vivo.
•  Testing for the function at the remaining SNPs with transfection experiments is 
complicated by both their position in intronic and untranslated regions of the ILS gene 
and their location beyond the translational start of ILS that occurs in exon 1. To 
overcome this technical limitation EMSA studies were used to test for aUele-spedflc 
protein-DNA binding.
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CHAPTER SIX
EXAMINATION OF NUCLEAR FACTOR BINDING TO SNPs IN  
THE /i^ G E N E
6.1.1
Introduction
Electrophoretic mobility shift assays (EMSA) were used to test whether the observed 
differences in primary respiratory cell haplotype-spedflc expression of IJL8 could be due to 
differential binding of transcription factors at SNPs within the IL8 haplotypes. Studies of 
the -251 polymorphism using transient transfection experiments had failed to produce clear 
evidence of function at this SNP. Testing for the function at the remaining SNPs with 
transient transfection experiments was complicated by both their position in intronic and 
untranslated regions of the IL8 gene (Figure 1.6) and their location beyond the translational 
start of IL8 which occurs in exon 1. To overcome this technical limitation EMSA studies 
were used to test for allele-spedflc protein-DNA binding. In the absence o f clear genetic 
epidemiological data to implicate a single SNP we sought to screen flve SNPs in the IL8 
gene (Intron 1: +396 G /T ; Intron 1: +781 T /C ; Intron 2: +1238 InsA; Intron 3: +1633 
T /C  and 3’end terminal: +2767 T/A) for DNA to protein interactions using EMSAs. As I 
have discussed in Chapter 5 there is evidence to suggest that the H460 cell line may not be a 
good model for IL8 gene regulation in primary respiratory cells. EMSA experiments in this 
chapter are therefore restricted mainly to using nuclear extracts from A549 cells. Where a 
spedflc transcription factor of interest was required as a positive control nuclear extracts 
from other cell lines were utilized. In the course of these EMSA experiments I wished to
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Figure 6.1 Screening for differences in allele-specific binding of nuclear proteins at 
IL8 polymorphisms using EMSAs with nuclear extracts from A549 cells after 
incubation with TNF (a) or RSV (b).
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determine whether TNF stimulation or RSV infection of A549 cells resulted in different 
patterns of allele-specific DNA-protein binding.
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Results
6.2.1
Screening for allele-speciûc binding o f nuclear factors to SNPs within the IL8 gene
EMSAs used nuclear extracts from A549 cells stimulated with TNF and probes 
corresponding to each allele of the +396, +781, +1238, +1633, and +2767 SNPs to screen 
for aHele-spedfic differences in binding. As shown in Figure 6.1a significant differential 
binding was observed only at the +781 polymorphism. This differential binding at the +781 
SNP was confirmed using nuclear extract from A549 cells stimulated with RSV (Figure 
6.1b).
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F igure 6.1 Screening for differences in allele-specific binding of nuclear proteins 
at IL 8  polymorphisms using EMSAs with nuclear extracts from A549 cells after 
incubation with TN F (a) or RSV (b).
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Figure 6.1
Screening for differences in allele-specific binding of nuclear proteins at IL8 
polymorphisms using EMSAs with nuclear extracts from A549 cells after incubation 
with TNF (a) or RSV (b). (a) When incubated with nuclear extracts from A549 cells no 
significant allele specific differences in binding could be seen at the +1238 polymorphism 
(Janes 5 and 6) and the +1633 polymorphism (Janes 7 and 8). AUele-spedfic differences in 
binding were seen at the +396 polymorphism (Janes 1 and 2) +781 polymorphism (lanes 3 
and 4) and the +2767 polymorphism (lanes 9 and 10) (indicated by the arrows). The 
spedfidty of the differential binding seen at the +396 and the +2767 polymorphisms was 
not confirmed in subsequent competition experiments (data not shown), (b) Differential 
binding at the +781 SNP was confirmed by EMSA smdies using nuclear extracts from A549 
cells stimulated with RSV (indicated by the arrow). No significant differential binding was 
seen for the +396, +1238, +1633 and the +2767 polymorphisms in nuclear extracts from 
RSV stimulated cells.
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The +2767 T /A  probe sequence contains a high proportion of adenine (A) and thymidine 
(T) bases. EMSA competition with either the poly(dI).poly(dC) non-specific inhibitor or the 
poly(dA).poly(d'I) non-specific inhibitor yielded equivocal results (data not shown). 
Optimisation experiments suggested that non-specific inhibition with both poly(dl) .poly(dC) 
and poly(dA).poly(dT) (Figure 6.2) gave the best complex resolution.
Initial EMSA experiments showed some binding of nuclear factors to the +396 and the 
+2767 polymorphisms (Figure 6.1a) that on further testing using competition proved to be 
non-specific and were not examined further. No significant differential binding was seen for 
the remaining SNPs (+396, +1238, +1633 and +2767) in nuclear extracts from RSV 
stimulated cells.
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Figure 6.2
Optimisation of EMSA of ILS 2767 SNP binding complexes in response to RSV 
infection of A549 cells. Nuclear extracts prepared from RSV-infected cells after 16 hours 
of incubation and used for EMSA. The 2767 radiolabeled probe contains a high number of 
adenine (A) and Thymidine (T) bases. In order to optimize the binding conditions with the 
correct type and concentration of non-specific inhibitor poly (dl) .poly (dC) and 
poly(dA) .poly(dT) were incubated alone at standard (0.125 mg/ml) and twice standard (0.25 
mg/ml) concentrations as well as together in the binding reaction. Optimal resolution of 
binding was achieved with both poly(dl) .poly(dC) at 0.125 mg/ml and poly(dA) .poly(dT) at 
0.125 mg/ml.
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6.2.2
Con& m ation o f allele-specific binding a t the +781 SN P b y  com petition
The specificity of binding to the +781 SNP is shown by competition experiments (Figure 
6.3). Here, complex I  was seen to bind in a constimtive manner in the presence of the 
+781T allele with non-activated, TNF-stimulated nuclear extract (Figure 6.3a, lanes 1 and 2) 
and RSV-stimulated nuclear extract (Figure 6.3b, lane 1 and 3). Complex I  was competed 
only by the +781T unlabeUed oligonucleotide in both TNF-stimulated (Figure 6.3a, lanes 3 to 
4) and RSV-stimulated nuclear extract (Figure 6.3b, lanes 4 and i). A second complex, 
complex JJ, bound constitutively to the +781C allele in the presence of TNF-stimulated 
nuclear extract (Figure 6.3a, lanes 7 and ^  at a greater affinity than the +781T allele (Figure 
6.3a, lane 1 and 2). As the degree of differential binding between alleles was less distinct this 
complex was not studied further.
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Figure 6.3 AUele-specific binding of nuclear proteins at position +781.
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Figure 6.3
Allele-specific binding o f nuclear proteins at position +781. (a) Probes were used
corresponding to the +781T allele (Janes 1 to 6) and +781C allele (Janes 7 to 12) m  EMSA 
with nuclear extracts from A549 cells harvested after no activation (NA) and after 
stimulation with TNF. UnlabeUed competitor oUgoduplex probes were added in molar 
excess as shown in lanes 3 to 6 (xlOT and xlOOT refer to xlO and xlOO molar excess of 
unlabeUed 781T probe respectively) and lanes 9 to 12 (xlOC and xlOOC refer to xlO and xlOO 
molar excess of unlabeUed 781C probe respectively). Complex I  (Cl) bound speciticaUy to 
the +781T probe. Complex II (C2) bound to the +781C probe (lanes 7 and 8) with greater 
affinity than the +781T probe (lanes 1 and 2). (b) Probes were used corresponding to the 
+781T aUele (lanes 1 and lanes 3 to 7) and +781C aUele (lane 2 and lanes 8 to 12) \n EMSA 
with nuclear extracts from A549 ceUs harvested after no activation (NA) and after 
stimulation with RSV. UnlabeUed competitor oUgoduplex probes were added in molar 
excess as shown in lanes 4 to 7 (xlOT and xlOOT refer to xlO and xlOO molar excess of 
unlabeUed 781T probe respectively) and lanes 9 to 12 (xlOC and xlOOC refer to xlO and xlOO 
molar excess of unlabeUed 781C probe respectively). Complex I  (Cl) bound specificaUy to 
the +781T probe.
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6.2.3
c-M yb was n o t dem onstrated to be a p a rt o f the com plexes binding in  the presence 
o f the +781TSN P
We searched for potential transcription factor binding sites in the +781T and +781C probes 
using a pattern search program in MATINSPECTOR (Quandt et al. 1995) that uses the 
TRANSFAC database (Wingender et al. 2000). Only in the +781T probe did we find a 
potential transcription factor binding site, in this case c-Myb, that was not present in the 
+781C probe. We found no transcription binding sites that were present in the +781C 
probe but absent in the +781T probe. The c-Myb consensus binding site, 5’-YAACNG-3’ 
(Y and N  indicate a pyrimidine and any base, respectively) has a central section (5’-YAAC-3’) 
that is essential for binding. The +781T lies in the centre of this essential transcription 
factor binding section (R: 5’-tgaaCAACtcctataag-3’; R indicates the reverse strand whilst the 
SNP is marked in bold). The c-Myb site is disrupted therefore by the change from +781T 
(R: 5’-tgaaCAACtcctataag-3’) to +781C (R: 5’-tgaaCGACtcctataag-3’).
In order to determine whether c-Myb was expressed in A549 cells a western blot was 
performed on nuclear extract firom non-activated, TNF stimulated and RSV infected A549 
cell nuclear extracts (Figure 6.4). C-Myb was not detected in A549 cell nuclear extract 
despite TNF or RSV stimulation. By contrast c-Myb was strongly expressed in Jurkat whole 
cell lysate, non-activated Jurkat cell nuclear extract and PMA stimulated Jurkat cell nuclear 
extract.
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Figure 6.4
Western Blot of c-Myb protein in Jurkat cell lysate, Jurkat cell nuclear extract and 
A549 cells nuclear extract. When assayed using anti-c-Myb antibody c-Myb protein 
(arrow) was detected in Jurkat whole cell extract (WC) (Jane /), nuclear extract stimulated 
with PMA (PMA) (Jane 2) and non-activated (NA) nuclear extract (Jane 3). No c-Myb protein 
was detected in A549 nuclear extract derived from non-activated (NA) (Jane 4), TNF (TNF) 
stimulated (lane 5) and RSV (RSV) stimulated (Jane 6) nuclear extracts. Jurkat cells were 
activated with PMA at 50 ng/ml for 20 hours. A549 ceUs were infected with RSV at an MOl 
of 1 and incubated for 24 hours. A549 ceUs were stimulated with TNF at 5 ng/m l for 24 
hours. Equal amounts of protein from control and activated cells were assayed using anti-c- 
Myb clone 1-1 antibody. The molecular mass (in kDa), determined by co-electrophoresed 
standards, is indicated on the right.
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The absence of the c-Myb protein from A549 nuclear extract precludes the transcription 
factor being part of the allele-specific binding complex (Cl) noted to be binding in the 
presence o f the +781T SNP (Figure 6.3), However, I wished to test whether the 
TRANSFAC predictions of binding were correct and wondered whether c-Myb may play a 
role in IL8 gene regulation in primary lymphocytes. To test these hypotheses 1 conducted 
studies of DNA-protein interaction using nuclear extract derived from Jurkat cells. In this 
cell line binding appeared to be less specific for both the +781T and +781C probes as Cl 
binding to the +781T probe was competed by 100 fold molar excess of unlabeUed +781C 
probe whUst C2 was competed by 100 fold molar excess of the unlabeUed +781T probe 
(data not shown).
In contrast, as shown in Figure 6.5a, there was avid {lane 1) and specific binding {lane 3) to a 
probe containing the c-Myb consensus sequence (Cl) but not to the probe containing the 
mutated c-Myb sequence (lane 6). Furthermore, as demonstrated in Figure 6.5b, supershift 
bands were observed when the c-Myb consensus sequence probe was incubated in the 
presence o f two different anti-c-Myb antibodies (lane 5 and lane 9). No supershift bands 
were seen in the presence of anti-c-Myb antibodies and the mutated c-Myb consensus 
sequence probe, the +781T probe or the +781C probe. Incubation of the c-Myb consensus 
probe and mutated c-Myb consensus sequence probe with non-specific antibody (anti-NFKB 
p65) resulted in no supershift bands (data not shown).
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As two other members o f the Myb family of transcription factors, A-Myb and B-Myb, share 
the same DNA binding domain (DBD) I sought to test whether the ubiquitously expressed 
B-Myb may be binding to the +781T probe. However, incubation of either the +781T or 
the +781C probe with and B-Myb antibodies did not result in supershift bands (data not 
shown). From these data I can conclude that c-Myb is present in Jurkat nuclear extract and 
does bind to the c-Myb consensus probe. However, neither the c-Myb nor B-Myb proteins 
bind in the presence of the +781T or the +781C SNPs in vitro.
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Figure 6.5
c-Myb does not bind in the presence of the +781T SNP in Jurkat cell nuclear extract
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Figure 6.5 c-Myb does not bind in the presence of the +781T SNP in Jurkat cell 
nuclear extract, (a) Probes were used corresponding to the c-Myb consensus sequence 
(wUdtype, wt) {lanes 1 to 5) and the mutated c-Myb consensus sequence (mutant, mt) (lanes 6 
to /O) in EMSA with nuclear extracts from Jurkat cells harvested after stimulation with 
PMA. UnlabeUed competitor oUgoduplex probes were added in molar excess as shown in 
lanes 2  to 5  and in lanes 7 to 10 (xlOwt and xlOOwt refer to xlO and xlOO molar excess of 
unlabeUed c-Myb wUdtype probe respectively; xlOmt and xlOOmt refer to xlO and xlOO 
molar excess of unlabeUed c-Myb mutated probe respectively). Complex /  (C1) bound in a 
specific manner to the c-Myb wUdtype probe as it was competed only by 100 molar excess of 
c-Myb wUdtype competitor probe (lane 3). (b) c-Myb wt (lanes 1, 5  and 9), c-Myb mt probes 
(lanes 2, 6  and 10), +781T probes (lanes 3, 7 and 11) and +781C probes (lanes 3, 7 and 11) 
were incubated in the absence (lanes 1 to 4) and presence of anti c-Myb antibodies (anti c- 
Mybl: clone 1-1: lanes 5  and S', c-Myb2: M-19: lanes 9 to 12). Complex I  (C1) is present after 
incubation with the c-Myb wt probe (lane 1). Supershifted bands (indicated by SS__) formed 
with both anti c-Myb antibodies are seen only in the presence of the c-Myb wt probe (lanes 5  
and 9).
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6.2.4
C /E B P p  is  pa rt o f  the complex binding in the presence o f  the +781T SNP
Inspection o f the sequence surrounding the +781 SNP showed that a C/EBP P consensus 
binding site (5’-RTTGCCGYAAY-3’, where R= A or G and Y= C or T) (Osada et al 1996) 
was present on the forward strand o f the +781T allele (GTTGTTCAA'IJ but was disrupted 
on the +781C allele (GTCGTTCAAT). 1 tested whether C /EBP P was present in the 
nuclear extracts of A549 cells. As a control 1 looked for C/EBP p in Jurkat cells as well as 
in COS cells transfected with a vector expressing C /EBP P (Figure 6.6). C /EBP P was 
found in both A549 and Jurkat nuclear extracts.
1 tested whether C /EBP P was a component of the allele-spedfic constitutively binding 
complex I  seen on the +781T probe in A549 cells by using specific antibodies to C /EBP p. 
1 observed a partial reduction in complex I  band intensity and a shifted band (Figure 6.7a, 
lane 2), whereas incubation of anti-C/EBP p antibody with the +781C probe had no effect 
(lane 4). By contrast, when this experiment was repeated in Jurkat cells (Figure 6.7b) there 
was no supershifted band present after incubation of the +781T probe with anti C /EBP P 
antibodies (lane 2) despite the presence of C /EBP P in the nuclear extracts. As there was 
only a partial reduction in the complex I  band binding to the +781T probe in A549 nuclear 
extract (Figure 6.7a) and no evidence of C/EBP P binding in Jurkat nuclear extract we 
sought to confirm C/EBP p specific binding to the +781T probe.
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Figure 6.6. C/EBP P is present in nuclear extracts from A549 and Jurkat cells. A 50
kDa band was detected on assay by Western blot for C/EBP P in A549 {lane 1) and Jurkat 
{lane 2) cell nuclear extract. C /EBP P was also detected in untransfected COS-7 cell nuclear 
extracts (lane J) and strongly detected in transfected COS-7 cell nuclear extract (lane 4). The 
molecular mass (in kDa), determined by co-electrophoresed standards, is indicated on the 
left.
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Figure 6 .7 C /EBP P binds in the presence of the +781T allele but not the +781C 
allele in A549 but not Jurkat nuclear extracts
Figure 6.7 C/EBP P binds in the presence of the +781T allele but not the +781C 
allele in A549 but not Jurkat nuclear extracts (a) EMSA showing nuclear extract firom 
A549 cells after incubation with probe in the absence (Janes 1 and 3) or presence of 
antibodies (Janes 2 and 4) to C /EBP p. Complex I  (Cl) is present after incubation with the 
+781T probe (Jane 1). A supershifted band (indicated by SS.J formed with the anti-C/EBP 
P antibody is seen only in the presence of the +781T probe (Jane 2) (b) EMSA showing 
nuclear extract firom Jurkat cells after incubation with probe in the absence (^ /anes 1 and 3) or 
presence of antibodies (Janes 2 and 4) to C /EBP p. Complex I  (01) is present after 
incubation with the +781T probe (Jane 1 and 2) whilst Complex 11 (02) is present after 
incubation with the +781C probe (Jane 3 and 4). No supershifted bands (indicated by SS_) 
formed with the anti-C/EBP P antibody.
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I performed additional experiments using whole extracts from COS-7 cells previously 
transfected with a vector expressing C /EBP P (Figure 6.8, lanes 2, 3, 5, 6) or an empty vector 
(Figure 6.8, lanes 1, 4). A complex binding to the +781T probe was seen only in the 
presence of expressed C/EBP p (Figure 6.8, lane 2) and this was supershifted by specific 
antibodies to C /EBP P (lane 3). By contrast, little binding of C/EBP P was seen in the 
presence of the +781C probe when incubated with the same whole COS-7 cell extract 
containing C/EBP P (lane i). Incubation of nuclear extracts with non-specific antibodies 
(anti-p65 NF-kB and anti-Oct-1) resulted in no supershifted bands (data not shown).
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Figure 6.8 Preferential binding of C/EBP P to the +781T allele but not the +781C 
allele confirmed. Whole ceU extract from COS-7 cells was incubated with probe in the 
absence {lanes 1, 2, 4 and i)  or presence of antibodies to C/EBP P {lanes 3 and 6). Cells were 
transfected with a plasmid construct expressing C /EBP P {lanes 2, 3, 5 and 6) or an empty 
vector {lanes 1 and 4). Complex I (C1) is seen only in the presence of both the +781T probe 
and C/EBP P protein expression {lane 2) and is supershifted significantly (indicated by S S ^  
when incubated with anti-C/EBP P antibody (^ iane 3).
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Discussion
6.3.1
Through a systematic examination of the DNA-protein interactions associated with the five 
SNPs in the IL8 gene I have shown that there is specific differential binding only between 
the +781T and +781C alleles. I have demonstrated that C/EBP P was a part of the 
complex I  which bound in a constitutive manner spedficaUy in the presence of the +781T 
allele. These data suggest that C/EBP P may bind to haplotype 2 which is associated with 
susceptibility to RSV-induced bronchiolitis but not to haplotypes 1 and 3 (Figure 1.6) which 
have no disease association. Moreover, C /EBP P did not bind to the +781T probe in 
Human T  lymphoblastic leukemia Jurkat cell nuclear extract, a fifiding which is compatible 
with the observation that there was no haplotype-spedfic expression of LL8 in primary 
lymphocytes.
In screening the five polymorphisms in the UL8 gene for DNA-protein interactions we 
acknowledge that this is strictly a test o f differential binding between alleles and does not test 
for function at an SNP. Furthermore the allele-spedfic nature o f that binding occurs in the 
absence of the chromatin and the normal architecture o f the nudeus. Therefore, more data 
is required on the spedfidty and functionality of C /EBP p binding to the +781T 
polymorphism in vivo. Moreover, further experiments would be required to eluddate why 
despite the presence of C /EBP P in both A549 and Jurkat ceU nuclear extract in vitro binding 
of C /EBP P only occurred in the former.
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6.3.2
Predictions o f  c-Myb binding to the +781T allele
In order to identify candidate transcription factors that would exhibit allele-specific binding 
to the +781 polymorphism we used predictions firom the MATINSPECTOR/TRANSFAC 
program. The suggestion that the c-Myb factor could bind to the +781T allele alone was 
biologically plausible. The c-Myb transcription factor is a sequence specific DNA-binding 
protein that plays an essential role in the development of the haematopoietic system (Graf 
1992) being expressed at high levels in the immature haematopoietic cells and down 
regulated at terminal differentiation. However, c-Myb also functions in non-haematopoietic 
cells as it is present during mouse development in the neural retina and airway epithelium 
and remains at high expression in adult tissues associated with rapid proliferation such as the 
hair follicles and gastrointestinal crypts (Sitzmann et al. 1995; Ess et al. 1999). The 
involvement of c-Myb in developing airway cells was of particular interest to our 
investigation of IL8 regulation in the airways of infants. In addition to its role in 
differentiation c-Myb, in association with other regulatory factors such as the CAAT- 
enhancer protein family (C/EBP), regulates genes relevant to the immune response such as 
lysozyme (Ness et al. 1993), myeloperoxidase (Bristos-Bray and Friedman, 1997) neutrophil 
elastase (Oelgeschlager et al. 1996) and cytokines (Kowenz-Leutz et al. 1997).
Contrary to the predictions of the MATINSPECTOR/TRANSFAC program (Wingender et 
al. 2000) neither c-Myb nor the ubiquitously expressed B-Myb, with which it shares the same 
DBD, bound to the +781T probe. I acknowledge that the
MATINSPECTOR/TRANSFAC profile predicts the likelihood that the sequence in 
question is a binding site rather than the binding affinity at that site. Quantitative prediction
147
of DNA-protein interactions using principal coordinates analysis systematically fitted to 
experimental data has been shown to have greater accuracy than the profile based models 
(Udalova et al. 2002) and could be o f use in assessing other transcription binding sites at or 
close to SNPs of interest.
6.3.3
C /E B P P  binding to the +781Tallele
It was the close association of c-Myb to C /EBP P which lead me to inspect the sequence 
close to the +781 polymorphism more closely for potential C /EBP P binding sites. 
C/EBP P is an important candidate transcription factor in influencing RSV-induced 
bronchiolitis pathogenesis as it has an important general role in the regulation of 
inflammation (Poli 1998) and is strongly induced by inflammatory stimulants such as TNF 
(Akira et al 1997) and RSV (Jamaluddin et al 1996). Detailed studies of ILS expression have 
shown that AP-1, IFN regulatory factor (IRF)-l and C /EBP P are all necessary for RSV- 
induced induction of the ILS promoter (Casola et al 2000, Mastronarde et al 1996). 
Moreover NF-kB and C/EBP P binding at the promoter synergistically activate ILS in 
response to TNF (Matsusaka et al 1993). Intriguingly, I found that C/EBP P binds to the 
haplotype that has significantly increased transcription. To our knowledge recruitment of 
C/EBP P has not previously been modulated by an intronic polymorphism. It is possible 
that C/EBP P could influence transcription from this location either by interacting with 
NF-KB through long-range interactions with the promoter as has been shown for c-Myb 
(Tahirov et al 2002) or through interaction with components o f the RNA transcript-
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associated heterogeneous nuclear ribonucleoprotein (hnRNP) complexes such as hnRNP K
(Miau et al 1998).
6.3.4
Concluding Points
•  O n systematic screening for allele-specific binding of nuclear factors to SNPs within the 
ILS gene significant differential binding was observed only at the +781 polymorphism.
• This aUele-spedfic binding was seen at the +781 polymorphism with both RSV 
stimulated A549 cell nuclear extract as well as TNF stimulated nuclear extract.
•  c-Myb was not demonstrated to be a part of the complexes binding in the presence of
the +781T SNP.
•  C /EBP P was found in both A549 and Jurkat nuclear extracts.
•  C /EB P P binds in the presence of the +781T allele but not the +781C allele in A549 
nuclear extracts and when over-expressed in COS whole cell extracts.
•  Notably C /EBP P is not part of the complex binding in the presence of the +781T SNP 
in Jurkat nuclear extracts.
•  These data suggest that C/EBP P may bind to haplotype 2 which is associated with 
susceptibility to RSV-induced bronchiolitis but not to haplotypes 1 and 3 which have no
disease association.
C /EB P P did not bind to the +781T probe in Human T  lymphoblastic leukemia Jurkat
cell nuclear extract, a finding which is compatible with the observation that there was no
haplotype-spedfic expression of IL8 in primary lymphocytes.
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CHAPTER SEVEN
DEMONSTRATION OF REGULATORY POLYMORPHISMS 
MODULATING HAPLOTYPE-SPECIFIC EXPRESSION USING  
HaploChIP
7.1.1
Introduction
In the preceding chapters I have established that IJL8 exhibits haplotype-specific 
expression which suggests a functional explanation for the association between 
haplotype 2 and RSV-induced bronchiolitis disease severity. Moreover, within 
haplotype 2 there is aUele-specific binding o f a transcription factor, C /E B P P known for 
its role in immune regulation. However the extent to which functional effects at an 
individual SNP within the IL8  gene can be established is limited by a number o f technical 
factors. Firstly, the European population structure o f the IL8  gene consists o f a mirror 
haplotype. Examination o f this structure gives Httie indication o f which SNPs are hkely 
to be functional in vivo. Secondly, only one o f the SNPs is present within the transcript. 
This prevents verification o f in vivo haplotype-specific expression with a second marker. 
Thirdly, five o f the six SNPs in the haplotype are located after the translational start site 
o f the gene. This means that in vitro transfection experiments would use constructs that 
tested SNP function outside the normal sequence o f regulatory elements.
The central aim o f this thesis was to explore the extent to which SNPs, alone or in 
combination, influence the transcriptional regulation o f genes that play a critical role in
150
the immune response. Given the limitations to the ILS  and RSV-induced bronchiolitis 
model 1 sought to progress the central objective o f the thesis using a different model 
system. 1 wished to demonstrate the principle o f SNP mediated gene regulation in vivo 
using a novel technology developed in our laboratory, namely haplotype-specific 
chromatin immunoprécipitation (haploChlP) (Knight et al 2003). This technique was 
applied to the tumor necrosis factor/lym photoxin-a (TN F /LTA) locus as there was data 
demonstrating haplotypic diversity in this region. It was our hope that once the utility o f 
haploChlP was demonstrated at the TN F/LTA  locus we could apply this technique to 
the problem o f understanding what effect the non-coding SNPs may have on modulating 
IL8  transcription.
The haploChlP technique has proved to be a sensitive method for detecting SNPs that 
affect gene regulation in vivo. Moreover the haploChlP method can do so even when 
there is no suitable genetic marker within the transcript as haploChlP uses the binding 
and activation o f transcriptional proteins as a surrogate maker o f transcription. For 
instance, for synthesis o f the transcript to occur RNA polymerase 11 (Pol 11) must be 
phosphorylated on specific serine residues in the C-terminal domain (CTD) after which 
the enzyme is released from the initiation complex. Within the CTD, phosphorylation o f 
the SerS marks the transition from mRNA initiation to elongation (Komamitsky et al 
2000). This is in constrast to phosphorylation at Ser2 which occurs at a later stage in 
elongation (Cho et al 2001). CTD phosphorylation o f SerS denotes also the beginning o f 
RNA capping (Schroeder et al 2000). The importance o f phosphorylation within the 
CTD has been verified by experiments which show that that the amount o f 
phosphorylated Pol 11 detected within chromatin is correlated with the transcription at 
that gene (Weeks et al 1993).
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Critical to the flexibility o f haploChlP is the ability o f this technique to demonstrate 
aUele-specific expression in genes where there are no transcribed markers. As shown in 
Figure 7.1, the haploChlP technique starts by crosslinking the activated Pol II protein to 
the DNA  through the use o f formaldehyde. Then through sonication the chromosomes 
are sheared to D NA fragments with a mean length o f less than 3 kilobases. The DNA 
fragments attached to Pol II are then retrieved through immunoprécipitation using 
antibodies specific for the SerS and Ser2 CTD forms o f Pol 11. These 
immunoprecipitated DNA fragments are then amplified by PCR and distinguished by 
primer extension (PE). Then, the relative abundance o f the two alleles, which were 
bound to Pol 11, are determined by MS. The size o f the DNA  fragments determines the 
distance at which the marker can be detected through the immunoprécipitation o f 
activated Pol 11. The technique is likely to be more sensitive where the genetic marker 
and the cross-linked protein are close to each other.
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Figure 7.1. Schematic diagram demonstrating the quantitation of differential 
protein-DNA binding in  vivo by HaploChlP. D N A  binding proteins are cross linked 
to the DNA with formaldehyde after which the DNA  is sheared through sonication. 
Fragments bearing cross-linked proteins o f interest are retrieved by immunoprécipitation. 
The bonds between the proteins and antibodies are reversed after which the crosslinks 
between proteins and the DNA are broken. The relative abundance o f alleles can then 
be measured by PE/M S. Diagram reproduced from Knight and co-workers, Nature 
Genetics 2003 and used with permission from the author.
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The HaploChlP approach was used to show differences in the amount o f Pol II bound 
to different alleles o f L T A  encoding lymphotoxin which were closely correlated with 
aUele-specific expression (Knight et al 2003). In this instance an aHele-specific difference 
was observed by quantitation o f LTA+252 (through haploChlP) and o f the marker 
LTA+723 found in the L T A  transcript. The haplotype carrying the LTA+252G  and 
LTAT123K  alleles could be functional as it was associated with higher L T ^l expression. 
However, closer inspection o f  the data reveals that the LTA^+252G allele may not in 
themselves be functional. Instead, the aUele-specific function may derive from other 
differences between the m ost common haplotype that did not contain the LTAl+252G 
allele and the other haplotype that did (Figure 7.2). Further detailed analysis o f the 
T N F /L T A  locus identified the LTA+SOA allele as being associated with reduced LTA 
protein production in human EBV immortalised B cells (Knight et al 2004). In addition 
chromatin immunoprécipitation confirmed that Activated B cell Factor-1 (ABF-1) bound 
only in the presence o f the low producing LTA+SOA allele m vivo (Knight et al 2004). I 
sought to confirm this finding, in collaboration with Julian Knight, by conducting a 
detailed analysis o f the T N F /L T A  haplotype clades described (Figure 7.2) using 
haploChlP. We hoped to demonstrate that there was reduced transcription at the 
LTA+SOA allele in accordance with the suppression o f protein production that has 
previously been reported. If  demonstrated this observation would be consistent with the 
conclusion that SNPs acting within a haplotype could modulate gene regulation m vivo at 
the level o f transcription and that these haplotype specific differences in transcript cause 
significant variation in the protein production.
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T
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2 LTA-293 0.423 ACC°/aCCT G G A G G G G
3 LTA+W 0.269 TCC°/aCAC 0 0 G G G G G
4 L 74+80 0.461 CCC^/aGCA C 0 0 0 C C C
5 LTA+252 0.269 ATG%TTC S S A A A A A
6 L74+368 0.461 G C F /cTCT G G S s G G G
7 L74+438 0.269 CTG(TCn) 9 9 9 9 10 10 10
8 774+495 0.269 GTG%GTG T T T T C C C
9 L74+723 0.269 GCA /^aCCT 0 0 C C C c C
10 7A/F-1031 0.231 AGAhcGAA T T T T s s ü
11 7/VF-863 0.154 CCC%CTT C 0 C C A C c
12 7/VF-308 0.173 ATG°/aGGA G A G G G G G
Figure 7.2. H ap lotyp e structure at the T N F /L T A  locu s. Cloning and sequencing of a 
lO-kb region of the locus spanning TNF and TTA  revealed 14 SNPs. Twelve of the SNPs that 
occurred at an allele frequency of greater than 0.1 in die 26 lymphocyte lines tested are shown 
together with their corresponding haplotypes. Minor allele frequencies are shown as well as the 
haplotype frequencies at the top of the clade columns. Designation of the polymorphisms refers 
to the nucleotide position relative to the translational start site. SNPs that uniquely define clades 
are shown as follows (white lettering): Clade A is defined by LTA+lOA, LTA+2S2G and 
LTX +723A ; Clade B is defined by L T 4 + 8 0 A  and L7M +368C; and Clade C L7M +438(10), 
LTA+495C and TNF-1032C. Adapted published figures (Knight 2003, 2004) used after 
permission from the author.
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Results 
7.2.1
O ptim isation and veriGcation o f  the haploC hlP m ethod for high through p u t 
chromatin production
In order to undertake a systematic investigation o f haplotype-specific expression at the 
TN F/L.TA  locus 23 EBV immortalised B cell lines from the CEPH repository were 
cultured. These lines were then stimulated with PM A/Ionomycin to initiate JLTA 
expression and then cross-linked with formaldehyde at time points o f 0, 30, 120 and 360 
minutes. To generate sufficient chromatin for the study the standard protocol for 
haploChlP (Knight et al 2003) had to be scaled up by four fold. This necessitated a 
number o f changes to the standard protocol.
Firstly, the sonication equipment and conditions were altered. The micro-tip used 
previously was changed to a medium-tip so that efficient sonication would occur in a 
larger volume o f extracted nuclear suspension. In addition, the sonication regime was 
changed from 30 second bursts o f which six were at setting 4 and six at setting 6. Here 
40 cycles (4 second burst with 8 seconds pause) at an amplitude o f 20% followed by 40 
cycles (4 second burst with 8 seconds pause) at an amplitude o f 30% were used. I sought 
to ensure that this modified sonification strategy provided firagments o f the expected 
average length o f less than 3 kilobases. As shown in Figure 7.3, sonication under these 
conditions produced fragments ranging from under 400 base paies to over 10,000 base 
pairs. However, the most significant band was seen at about 1.5 kilobases.
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Figure 7.3. Demonstration of DNA fragments size after sonication of extracted 
nuclear suspension. A sample o f DNA fragments obtained from nuclear extraction of 
selected CEPH EBV immortalized B cells is shown. Samples were diluted with N- 
laurosarcosine (Sigma) to 0.5% and run on a 1.4% TBE agarose gel. Electrophoresis o f 
standard size markers of DNA (DNA ladder, DL) is displayed in lanes 1 and 22. In aU 
cases fragments vary in size between 400 base pairs (bp) and over 10 kilobases (kb) with 
the main band occurring at about 1.5 kilobases.
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Secondly, the requirement for a Caesium Chloride (CsCl) column for final purification o f 
the chromatin fragments was likely to be a significant rate limiting step to the processing 
o f larger volumes o f chromatin as ultra-centrifugation over twenty hours was required. In 
addition limited volumes o f material could be placed on the CsCl column. Chromatin 
was prepared for immunoprécipitation with and without CsCl purification. The resulting 
DNA was tested for aUele-specific expression to ensure that the previously published 
observation o f an effect associated with the LTA+252 SNP was reproduced with or 
without CsCl column purification. As shown in Figure 7.4, there appears to be 
significant aUele-specific expression associated with the LTA+252 polymorphism when 
using DNA  fragments that have been purified both with and without CsCl column 
purification. Within this cell hne, however, the allelic ratio shows that greater L T A  
transcription is associated with the LTA+252A  allele and not the LTA+252G  allele. 
Based on this experiment there appears to be no difference between DNA fragments 
prepared by CsCl column purification and those which are not. Therefore the CsCl 
column purification was dropped from the protocol. However, the association o f greater 
L T A  transcription with the LTA+252A  allele as compared with LTA+252G  in the 
context o f haplotypes C and A respectively, is a novel observation. This observation 
does not contradict recent findings suggesting that the LTA+SOA allele found in 
haplotype B has a suppressor effect on LTA protein production (Knight et al 2004).
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Figure 7.4. Allele specific loading of phosphorylated Pol II in  vivo at LTA  after 
chromatin preparation with and without CsCl purification. The ratio o f 
phosphorylated Ser 5 Pol II loading between alleles A and G  at the LXA+252 SNP is 
shown for a single B cell hne, heterozygote for haplotypes A and C, after stimulation 
with PMA/ionomycin over time. DNA fragments were purified with (a) and without 
(b) CsCl column purification. In each case the mean ±  the standard error o f the mean is 
shown for four independent PCR amphfication reactions each o f which was spotted four 
times on a chip for PE/M S. Genome represents the LTA+252 aUehc ratio for genomic 
DNA.
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7.2.2
LTA+80, LT A +367andL TA +723 are independendy associated with 
allele-speciûcpolym erase loading
It has been previously shown (Knight et al 2003, Knight et al 2004) that twelve 
polymorphic sites present within the T N F /L T A  locus, at an allele frequency o f greater 
than 10% could be used to define three major haplotype clades across the T N F /L T A  
locus (Figure 7.2). For the work presented in this chapter six SNPs were used, namely 
LTA+10, LTA+80y LTA+252, LTA+368, LTA+725 and TNF-1031, as markers for 
the haplotype clades. In order to investigate the relationship between genetic variation at 
the L T A / TNF  locus and Pol II loading the 23 B cell lines previously cultured, stimulated 
and cross-linked were typed to determine their haplotype-clade. O f the 23 B cell lines 16 
were shown to be heterozygous for two o f the three clades under study. 
Haplotype-specific Pol II loading at 0, 30, 120 and 360 minutes after PMA/ionomycin 
stimulation was then assayed using haploChlP. In conducting these experiments it was 
important to control for experimental variation between SNP assays across cell lines and 
for systematic allelic difference in PE/M S signal intensity. To do this we paired genomic 
DNA and haploChlP DNA from the same cell line for assay o f each SNP by PE/M S. 
The genomic D NA ratio was used to prove a correction factor for systematic differences 
in signal intensity for each assay. This correction factor was applied equally to both 
genomic DNA and haploChlP DNA. To account for variation between experiments the 
haploChlP D NA ratio at each time point was divided by the mean genomic DNA  ratio 
for each assay within that cell line.
In the first instance univariate linear regression was used to investigate whether any the 
six marker SNPs were significantiy associated with haplotype-specific loading o f Pol II. 
O f the six SNPs assayed only three SNPs, LTA+80 (^<0.0001), LTA+367 (/)=:<0.0001)
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and LTA+723 (p=<0.0001) were significantly associated with aUele-specific expression. 
However, the high linkage disequilibrium across the L T A  locus means that an SNP on 
univariate analysis could appear to be functional when in fact it is acting as a marker for 
an adjacent SNP to which it is closely linked. To test whether these three SNPs had 
independent effects on Pol II loading LTA+10, LTA+80 and LTA+723 were tested 
together in a multivariate regression model. As shown in Table 7.1, all three appeared to 
be independently associated with aUele-specific expression o f LT A .
SNP Coefficient Standard Error 95% Confidence interval p  value
z r ^ + 8 0 -0.102 0.029 -0.159, -0.044 0.001
LTA+367 0.181 0.038 0.107, 0.255 <0.0001
LTA+723 -0.182 0.034 -0.249, -0.115 <0.0001
Table 7.1. Multivariate regression model of haploChlP DNA ratio against SNP.
Linear regression o f haploChlP (dependent variable) against SNPs in the L T A  locus 
which occur at an allele frequency o f over 10% and which were independendy associated 
with aUele-specific polymerase loading.
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7.2.3
Polym orphism s LTA +80 and LTA+367 are associated with tim e dependent 
reduced haplotype-specific polym erase loading
We sought to determine which o f the alleles on the LTA+80, LTA+367 and LTA+723 
polymorphisms were associated with functional effects. As shown in Figure 7.2 
LTA+80A  and LTA+368C  define clade B whilst LTA+723A  is found in clade A and 
TNF-1031C is found in clade C. The haploChlP experiments generated data in the form 
o f haplotype ratios. In order to understand the relationship o f haplotype clades A, B and 
C to each other I compared haplotype ratios that shared a common denominator. 
Therefore, a comparison o f A to B could occur by regression o f A /C  with B /C . 
Similarly, A to C can be compared with regression analysis o f A /B  against C/B.
As shown in Figure 7.5a comparison o f haplotype clade B, containing alleles LTA+SOA, 
LTA+368C  and LTA+723C, with haplotype clade A (LTA+80C, LTA+368G  and 
LTA+723A) shows that there appears to be significandy reduced polymerase loading 
associated with clade B at 120 minutes after induction (A/C 1.44, B /C  1.07;7>=<0.00G1) 
and at 360 minutes after induction (A/C 1.44, B /C  1.05; jf)=0.005). This is consistent 
with previous data that demonstrated a repressor effect associated with LTA+80A. By 
contrast, as shown in Figure 7.5b when clade A (containing LTA+723A) was compared 
with clade C (containing LTA+723C) there was no significant differences in polymerase 
loading at either 120 minutes (A/B 1.05, C /B  0.97; J>=0.067) or 360 minutes (A/B 0.99, 
C /B  1.00; p —0.737). The absence o f a difference in polymerase loading between clades 
A and C confirms the results o f the univariate and multivariate analyses which suggested 
that polymorphisms LT A + \0, LTA+252 and TNF-1031 may not have functional 
genetic properties. Furthermore it implies that the allele LTA+723C  present in clades C
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and B may not have functional properties when separated from the alleles LTA+80A  
and L,TM+368C found on clade B.
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Figure 7.5 Comparison over tim e ofhaplotype-speciG cloading o f  phosphorylated  
polym erase II.
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Figure 7.5 Comparison over tim e ofhaplotype-speciG cloading o f  phosphorylated  
polym erase II. (a) Over time haplotype-specific ratios o f polymerase loading were 
measured in cell lines heterozygous for haplotypes A  and C and compared to cells 
heterozygous for haplotypes B and C. Significantiy greater polymerase loading was 
associated with haplotype A when compared to B at 120 fA /C  1.44, 95% Cl 1.63, 1.25; 
B /C  1.07 95% Cl 1.00, 1.14; ^=<0.0001) and 360 minutes (^A/C 1.44, 95% Cl 1.71, 
1.18; B /C  1.05 95% Cl 0.98, 1.13; 7^ —0.005). (b) Over time haplotype-specific ratios o f 
polymerase loading were measured in ceh fines heterozygous for haplotypes A and B and 
compared to cells heterozygous for haplotypes C and B. N o significant differences in 
polymerase loading were seen associated with haplotype A when compared to C at either 
120 CA/B 1.05, 95% Cl 0.99, 1.11; C /B  0.97 95% Cl 0.93, 1.02; p ^O M l) or 360 
minutes C*A/B 0.99, 95% Cl 0.92, 1.06; C /B  1.00 95% Cl 0.95, 1.05; p^O .lS l). Data is 
represented as means with 95% confidence intervals.
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Discussion
7.3.1
L im ita tio n s o f  th e  IL 8  lo cu s as a  m o d el o f  in  vivo  h ap lo type-specific  transcrip tion
This thesis aims to test the hypothesis that natural variation in the genome, in the form 
o f single nucleotide polymorphisms, influenced the regulation o f genes critical to the 
immune response. A mechanism for this would be by influencing gene regulation at the 
level o f transcription by changing the affinity with which transcription factors bind to 
that site. 1 reasoned that this small but significant alteration in gene expression produced 
differences in the protein production that would alter the individuaTs susceptibility to 
common disease states. Exploration o f IJL8 gene regulation in the context o f RSV- 
induced bronchiolitis disease severity has demonstrated some but not aU o f these 
principles. RSV-induced bronchiolitis disease severity is linked with increased lung 
inflammation. 1 have shown that a haplotype o f IJL8 associated with host disease 
susceptibility has significantly greater expression in primary respiratory cells m vivo and 
that this haplotype is associated with allele-specific binding o f C /E B P P in vitro. 
However, 1 do not have data on how lL-8 protein production in respiratory cells relates 
to the two most common haplotypes in the European population. Moreover, 1 have not 
been able to resolve with certainty which o f the SNPs within the IL8  haplotype, acting 
alone or in concert, have functional properties in vivo. 1 reasoned that the HaploChlP 
technique may be able to resolve the extent to which non-coding polymorphisms 
modulate IL8  transcription. However, prior to applying HaploChlP to IL8  1 sought to 
optimise the method at the L T A /T N F  locus. Having achieved this aim 1 proceeded to 
explore the extent to which non-coding polymorphisms affect the previously 
demonstrated haplotype-specific expression seen at the L T A  gene.
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7.3.2
H aploC hlP  a t the LTA locus as m odel o f  in  vivo haplotype-speciG c transcription
However, the study o f the T N F /L T A  locus as a model system has served to 
demonstrate the central hypotheses o f the thesis more fully. The LTA+252 SNP has 
been associated with both susceptibility to infection (Struber et al. 1996, Majetschak et al.
1999) and inflammation (Yamaguchi et al. 2001, Badenhoop et al. 1992) as well as other 
conditions such as asthma (Albuquerque et al. 1998, Moffatt et al 1997) and myocardial 
infarction (Ozaki et al. 2002). Studies o f transcript and polymerase loading suggest that 
there appears to be increased allele-specific transcription at the L T A  locus associated 
with the haplotypes carrying the LTA+252G  allele (Knight et al. 2003). Further study o f 
the L T A  locus refined the functional location at the L T A  locus to the LTA+368C  and 
LTA+80A  alleles and showed that these SNPs appeared to determine reduced L T A  
protein production (Knight et al. 2004). Moreover, it was demonstrated that the 
transcriptional repressor ABF-1 was recruited to bind in the presence o f the LTA+80 
polymorphism both in vitro and in vivo. Finally, the recruitment o f ABF-1 has been 
shown to suppress reporter gene expression in vitro (Knight et al. 2004). The findings 
presented here confirm that the LTA+80A  and LTA+368C  polymorphisms are 
functional determinants o f haplotype-specific LTA protein production but more critically 
demonstrate that this haplotype-specific regulation occurs in vivo at the level o f 
transcription. The time dependent nature o f the reduced polymerase loading associated 
with the LTA+80A  and LTA+368C  polymorphisms is compatible with the recruitment 
o f transcriptional repressors such as ABF-1 to that haplotype. These data serve also to 
demonstrate that the LTA+10, LTA+252 and the TNF-1031 polymorphisms do not 
appear to have a functional role.
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The role o f the LXA+723 polymorphism in governing haplotype-specific LX A  protein 
production is less certain. Previously, the L.TA+723 was found to be individually 
associated with LTA protein production. However, this association did not remain true 
when the LTA+723 polymorphism was analysed within the context o f a stepwise linear 
regression model (Knight et al. 2004). In this study the LTA+723 has been associated 
with allele-specific polymerase loading in both univariate and multivariate models. This 
suggests that the association with polymerase loading detected at this locus is not merely 
a function o f the fact that the LTA+723C  allele is closely linked to the LTA+80A  and 
LTA+368C  polymorphisms. However, on testing the relationship o f polymerase loading 
to the haplotype clades the LTA+723C  allele did not appear to exhibit a functional effect 
when tested against the LTA+723A  allele seen in haplotype clade A. This suggests that 
the LTA+723C  allele only becomes functional when on the same haplotype as the 
LTA+80A  and the LTA+368C  polymorphisms. It is possible therefore that in addition 
to influencing the binding o f transcriptional factors such as ABF-1 these three 
polymorphisms act in concert to influence the binding o f other factors necessary for the 
regulation o f transcription. These data suggest therefore that the functional unit for 
modulation o f gene regulation by D NA  variation should occur at the level o f the 
haplotype as an analysis based on individual SNPs could prove to be misleading.
7.3.3
Comparison o f  haploC hlP as a m easure o f  function a t a haplotype as com pared  
with assays o f  transcript orprotein  abundance
An important caveat is that functional genetic properties were detected at the 
LTA+723C  allele using polymerase loading, which acts as a surrogate for transcriptional 
activity, when no such function was established between this allele and protein 
production. It is possible that there may be differences in the sensitivity o f these two
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methods to detect function at polymorphisms within haplotype clade B. Given that gene 
regulation governed by polymorphisms appears to occur at the level o f transcription it is 
possible that the functional properties o f polymorphisms are more readily detected when 
using tests o f polymerase loading. This is because haploChlP measures a ratio o f RNA 
polymerase loading between alleles which may be a more accurate reading o f 
transcription than the steady state concentration o f transcript or protein at any given 
time point. Moreover, the functional ‘signal’ attributed to a polymorphism may be 
‘dampened’ by factors influencing transcript abundance and through other regulatory 
methanisms affecting translation and protein export This could mean that 
polymorphisms that contribute to gene regulation only within the context o f other 
functional polymorphisms may be detected more readüy through haploChlP than 
through assays o f transcript abundance or through ELISA studies.
7.3.4
Differences in  the examination o f  haplotype-speciG c expression in  an individual 
as com pared to a population
By including all the haplotypes from the diverse population structure o f the T N F /L T A  
locus it is possible to begin to make general inferences about the factors governing 
haplotype-specific gene expression at this locus. A number o f other studies have noted 
that haplotype-specific expression varies between individuals (Bray et al 2003, Lo et al 
2003, Yan et al 2002, Cowles et al 2002). In the optimisation o f the haploChlP 
technique 1 have shown in one B cell line a consistent increase in allele-specific 
polymerase loading associated with the LTA+2S2A  allele in the context o f haplotypes A 
and C (Figure 7.4). Such aUele-specific loading was not demonstrated in a B cell line o f 
the same genotype in previously pubhshed data (Knight et al 2003). The difference 
between studies in aUele-specific polymerase loading in cells o f the same genotype might
169
be a fiinction o f random experimental variation. However, the design o f the studies we 
have conducted at the TN F /LX A  locus is highly conservative in that random variation at 
individual polymorphisms is less likely to produce significant effects when considered 
within the context o f the other polymorphisms that define the three haplotype clades in 
the chromosomes assayed. Alternatively, differences in allele-specific polymerase loading 
in cells o f the same genotype might imply that there are other epigenetic, host /ra^r-acting 
and environmental factors that also influence allele-specific transcription. However, the 
detection o f haplotype-specific influences on gene expression across 32 chromosomes 
suggests that despite the potential presence o f other influences iu these experiments gene 
regulation through polymorphic variation is the predominant factor.
The inclusive approach adopted here for gene expression is in contrast to previously 
published studies o f aUele-specific expression in human cells (Yan et al 2002, Bray et al 
2003, Lo et al 2003). Yan et al. (2002) examined 13 genes in 96 individuals from the 
CEPH families. They identified allelic variation in 6 o f the 13 genes studied with the 
ratio o f transcripts varying from between 1.3 to 4.3. However, the number o f individuals 
exhibiting such variation ranged from only 3 to 30%. N o analysis is made o f the 
significance o f aUele-specific expression at a given gene across all individuals possessing 
an informative heterozygous genotype. Similarly, Bray et al. (2003a) screened 19 subjects 
and found aUele-specific differences in seven o f the 15 genes expressed in brain tissue. 
However, in five o f the genes assayed aUele-specific expression was seen in only one o f 
the 19 subjects. Here again, it is unlikely that aHele-specific expression at a gene would 
be considered significant if  it were assessed in the context o f the whole study population 
instead o f at the level o f the individual. Lo and co-workers used a microarray method 
called HuSNP oHgo array to screen 602 genes fiom seven individuals for allele-specific
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differences in expression. They found that 326 genes (54%) showed preferential 
expression o f one allele in at least one individual. O f the subset o f these 23 genes shown 
in the article 9 genes do not preferentially express the same allele in 80% o f the samples 
assayed. In that same subset 17 out o f the 23 genes were not aHele-specificaUy expressed 
in the majority o f the individuals.
The finding that allele-specific expression is consistently observed in a minority o f 
individuals may stül yield important information about gene regulation. However, the 
attraction o f genetic epidemiology and functional genetic investigations lies in part in the 
potential for discovering fundamental mechanisms o f genetic regulation around which 
drug and vaccine development can occur. If  functional genetic studies reveal means o f 
genetic regulation that are restricted to a small number o f individuals then the scope for 
applying these findings to the development o f a therapeutic intervention is limited.
7.3.5
Lim itations and strengths o f  the haploChIP data dem onstrated a t the LTA  locus
The data presented here in this chapter would be strengthened by further experiments. 
Firstly, the haplotype-specific effects observed for polymerase loading and protein 
production should be verified with the addition o f data on transcription abundance. 
Secondly, the role o f the LTA+36S and LXA+723 polymorphisms in iufluencing 
expression at haplotype clade B requires further study. The means by which these 
polymorphisms may interact with transcriptional factors bindiug in the presence o f 
JLTA+80, needs to be clarified.
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In conclusion, this chapter demonstrates the utility o f haploChIP as a means o f assaying 
polymerase loading. It demonstrates that polymerase loading can be a powerful tool in 
dissecting the functional properties o f haplotypes with a diverse population structure. 
The work demonstrates the principle that natural genetic variation alters the 
transcriptional regulation o f genes critical to the immune response and that this alteration 
in transcription is consistent with differences in protein expression. Together with the 
haplotype-specific data on IL8 shown in Chapter 4, this chapter demonstrates that 
differences in haplotype-specific expression can be detected across whole study 
populations with the relevant genotype. It also shows that HaploChIP could be suitably 
applied in future to the study o f gene regulation at the IL8  gene. This implies that the 
functional basis o f in vivo haplotype-specific expression may occur through ^-acting 
regulatory mechanisms that are modulated by polymorphisms in the DNA. Moreover, 
the haploChIP experiments detailed here suggest that functional polymorphisms may be 
located not only in the 5’ untranslated region o f the gene but also within intronic regions.
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7.3.6
Concluding Points
•  The haploChIP method can be optimised for high through-put chromatin 
production.
•  LTA+80, JLTA+367 and LTA+723 are independently associated with aUele-specific 
polymerase loading.
•  Haplotype B defined by the polymorphisms L.TA+80 and JLXA+367 is associated 
with time dependent reduced haplotype-specific polymerase loading.
•  CTL4+723C allele on haplotype B may only become functional when on the same 
haplotype as the JLTA+80A and the LTA+368C  polymorphisms.
•  These data suggest that the functional unit for polymorphic modulation o f gene 
regulation occurs at the level o f the haplotype.
•  Given that gene regulation governed by polymorphisms appears to occur at the level 
o f transcription it is possible that the functional properties o f polymorphisms are 
more readily detected when using tests o f polymerase loading.
•  The demonstration o f haplotype-specific expression across whole smdy populations 
implies that some o f the functional basis o f in vivo haplotype-specific expression may 
occur through ^-acting regulatory mechanisms that are modulated by 
polymorphisms in the DNA.
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CHAPTER EIGHT
T H E S I S  S U M M A R Y  
8.1
This thesis explores the extent to which natural variation in DNA sequence may influence 
the transcriptional regulation o f genes that play a critical role in the immune response to 
infection. Using both novel in vivo and traditional in vitro techniques this thesis seeks to 
demonstrate that functionally important genetic variation may facilitate our understanding of 
disease associations. In this thesis I chose to examine Respiratory Syncytial Virus (RSV) 
infection as it is common and has a robust genetic association with disease severity. The 
principal determinant of that disease severity is believed to be the host immune response.
An increasing number of smdies have shown associations between single nucleotide 
polymorphisms (SNPs) simated in or close to candidate genes and differences in disease 
severity. Until recently demonstrating the functional genetic basis for this has been limited 
by a number of factors. Firstly, smdies relying only on in vitro assays o f protein-DNA 
interaction and plasmid reporter gene expression take no account of the regulatory nature o f 
the normal chromatin structure of DNA. Secondly, modulation o f gene regulation could 
depend on the interaction o f combinations of SNPs on an allele (the haplotype) whereas 
these same in vitro assays tend to analyse SNPs in isolation. In this thesis three methods of in 
vivo aUele-specific quantitation o f gene expression are used, namely Mutant analysis by PCR 
and restriction enzyme cleavage (MAPREC), primer extension mass spectrometry (PE/MS) 
and haplotype-specific chromatin immunoprécipitation (haploChIP). I used these methods
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to measure haplotype-specific transcription in living human primary cells. This was achieved 
by analyzing cells fiom individuals heterozygous for SNPs that acted as markers to 
distinguish between alleles. In cells heterozygous for an SNP marker, it was possible to 
determine the relative differences in expression between the two alleles. I proceeded to try 
and determine the molecular mechanism for haplotype-specific expression due to specific 
SNPs using in vitro assays o f protein-DNA interaction and plasmid reporter gene expression 
in immortalised cell hnes.
IL-8 has been implicated in the pathogenesis of RSV-induced bronchiolitis as it may play a 
role in the activation and migration o f neutrophils that characterize the inflammatory 
infiltrates seen in the airways of affected individuals. Previously, the Kwiatkowski laboratory 
has described an association between bronchiolitis disease severity and a common single 
nucleotide polymorphism 251 base pairs (bp) upstream (-251) upstream of the IL8 
transcription start site. Further smdies defined this finding further by demonstrating that a 
specific IL8 haplotype comprising six SNPs
(-251A/+396G/+781T/+1238deLA/+1633T/+2767T, haplotype 2) was associated with 
RSV-bronchiolitis disease severity. This second smdy suggested that the —251 SNP may not 
be functional and that the association was refined by the addition o f the +781 SNP.
In this thesis I investigated the functional basis for this association by measuring haplotype- 
specific transcription in vivo through MAPREC and PE/M S in human primary cells. When 
assayed by PE/M S I found a significant increase in the transcript level derived from the IL^ 
haplotype 2 relative to the mirror haplotype 1
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(-251T/+396T/+781C/+1238insA/+1633C/+2767A). This difference in
haplotype-specific expression was seen in respiratory epithelial cells but not in lymphocytes.
I proceeded to investigate the extent to which an immortalized cell Une, heterozygote for 
haplotypes 1 and 2, was an adequate model for in vivo allele-spedfic expression. Contrary to 
the result seen in primary respiratory cells the Human H460 pulmonary epithelial cell line 
(H460), showed increased haplotype-specific expression of haplotype 1. However, on 
examination of the H460 karyotype with fluorescent in situ hybridization it become clear that 
there were gross irregularities in both the chromosome 4 number and in the 11^ copy 
number in the H460 genome. The results o f in vivo haplotype-specific expression smdies in 
this cell line were therefore difficult to interpret accurately.
The -251 polymorphism is the only SNP in the haplotype to occur prior to the translational 
start site o f IL8. I used in vitro reporter gene experiments containing the —251 
polymorphism, in the context o f the +1409 nucleotides prior to the transcriptional start site, 
to examine this SNP for allele-spedfic differences in reporter gene expression in two cell 
lines. A significant increase in transcription was associated with the -251T polymorphism in 
H460 but not in A549 cell lines. Furthermore differences in protein-DNA binding were 
seen at the -251 polymorphism between the H460 and A549 cell lines. The results o f the 
transcription experiments in H46G cells were consistent with the haplotype-spedfic data 
derived from the same cells. However, as ndther the haplotype-spedfic data nor the 
transfection experiments in H460 cells accurately reflected what was seen in the primary 
respiratory cells this cell line was not used further.
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For the remaining SNPs that were located beyond the translational start site of IL8 I tested 
the hypothesis that the observed differences in haplotype-specific expression seen in primary 
respiratory cells could be due to differential binding of transcription factors at SNPs within 
the IL8 haplotypes. To do this, electrophoretic mobility shift assays (EMSA) were used to 
systematically screen for allele-spedfic differences in DNA-protein binding. When using 
A549 nuclear extracts, significant differences in protein-DNA binding were seen only at the 
+781 polymorphism. Inspection o f the sequence surrounding the +781 SNP showed that a 
C /EBP P consensus binding site was present on the forward strand of the +781T allele but 
was disrupted on the +781C allele. A western blot showed that C/EBP P was present in 
A549 nuclear extract. In this same extract, supershift assays showed that C/EBP p binds to 
the +781T but not to the +781C polymorphism. The spedfic binding o f C /EBP P to the 
+781T probe was confirmed using whole extracts from COS-7 cells previously transfected 
with a vector expressing C/EBP p. Intriguingly, therefore a transcription factor assodated 
with the activation of genes central to the immune response appears to bind in vitro to the 
+781T allele found on the high producing IL8 haplotype 2. These data suggest that the 
mechanism for IL8 regulation may occur through differences in protein-DNA binding at 
functional polymorphisms within the IL8 haplotype 2.
I investigated the nuclear extract of Human lymphocytic Jurkat cells in an attempt to define 
a mechanism for absence o f allele-spedfic expression in primary lymphocytes. A western 
blot showed that C/EBP P was present in Jurkat cell nuclear extract. However, in supershift 
assays of Jurkat cell nuclear extract C /EBP P bound to neither the +781T allele nor the
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+781C allele. It is possible, therefore that the cell specific nature o f IL8 regulation may 
occur through differences in C/EBP P binding.
The unusual micror haplotype structure of IL8 in European populations gave Httie indication 
o f which SNP within the haplotype was likely to be functional in vivo. In order to 
demonstrate the principle that a non-coding polymorphism may alter transcriptional 
regulation in vivo I smdied a second model system namely the tumor necrosis 
factor/lymphotoxin-a (TNF/LTA) locus with a novel technique. The haplotype-specific 
chromatin immunoprécipitation (haploChIP) technique developed in the Kwiatkowski 
laboratory to measure differences in the loading o f RNA polymerase between alleles in 
EBV-immortalized B lymphocytes. The loading of RNA polymerase reflects the 
transcriptional activity of the gene and was used to define allele-specific gene expression in 
the absence of a coding polymorphism. It was this critical attribute that made it a suitable 
method with which to dissect the extent to which non-coding polymorphisms might 
modulate IJL8 regulation. Optimisation o f the HaploChIP technique exploited the diverse 
haplotype structure o f the TN F /LTA  locus and the knowledge that aUele-spedfic 
expression occurred on LT A  induction to test for the presence o f functional 
polymorphisms. A previous smdy has demonstrated that the LTA+80A  allele is associated 
with low protein production through the recruitment of the transcriptional repressor protein 
Activated B cell Factor-1 (ABF-1). I extended this observation by demonstrating that 
allele-spedfic RNA polymerase loading was independently associated with the LTA+80, 
LTA+368 and LTA+723 polymorphisms. This association was refined to demonstrate that 
the polymerase loading at this locus appeared to be determined in vivo by the LTA+80A  and 
LTA+368C alleles both o f which occur on the same haplotype. These data may imply that
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functional SNPs act in concert to influence transcription. Moreover, I infer that the 
functional basis for aUele specific effects at critical candidate genes wül have to be dissected 
in vivo at the level of the haplotype. HaploChIP has therefore shown itself to be a suitable 
method with which to understand the extent to which polymorphisms from within the IL8 
locus might alter transcription at that gene.
In summary therefore, this thesis provides evidence in vivo for haplotype-specific expression 
at the IL8 locus that may explain the functional basis o f the observed genetic association 
with RSV-bronchiolitis disease susceptibility. In vitro smdies suggest that allele-specific 
binding o f C/EBP P may be a factor in the in vivo haplotype-specific expression seen in 
primary respiratory cells. In a different in vivo model system I demonstrated that functional 
polymorphisms acting from within a haplotype can influence the degree to which RNA 
polymerase binds to an allele. Taken together these findings support the conclusion that 
genetic polymorphisms in non-coding DNA may influence the transcriptional regulation o f 
genes important to the host’s susceptibility to common infectious diseases.
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APPENDIX 1
SYNERGISTIC INDUCTION OF NITRIC OXIDE BY CYTOKINES AND RSV
INTRODUCTION
A l.l l
The role o f  nitric oxide in lung inflammation
Nitric Oxide (NO) is a highly reactive biological mediator with a broad range of roles which 
include smooth muscle relaxation, neurotransmission, inflammatory and immunosuppressive 
effects as well as trie modulation of cytokine and criemokine production (Bogdan 2001). 
There is increasing evidence that nitric oxide (NO) plays a key role in both the physiological 
and pathological processes in trie airways o f the lung (Barnes 1995).
NO is produced from conversion of L-arginine and molecular oxygen to dtruUine and NO 
by NO  synthase (NOS). There are three types o f NOS, neuronal NOS (NOSl), inducible 
NOS (NOS2) and endothelial NOS (NOS3). N O Sl and NOS3 are known collectively as 
constimtive NOS because unlike NOS2 they exist as constimdvely expressed proteins which 
are regulated by calcium fluxes and calmodulin (Nathan et al. 1994) as well as at trie level of 
transcription (Forstermann et al. 1998). Constimtively expressed NO is thought to act as a 
bronchodüator, a potent vasodilator o f pulmonary circulation of trie lung and may riave 
some role in mucociliary clearance (Jain et al. 1993). Its expression is not restricted to 
neurons and endothelial cells. In contrast NOS2 expression is regulated by cytokines. For 
instance, human type II alveolar epithelial cell Hnes (A549) express NOS2 and produce NO  
when stimulated with a combination of IL-ip, T N Fa and IFNy (Asano et al. 1994). NOS2 
expression is determined by de novo synthesis and stabiHty o f NOS2 mRNA and protein. In
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addition, NOS2 produces NO  at a high amplitude and is thought to function principally in 
response to infection. However, recent evidence suggests that all three isoforms of NOS 
have a role in the immune system (Bogden 2001).
Al.1.2
Role o f  inducible nitric oxide synthase in infectious disease
NO has a wide variety of actions in infection. N O has direct effects on microbes through 
the formation of free radicals, such as peroxynitrite (ONOO ), which peroxidate membrane 
lipids, inhibit protein synthesis and mutate DNA. However, NO has a number of indirect 
functions such as cytokine regulation which may play an important role in the host response 
to infection. For instance, o f relevance to the marked leukocyte response seen in RSV- 
induced bronchiolitis is the way in which NO  can inhibit the activity o f IL-8 (Sato et al.
2000). However, the expression o f NOS2 in some infections is associated with a severe 
disease outcome through mechanisms such as NO-mediated cytotoxicity, induction o f T  cell 
apoptosis or from the generation o f viral escape mutants (Akaike et al. 2000).
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Al.1.3
Role o f  inducible nitric oxide from A549 cells in Respiratory syncytial vim s infection
Recent reports have shown NO production from human A549 cells in response to 
stimulation with unpurified respiratory syncytial virus (RSV) both with (Tsutsumi et al. 1999) 
and without the addition o f exogenous cytokines (Kao et al. 2001). However, RSV infected 
A549 cells produce IL-8, interleuldn-la (IL-la), interleukin-1 P (IL-IP) and tumor necrosis 
factor a  (TNFa) (Patel et al. 1995, Patel et al. 1998). It is not clear from these experiments 
whether production o f NO  is due to the presence o f contaminating cytokines in the cellular 
component o f the viral preparation or whether the virus itself can directly induce NO.
R E S U L T S
Al.2.1
Synergistic induction o f  N itric Oxide b y  Cytokines and RSV
RNI concentration was assayed in the supernatant of cells cultured in media alone (control), 
cells infected with purified RSV alone, cells treated with cytokines and from cells infected 
with purified RSV which were also treated with exogenous cytokines. As shown in Figure 
A .l, A549 cells infected with purified RSV produced little NO. When incubated with 
cytokines they produced significantiy more RNI than uninfected cells incubated with 
cytokines alone (mean RNI 28.5 pM (SE 1.9) and 21.3 pM (SE 2.1) respectively, p = 0.025). 
Adjustment of the RNI for protein content, as shown in Figure A.2, demonstrates that A549 
cells infected with purified virus alone do produce significantly more NO  than controls 
(111.3 nM /pg (SE 25.2), 65.3 nM /pg (SE 4.9) respectively, p = 0.01). There was no
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significant RNI production in cells exposed to inactivated RSV (data not shown). RNI 
production was inhibited with a 1 mM concentration of L-NMMA (data not shown).
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Figure A l.l. Mean Reactive Nitrogen Intermediates in A549 cell supernatants exposed to 
purified RSV, Cytokines and RSV with Cytokines for 72 hours. Vertical bars represent the 
standard errors of the mean for duplicate readings from five separate experiments.
* p = 0.025
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Figure A1.2. Mean Reactive Nitrogen Intermediates corrected for protein content in A549 
ceU supernatants exposed to purified RSV, Cytokines and RSV with Cytokines for 72 hours. 
Vertical bars represent the standard errors of the mean for duplicate readings from two 
separate experiments, fp  = 0.01, ijip = <0.001
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D IS C U S S IO N  
Al.3.1
We have shown that infection with purified RSV produces relatively little N O  from A549 
cells at 72 hours in the absence o f exogenous cytokines, despite evidence o f viral protein 
expression at 24 hours and syncytia formation thereafter. This is in contrast to a previous 
report o f relatively high levels o f N O production when the same cell line is stimulated with 
unpurified viral preparations (Kao et al. 2001). This may be due to the removal during virus 
purification o f known NO-activating cytokines such as T N F a and IL -ip  both of which are 
present in unpurified RSV preparations grown on HEp2 cells within our laboratoryD
Wfiien exogenous cytokines were added to A549 cells however, we observed that NO  
production was substantially increased by infection with purified virus. Synergistic induction 
of NO production has previously been demonstrated for combinations of cytokines (Asano 
et al. 1994), for hepatitis B virus with cytokines (Majono et al. 1998) and for unpurified RSV 
with cytokines (Tsutsumi et al 1999). These data suggest that the ability o f RSV to induce 
NO production by respiratory epithelial cells may depend more on a cytokine cascade than 
on a direct stimulation effect of the virus.
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